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Vscientific environment
The Department of Pharmacy and Biotechnology (FaBiT), at the University of Bo-
logna (founded in 1088), promotes and coordinates research and education in the 
chemical-pharmaceutical-technological, biomedical, biotechnology, organic and 
biological molecules.
Prof. Brigidi’s research group is involved in the study of the gut microbiota by the 
most advanced molecular methods, in the perspective of the modulation and the 
promotion of human gut health and are pioneers in the use of probiotics for the tre-
atment of gastrointestinal functional disorders and have contributed to the develop-
ment of new probiotic strains utilized in clinical trials.
The Fondazione Edmund Mach in San Michele all’Adige is an institution with a 
history dating back more than 140 years, specialising in research, training and 
the transfer of technology in the agricultural, food and environmental sectors. The 
Fondazione Edmund Mach (FEM) is a private research center established by the 
government of the Autonomous Province of Trento (PAT). The Center of Resear-
ch Institute (CRI) is organised in five Departments (divided in Research Groups 
and Technological Platforms) and one Research Consortium. Its goals are sharing 
knoledge and to contribute to economic growth, social development and the overall 
improvement of quality of life. The Nutrition and Nutrigenomics (NN) group, where 
I worked, is part of the Research and Innovation Centre (CRI), Food Quality and 
Nutrition Department (DQAN). The aim of NN group is to measure how food and 




This study aims to measure the impact of protein and amino acid fermentation 
on the composition and metabolic output of gut microbiota. Although dissimila-
tory pathways have been described for most amino acids, microbial degradation 
routes within the gut microbiota are relatively unexplored. The objectives were (1) 
to characterize amino acid breakdown by the  colonic microbiota, (2) to determine 
the fermentation products formed from individual amino acids/protein (3) to exami-
ne how amino acid metabolism is impacted by the presence of a fermentable fiber 
(prebiotic inulin) and finally (4) to evaluate with an in vivo model (trout fish) diet:-
microbe interactions and the development of gut microbiota during fish farming. 
Interactions between the healthy human intestinal microbiota of the distal colon 
and different combinations of nutrients were simulated using in vitro pH-controlled 
anaerobic batch cultures of human faeces. Combining high-throughput sequen-
cing of 16S rRNA amplicons, with high-throughput 1H NMR, changes in faecal 
microbiota composition and metabolic output were measured. During exogenous 
substrate microbial fermentation (e.g. beef, Trp or fish feed) in the large bowel 
bioactive compounds (harmful or beneficial) are produced. Many factors affect the 
gut-microbial metabolism including pH, type and quantity of growth substrate (e.g. 
protein/carbohydrate) and make up of the gut microbiota. Considerable interindivi-
dual variation was observed in response to different digested substrates but over 
all, the beneficial impact of prebiotic fiber fermentation on production of bioactive 
compounds from amino acids/proteins was confirmed in this study. In trout, althou-
gh our dietary intervention with essential oils had little impact on the gut microbiota, 
the study showed for the first time a dramatic shift in the composition and diversity 
of the gut microbiota in juvenile, compared to adult fish. Thse observations may 
have relevance in designing dietary strategies to reduce chronic diseases like colon 
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Introduction
1Human beings have communities of microorganisms in different parts of the body, 
such as in the surface or deep layers of the skin (skin microbiota), the mouth (oral 
microbiota), the vagina (vaginal microbiota) and so on, but the majority of micro-
organisms,  an estimated 100 trillion microorganisms, reside in the gut (Backhed, 
2005). The gut microbiota is the global microbial community inhabiting the gastroin-
testinal tract (GIT) of all animals with an organised intestine. It is composed of a 
wide variety of microbial species and strains that interact with one another and with 
the host. Total numbers of microbial cells in the body outnumber the human cells by 
a factor of ten (Abbott, 2016; Savage et al., 1977). What is really interesting is that 
the genetic diversity and functional capabilities of all these micoorganisms together 
is massive. Bacteria add about 8 million genes to the 22 000  genes of the human 
genome (Ravel et al., 2014). This “metagenome” therefore has a great influence on 
host metabolic capabilities and it is not surprising that it is now recognised to play 
an important role in host health and disease.  
1.1 The gut microbiota  
2
Fig. 1 Human microbiome
31.1.1 Gut microbiota development during early life
It appears that closely related individuals have more similar microbiota composi-
tion than unrelated people and both genetic and environmental factors play a role 
in the acquisition and maintenance of the gut microbiota (Turnbaugh et al., 2009). 
All of our bacteria come from the environment initially (with other people included 
as part of our environment), so a mother and daughter are likely to be exposed to 
the similar microorganisms both via contact with each other and contact with their 
shared environment (Faith et al., 2013). The genetic influences impacting on these 
interactions are highly complex and have not been fully worked out. 
Microorganisms  are everywhere. Even the statement that fetuses remain sterile in 
the womb has recently come under scrutiny (Funkhouser and Bordenstein, 2013). 
Early studies found low numbers of mainly facultative anaerobes in amniotic fluid, 
especially from mothers with membrane disruption, but were limited by a relian-
ce on culture based methodologies, which only detect a tiny fraction of microbial 
diversity under natural conditions (Miller et al., 1980). Umbilical cord blood from 
healthy neonates, born by elective cesarean section, was investigated and found to 
harbour bacteria belonging to the genus Enterococcus, Streptococcus, Staphylo-
coccus, or Propionibacterium (Jiménez et al., 2005). More recently,  meconium, 
which is the earliest “faeces-like excretion” composed of materials ingested during 
the gestation, was shown to contain a complex microbiota, predominantly of gene-
ra Enterococcus and Staphylococcus (Jiménez et al., 2008; Moles et al., 2013). Me-
conium appears to contain a specific microbiota from which you can infer specific 
condition of the baby (e.g. Serratia - strongly associated with neonatal immaturity), 
as well as hospital-related parameters (e.g. antibiotherapy and mechanical venti-
lation) (Moles et al., 2013). Finally, fetal membranes analyzed by broad-range 16S 
rDNA PCR, resulted positive for bacteria known to reside in the vaginal, gastroin-
testinal or respiratory tract including Ureaplasma parvum, Lactobacillus crispatus, 
Fusobacterium spp., Pantoea spp. and Eubacterium rectale (Jones et al., 2009). 
Although microorganisms have been observed associated with these habitats even 
before or very shortly after birth, indicating that the gastrointestinal tract might not 
be sterile in utero, all studies agree numbers are very low and it is not until birth that 
a significant colonization of the gastrointestinal tract takes place.
Almost immediately upon exiting the uterus, babies are exposed to a number of 
microorganisms from their mother (from vaginal and intestinal tracts) and also 
microorganisms from their immediate environment (handling physicians, surfaces, 
etc.) which rapidly colonize their skin and intestine (Gilbert, 2014). Generally, due 
4to the abundance of oxygen in the neonatal gut, facultative anaerobes, mainly 
Enterobacteriaceae, Enterococcus, and Streptococcus species, represent the first 
colonizers. The Escherichia coli, Enterococcus faecalis, and Enterococcus faecium 
are commonly found, followed by Klebsiella and Enterobacter, and more rarely and 
transiently, Aeromonas, Pseudomonas, Acinetobacter, α-hemolytic Streptococcus, 
and coagulase-negative Staphylococcus. The gradual consumption of oxygen in 
the gut promotes the proliferation of obligately anaerobic bacteria, such as Bifi-
dobacterium, Bacteroides, and Clostridium, followed by Veillonella, Eubacterium, 
and Ruminococcus species. Many factors determine the make up of the infant 
gut microbiota including, mode of delivery (vaginal delivery or caesarian section) 
(Bäckhed et al., 2015; Jakobsson et al., 2014), full-term or pre-term birth (Groer et 
al., 2014), maternal diet (Paul et al., 2016; Gohir et al., 2015), health status (inclu-
ding autoimmune diseases, perinatal antibiotic exposure, diabetes and stress) (So-
derborg et al., 2016; Persaud et al., 2015) and even body weight (Santacruz et al., 
2010). Babies born vaginally have been shown to be colonized predominantly by 
Lactobacillus in the first few days, whereas in cesarean delivered babies potentially 
pathogenic bacteria typically found on the skin and in hospitals, such as Staphylo-
coccus and Acinetobacter appear to be more commonly encountered (Neu and Ru-
shing, 2011). Infant diet also plays a critical role in shaping the composition of the 
infant gut microbiota both in terms of species present and their relative abundance. 
Infants fed human breast milk rapidly develop a microbiota dominated by species 
of bifidobacteria. Breast milk contains many different factors which influence the 
gut microbiota, not least immune molecules (like leukocytes, immunoglobulins and 
lactoferrin) (Hassiotou et al., 2013) and non-digestible oligosaccharides, which 
escape digestion in the upper gut and act as specific growth substrates for bifido-
bacteria further along the alimentary canal (Ballard and Morrow, 2013). Commonly, 
infants fed formula milk have significantly higher counts of faecal Clostridium and 
Streptococcus species, Bacillus subtilis, Bacteroides vulgatus, Veillonella parvula, 
Lactobacillus acidophilus, Escherichia coli, Pseudomonas aeruginosa, Enterococ-
cus faecalis, and Atopobium, but lesser amounts of Lactobacillus rhamnosus and 
staphylococci, compared to breast fed infants (Guaraldi and Salvatori, 2012). Such 
differences between breast fed and formula fed infants, are particularly evident in 
earlier studies, while more recent studies, especially with modern feed formulations, 
which often contain prebiotics, show these differences in microbiota composition 
and relative abundance to be less obvious. 
5Recently, breast milk too has been shown to possess a distinct microbiota itself 
made up predominantly of species of Bifidobacterium (Wickramasinghe et al., 2015) 
and also species of staphylococci, streptococci and lactic acid bacteria (Fernández 
et al., 2013). This breast milk microbiota is suggested to act in the manner of an 
inoculum for the developing infant, assisting the successional development of the 
gut microbiota and possibly mediating vertical transmission of certain species from 
mother to infant. It remains debated, however, where these bacteria come from, 
with data supporting both maternal origin, via the blood stream possibly in immune 
cells, or via colonisation of the mothers breast from the infant itself during suckling 
(Fernández et al., 2013; Martı́n et al., 2004). In either case, viable bacteria (usually 
bifidobacteria and lactobacilli), have been isolated from breast milk during breast 
feeding, highlighting the importance of breast feeding, in the successional develop-
ment of the gut microbiota and infant health. 
Colonization early in life may have lasting implications for health, especially in terms 
of immune function, metabolic diseases risk and even for proper brain develop-
ment. The American Academy of Pediatrics in 2013 noted that prematurity and 
hospitalization were associated with higher prevalence of Clostridium difficile an 
opportunistic gut pathogen and that antibiotic treatment in early life has been as-
sociated with decreased numbers of bifidobacteria and Bacteroides. Finally, infants 
with older siblings have slightly higher numbers of bifidobacteria compared with 
infants without siblings (Committee on infectious diseases, 2013; Penders et al., 
2006). Similarly, close contact with animals, both farm animals (Sjögren et al., 2009) 
and companion animals (dogs especially), has been shown to impact on the com-
position of the gut microbiota in children and is suggested to help train the immune 
system to respond appropriately to new immunological stimuli (Azad et al., 2013).
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81.1.2 Microbiota distribution along the GI tract
The microorganisms that inhabit the intestine have a complex and sometimes 
dichotomous relationship with the host. Through their activities they influence many 
aspects of human physiology and disease risk. In fact, one could view the human 
intestine as an organ that was largely shaped by its microbiota during evolution. 
This theory is supported by findings that some members of the intestinal microbiota 
at least, e.g. Bacteroides thetaiotaomicron, occupy stable ecological niches within 
the gut, despite dietary changes and attack by the human immune system (Com-
stock and Coyne, 2003). Furthermore, Bacteroides thetaiotaomicron is also able 
to modulate the expression of several human genes implicated in host metabolic 
pathways, illustrating direct microbiota regulation of host physiology  (Zocco et al., 
2007). Moreover, the microbiota performs functions which the host is not been able 
to carry out alone, such as polysaccharide break down, which represents the main 
energy source for the intestinal microbiota, about 50% of the energy required for 
the gut wall and about 10% of human daily energy intake (Cummings and Macfar-
lane, 1997). This production of energy, mainly from the microbial fermentation of 
non-digestible carbohydrates or fibers, may be especially important where diets are 
low in calories and high in fiber, such as traditional Mediterranean diets and rural 
African diet (De Filippo et al., 2010). 
The human body influences its microbial community creating different habitats and 
niches along the gut by modulating levels of moisture, oxygen, bile acids, pH, dige-
stive secretions and interactions with the immune system (Boon et al., 2014). The 
intestinal microbiota changes, both in number and in species composition, along 
the alimentary canal from mouth to anus (Goktepe et al., 2006). The mouth micro-
biota shows predominance of Gram-positive aerobic and anaerobic cocci (Neut et 
al., 1985). In the oral cavity of newborns, Streptococcus are the pioneer organisms, 
followed by colonization by Actinomyces, Veillonella, Fusobacterium, Porphromo-
nas, Prevotella, Treponema, Nisseria, Haemophilis, Eubacteria, Lactobacterium, 
Capnocytophaga, Eikenella, Leptotrichia, Peptostreptococcus, Staphylococcus, 
and Propionibacterium (Avila et al., 2009). Low abundances and transitory microor-
ganisms populate the esophagus (pH < 4.0) including Bacteroides, Gemella, Mega-
sphaera, Pseudomonas, Prevotella, Rothia spp., Streptococcus, Veillonella (Liu et 
al., 2013). The predominant phyla found in the stomach (pH 2) are: Streptococcus, 
Lactobacillus, Prevotella, Enterococcus and Helicobacter pylori (Andersson et al., 
2008; Bik et al., 2006). Duodenal is the first section of the small intestine and the 
most abundant phyla encountered are: Firmicutes, Proteobacteria, Bacteroidetes, 
9Actinobacteria, and Fusobacteria (Li et al., 2015). The small intestine is designed to 
promote a fast flow of contents a feature that has the effect of discouraging micro-
bial growth by washing microorganisms through before they can establish themsel-
ves. From duodenum towards ileum numbers, microbial diversity and the propor-
tion of anaerobes all increase. In the jejunal and ileum microbial communities mainly 
comprise streptococci, lactobacilli, γ-Proteobacteria, Enterococcus and Bacteroi-
des group. Most of the species are facultative anaerobes and acid-tolerant (Hayashi 
et al., 2005). Towards the end of the ileum, the lumen is colonized prevalently by 
streptococci, enterococci and coliforms, while in the mucosa, obligate anaerobes, 
such as Bacteroides spp., Clostridium spp., Bifidobacterium spp., increase in relati-
ve abundance (Booijink et al., 2010). 
The flow of contents through the colon is slow and microorganisms can easily 
establish themselves and reach concentrations that are high enough to make up at 
least 30 percent of human colonic contents by weight. In the colon, bacteria per-
form an important role in metabolising food components which escape digestion in 
the stomach and small intestine. They also metabolise material such as mucin and 
enzymes secreted into the lumen by the host and the host epithelial cells from the 
gut wall, which slough off continuously into the intestinal lumen. The colon contains 
a vast and complex microbial ecosystem. In humans, the vast majority of microor-
ganisms inhabiting the large intestine are bacteria. Protozoa are seldom detected in 
healthy people but yeasts and other fungi can sometimes be recovered, although 
their cell population densities are low (Macfarlane and Macfarlane, 2011; Rizzetto 
et al. 2015). More than 90% of the species belong to the bacterial phyla Firmicutes 
and Bacteroidetes. Although, there is a high inter-individual variability in gut micro-
biota composition, a conserved set of gut colonizers or at least in gene/metabolic 
functions, appears to be  shared amongst individuals and may be required for the 
correct functioning of the gut (Tremaroli and Bäckhed, 2012). In the proximal colon 
the pH ranges from 5-5.7 and  the most abundant bacteria are obligate anaerobes 
mainly made up of species from the genera Bacteroides, Clostridium, Prevotella, 
Porphyromonas, Eubacterium, Ruminococcus, Lachnospira, Roseburia, Butyrivibrio, 
Streptococcus, Enterobacterium, Enterococcus, Lactobacillus, Peptostreptococ-
cus and Fusobacterium. The pH changes across the proximal (pH 5.5), transverse 
colon (pH 6.6) and to the distal colon pH close to neutrality, with some change in 
species composition but major changes occur in metabolic activity of the resident 
microbiota due to changes in substrate availability (Gibson and Roberfroid, 1999). 
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Recent studies using next generation sequencing and statistical models to describe 
community structure and species co-occurance suggest the existance of different 
phylogenetic clusters or “enterotypes” that distinguish an individuals gut micro-
biota. Each enterotypes is identified by variation in the levels of one of three main 
genera: Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus 
(enterotype 3) (Siezen and Kleerebezem, 2011). The concept of these enterotypes is 
based on statistical probabilities and co-variance within large sequence based da-
tasets and both their biological relevance and indeed their very biological existance 
outside computational models remains hotly debated.
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The gut microbiota protects against enteropathogens, extracts nutrients and energy 
from our diet and contributes to normal physiological and immune function (Ma-
slowski and Mackay, 2011). A dense resident community of commensal bacteria 
prevent overgrowth of invading pathogens through several strategies such as, pro-
ducing bacteriocins (proteinaceous toxins), which inhibit members of the same or 
similar bacterial species, producing short chain fatty acids (SCFA), which alter host 
environmental conditions (e.g. pH) and also down-regulate the expression of seve-
ral virulence genes. Moreover, commensal bacteria can consume common limited 
resources (e.g. oxygen, specific nutrients, iron), causing the starvation of competing 
pathogens, and they may also induce indirectly development of host’s Th17 cells in 
the intestine which are important for protection against pathogens (Kamada et al., 
2013). Dominant colonic organisms such as Bacteroides, Roseburia, Fecalibacte-
rium, Bifidobacterium and Enterobacteria, are able to carry out the fermentation of 
non-digestible oligosaccharides and fibers, resulting in the synthesis of short chain 
fatty acids (SCFA), mainly acetate, propionate and butyrate. These organic acids, 
are rich sources of energy both for certain species of gut bacteria and for the host. 
Similarly, they play an important role in modulating the immune system, as men-
tioned above. Cross-feeding between gut bacteria on SCFA, released by primary 
fermenting bacteria occurs with both, acetate and lactate, shown to be converted 
into butyrate, during cross-feeding (Duncan et al., 2004).
The intestinal microbiota not only modulates, but orchestrates the formation of the 
host’s immune system, supporting the “hygiene hypothesis”,  which aims to explain 
the peculiar generational rise in immune dysregulation – the incidence of autoimmu-
ne and allergic disease has reached epidemic proportions in the developed world 
since the 1950’s (El Aidy et al., 2015). During early life, the intestinal microbiota 
plays an important role in gut-associated lymphoid tissue (GALT) formation and 
education. The GALT is a complex immune organ designed to recognise pathoge-
nic microorganisms  and mediate an appropriate defensive response (Forchielli and 
Walker, 2005).  GALT produces IgA which can modulate innate immune responses 
when fragments of capsular polysaccharide of commensal bacteria encounter 
Intestinal dendritic cells (DCs). These IgAs can also play a direct clearance role, 
by binding to specific unwanted microorganisms in the lumen of the intestine and 
clearing them in faeces, while allowing commensals to persist and colonise the GI 
tract (Lebeer et al., 2010). Gut microorganisms are also responsible of production 
of anti-inflammatory metabolites, mainly SCFA from carbohydrate fermentation, 
1.1.3 The physiological role of the gut microbiota
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such as propionate and butyrate which increase the differentiation of regulatory T 
(Treg) cells, belonging to the class of CD4+ T cells. Tregs appear to play a key role 
in preventing autoimmune diseases by maintaining self-tolerance, suppression of 
allergy, asthma and pathogen induced immunopathology, feto-maternal tolerance 
and oral tolerance. Some probiotics (e.g. Lactobacillus sakei, L. reuteri, L. paraca-
sei, L. plantarum, L. acidophilus, L. salivarius and Bifidobacterium breve), although 
their mechanism of action is not yet clear, appear to down regulate proinflammatory 
cytokines IL-8 and interferon-γ, while up regulating anti-inflammatory cytokine IL-
10, and inhibiting TNF-α ( Ganguli et al., 2013; Thomas and Versalovic, 2010; Pena 
et al., 2005). 
In humans, the immune system and host metabolism appear to be intricately rela-
ted and both are regulated  by the activities of the gut microbiota. Recent studies 
have shown a clear difference between the gut microbiota of lean individuals and 
that of obese subjects (Ley et al., 2006; Kasai et al., 2015). Diets which support 
a “healthy” and diverse gut microbiota, e.g. high in fiber and whole plant foods, 
also are protective against obesity and metabolic disease. The pathophysiology of 
obesity is still not completely understood, probably due to its multifactorial aetio-
logy. Some evidence links obesity with a low-grade systemic chronic inflammation 
status, suggesting that inflammation could be a potential mechanism by which 
obesity leads to insulin resistance (Shoelson et al., 2007). Studies have shown that 
the gut microbiota and their metabolic activities, play an important role in regulating 
gut permeability and the flow of inflammatory molecules from the intestinal lumen 
(e.g. lipopolysaccharide, LPS), which have been shown to trigger the systemic 
inflammation which goes on to cause insulin resistance and metabolic disease ( 
Cani et al., 2007). Indeed, in animals with high fat diet induced obesity and insulin 
resistance, prebiotic microbiota modulation and fortification of the gut wall redu-
ces systemic inflammation, cause by intestinal LPS and amelioriates markers of 
metabolic disease ( Cani et al., 2007).  Nevertheless, several studies confirm the 
modulatory action of some probiotics (belonging to the genus Lactobacillus and 
Bifidobacterium) in the control and reduction of body weight (Minami et al., 2015; 
Yoo et al., 2013). For example, B. breve seems to prevent intestinal inflammation 
through stimulation of the development of IL-10, producing Treg1 cells in the large 
bowel (Jeon et al., 2012). Comparative meta-analysis of Lactobacillus species has 
associated Lactobacillus plantarum and Lactobacillus gasseri with weight loss 
in animals and humans (Million et al., 2012). Different studies suggest that these 
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bacteria protect against obesity through multiple mechanisms of action, such as 
hydrolyzing bile salt, reducing cholesterol, and inhibiting the accumulation of lipid in 
pre-adipocytes, reducing plasma leptin levels, down-regulating adipogenesis and 
strengthening intestinal integrity (Wu et al., 2015). Disruptions to the normal balance 
between the gut microbiota and the host have been associated also with type 2 
diabetes, characterized by an altered gut microbiota composition with an elevated 
Firmicutes/Bacteroidetes ratio compared with healthy people which leads to a pro-
gressive insulin resistance (pre-diabetes condition) (Zhang and Zhang, 2013). Many 
other pathological conditions were also ascribed to a dismicrobism or dysbiosis 
within the gut microbiota, including malnutrition (Gordon et al., 2012), inflammatory 
bowel disease (IBD) (Sartor and Mazmanian, 2012), neurological disorders (Perlmut-
ter and Loberg, 2015) and bowel cancer (Poutahidis et al., 2014). However, in most 
cases direct cause an deffect between either microbiota composition or dietary 
supplementation with probiotics remains to be clearly demonstrated in well control-
led human trials, limiting our ability to effectively treat obesity through microbiota 
modulation.
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The gut-brain axis includes the central nervous system (CNS), the neuroendocrine 
and neuroimmune systems, the sympathetic and parasympathetic arms of the au-
tonomic nervous system (ANS), the enteric nervous system (ENS) and the intestinal 
microbiota (Grenham et al., 2011). Visceral messages from the gut can influence 
brain function and the possibility of regulating the gut microbiota is opening up 
a new therapeutic target for a host of brain disorders. Brain levels of serotonin, 
the major chemical involved in the regulation of mood and emotion, are regulated 
by the bacteria in the gut. Work in germ-free mouse models has shown how the 
absence of bacteria can affect brain serotonin concentrations and has highlighted 
that, this appears to occur in a gender-dependent component, with male brain 
serotonin levels more liable to alteration than that of females. Indeed, colonization 
with the gut microbiota in early live, and even the sequential pattern of microbiota 
colonization or the successional development of the microbiota, appears to shape 
neonatal brain bevelopmental processes. The brain circuitry laid down in germ-free 
mice, in the absence of a gut microbiota, appears to be permanent and different 
from conventional animals. This indicates the important and long lasting effects of 
appropriate microbial colonisation in infancy in programming brain development 
and function throughout life (Dinan and Cryan, 2012). There are many potential 
signaling mechanisms by which gut microbiota could influence brain activity inclu-
ding changes in microbiota-produced signaling molecules, such as SCFA and ke-
tone bodies (Cummings and Macfarlane, 1991; Kimura et al., 2011), phenolic acids 
(Gasperotti et al., 2015), steroids (Gérard, 2013), amino acids and their derivatives 
(Fernstrom, 2012; Dai et al., 2011), catecholamines (Rhee et al., 2009), incretins –  
gut hormones (Cani, 2015; Cani et al., 2009), mucosal immune mechanisms (Sher-
man et al., 2015; El Aidy et al., 2014), and enterochromaffin cell-mediated vagal 
activation (Rhee et al., 2009; Raybould, 2010), as summarized in Figure 2. However, 
it is still unclear which specific metabolites may be involved in the cerebral me-
chanism and what the contribution of the microbiota per se is to systemic levels of 
these metabolites and any subsequent impact on brain function.
The gut microbiota, appears to be involved in the development of both central and 
peripheral neural processes (Tuohy et al., 2015; Sherman et al., 2015). Most of the 
studies exploring intestinal microbiota interactions with the CNS have been perfor-
med using animal models, typically mice. The gut microbiota has been shown to 
influence the development of the hypothalamic–pituitary–adrenal (HPA) axis, with 
exaggerated release of corticosterone and adrenocorticotropic hormone in germ-
1.2 Gut – microbiota – brain axis
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free (GF) mice in response to stress compared to mice carrying a specific pathogen 
free (SPF) microbiota. This situation could be reversed in a time dependant manner 
by colonization with the probiotic B. infantis in the post natal period. However, colo-
nization with E. coli led to an exaggerated response to the stress in the ex-GF mice, 
indicating early life exposure of microorganisms is required for the HPA system to 
become fully susceptible to inhibitory neuronal activity (Sudo et al., 2004). Impor-
tantly, it also shows that specific microbial encounters in early life or the sequence 
of such encounters, can have a dramatic effect on host physiological devemop-
ment and brain function in later life. Neuromodulators, such as corticotropin release 
factor 1 (CRFR1) in the colon, seem to play an important role in stress-induced 
permeability dysfunction and modulation of mucosal immune and inflammatory re-
sponses (Larauche et al., 2009). Intestinal permeability is linked to systemic inflam-
mation, a trigger for both inflammatory and metabolic diseases and possibly also 
responsible for increasing inflammation in the brain. Conversely, social stress has 
been tested in mice and shown to impact on gut microbiota composition, with a re-
duction in the relative abundance of Bacteroides and a concommitant incresase in 
caecal clostridia (Lyte, 2013). Stressor exposure significantly changed the commu-
nity structure of the gut microbiota at genus level, modulating Coprococcus, Pseu-
dobutyrivibrio, and Dorea, with a significant correlatation with increased circulating 
levels of IL-6 and MCP-1 (Bailey et al., 2011). GF mice showed increased motor 
activity and reduced anxiety compared to SPF mice, together with altered expres-
sion of secondary messenger pathway and synaptic long-term potentiation genes 
in brain regions involved in motor control and anxiety-like behaviour (Diaz-Heijtz et 
al., 2011). These effects could be reversed by early colonization with specific-pa-
thogen-free microbiota in the neonatal period. Intervention with various probiotic 
microorganisms, both lactobacilli and bifidobacteria, has been shown in animal mo-
dels to alleviate anxiety-like behaviour to standard animal stress challenges. Rats 
fed B. infantis showed a significant reduction of pro-inflammatory cytokines, such 
as IFN-γ, TNF-α, and IL-6, following mitogen activation; elevated concentrations of 
tryptophan; kynurenic acid; 5-hydroxyindole acetic acid – serotonine metabolite (in 
the frontal cortex); 3,4-dihydroxyphenylacetic acid – dopamine metabolite (in the 
amygdaloid cortex), compared to control animals (Desbonnet et al., 2008). 
B. infantis could counteract the stress effects. In mice, who had been subjected to 
maternal separation, a recognised model of depression, B. infantis decreased nora-
drenaline in the brain, elevated systemic IL-6 and amygdala corticotropin-releasing 





factor mRNA. In rats fed a probiotic mix (Lactobacillus helveticus R0052 and B. lon-
gum R0175), reduced anxiety-like behaviour was observed and the same probiotic 
mix in humans alleviated psychological distress (Messaoudi et al. 2011). The pro-
biotic L. rhamnosus JB-1 has been shown to reduce stress induced by corticoste-
rone, anxiety and depression related behaviour and concomitantly, induced chan-
ges in γ-aminobutyric acid (GABA) receptor expression in different regions of the 
brain. In the probiotic fed animals, GABA B1b receptor was upregulated in cingu-
late and limbic cortical regions and down regulated in the hippocampus, amygdala 
and locus coeruleus, compared to control animals (Bravo et al., 2011). Similarly, 
GABA Aα2 receptor expression was reduced in the prefrontal cortex and amygdala, 
while it increased in the hippocampus. Importantly, neither behavioural changes nor 
changes in GABA-receptor expression induced by the probiotic occured in vagoto-
mized mice, indicating the central role of the vagus nerve in the gut:brain commu-
nication highway. The mRNA expression of GABA B1b receptor after treatment with 
Lactobacillus rhamnosus, was increased in cortical regions, and decreased in the 
hippocampus, amygdala, and locus coeruleus; while mRNA expression of GABA 
Aa2 receptor, was reduced in the prefrontal cortex and amygdala, and increased 
in the hippocampus (Bravo et al., 2011). Similarly, the expression of m-opioid and 
cannabinoid receptors in intestinal epithelial cells could be induced by Lactobacil-
lus strains, which mimic the effects of morphine in promoting analgesia (Rousse-
aux et al., 2007). It may be therefore that the successional development of the gut 
microbiota, relative exposure to probiotic or pathogenic microorganisms in early 
life, plays a role in brain development at a critical point in neurological development 
that can have far reaching consequences for behaviour and disease risk throughout 
life. However, there is a clear lack of human data describing the contribution of gut 
microbiota successional development to either immunological or metabolic com-
munication along the information highways linking gut and brain.
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1.3 Diet:microbe interactions 
The digestive system is responsible for the breakdown and modification of complex 
food macromolecules into smaller components and usable nutrients, electrolytes, 
and fluids. In addition, it excretes unabsorbed residues in faeces, provides a pro-
tective barrier against the entry of toxic substances and infectious agents, serves 
as the largest endocrine organ in the body and interacts with other endocrine or-
gans, the nervous system, circulatory system and the immune system (Yaqoob and 
Childs, 2016; Furness, 2000). Chemical digestion of food, begins in the mouth and 
continues in the stomach, small intestine and finally the colon. Enzymes secreted 
by the salivary glands, pancreas, stomach, and small intestine all play a role in the 
digestion of the carbohydrates, proteins, and fats found in our food. 
Compounds which escape digestion and absorption in the stomach and small 
intestine reach the colon where they come in contact with the majority of the gut 
microbiota. As an anaerobic environment, fermentation is an important activity 
within the gut microbiota and indeed can be viewed as a key form of metabolism, 
providing both energy and carbon for the fermentative microorganisms themselves 
and other organisms which cross-feed off their metabolic end-products (Macfarlane 
and Macfarlane, 2011). Two major forms of fermentation predominate within the 
gut microbiota, saccharolytic or carbohydrate fermentation, and protein/amino acid 
fermentation. When and where these two forms of fermentation occur appears to 
change with pH and substrate availability in different regions of the colon and may 




Carbohydrate metabolism begins in the mouth with the secretion of the enzyme 
salivary amylase, which breaks down digestible starch and glycogen into disac-
charides. Chyme, the product obtained by gastric activities (consists of bolus and 
gastric juices), empties into the small bowel where monosaccharides (e.g. gluco-
se) are absorbed into the bloodstream. Gastric emptying is regulated by incretins, 
especially glucagon-like peptide-1 (GLP-1), a hormone produced in the upper 
intestine but which appears to be under direct regulation of SCFA concentrations 
in the large bowel, via the neuro-endocrine system (Kasubuchi et al., 2015). Howe-
ver, not all dietary carbohydrates are digested efficiently or equally in the stomach 
and small intestine. Many studies in the last decades have endeavoured to identify, 
classify and estimate, the amount of carbohydrate which escapes digestion and 
enters in the colon. The exact amounts and types of carbohydrate that reach the 
colon and are available for fermentation remains uncertain due to several fac-
tors, such as the complexity of the anatomical area under study, several different 
methodological approaches, food processing, maturity stage of plant foods tested, 
fluctuations in food intake and individual differences in the intestinal physiology/fun-
ctions. However, FAO estimate that about 20-40 g carbohydrates reach the colon 
each day in populations following a typical “westers-style” diet, rich in refined car-
bohydrates/sugars, fat, red and processed meats, while they estimate that at least 
50 g carbohydrate per day reaches the colon in people following more “traditional” 
diets, rich in whole grains, fruit and vegetables (e.g the Mediterranean or Okinawan 
diets). This carbohydrate not digested in the stomach or small intestine is mainly 
made up of non-starch polysaccharides, resistant starch, oligosaccharides, polyols 
and lactose (Mann et al., 2007). Carbohydrates that reach the large intestine enter 
into a very different type of metabolism, determined by the anaerobic microbiota 
and mainly driven by anaerobic fermentation. Intestinal bacteria secrete extracel-
lular enzymes or express membrane bound enzymes, which hydrolyse polysac-
charides into oligosaccharides and monosaccharides which in turn enter into the 
bacterial cells where they are fermented, producing energy (ATP), SCFA  and gases 
(mainly carbon dioxide - CO2, hydrogen - H2, and methane - CH4) (see equation 1). 
Microbial carbohydrate fermentation in the colon is a relatively efficient process and 
almost completely catabolizes starch, lactose, alcohol-sugars and fructans. Few 
plant derived polysaccharides escape colonic fermentation completely untouched 
even cellulose. Human colonic microbiota metabolize available carbohydrate to 
obtain energy for their own growth and maintenance (e.g. motility, enzyme synthe-
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sis, maintenance of ionic and osmotic gradients, and active ion transport) (Williams 
et al., 2001). 
57.5 C6H12O6 + 45 H2O → 65 Ac + 20 PPA + 15 BTR + 140 H2 + 95 CO2 + 288 ATP
Eq. 1 General equation of anaerobic fermentation. Acetate (Ac), propionate (PPA), 
butyrate (BTR), adenosine triphosphate (ATP). 
Not all carbohydrates are, however, fermented in the same way. One of the first 
characteristics affecting the fermentation susceptibility is their solubility. The more 
soluble substrates being more accessible to hydrolytic enzymes, are likely to be 
degraded more rapidly. Nevertheless, some soluble fibres, such as alginates or car-
rageenans are poorly fermented, because of their chemical structure. Other factors 
involved in carbohydrate susceptability to fermentation include chemical structure 
and binding, the individual differences in the intestinal microbiota and the environ-
mental conditions (e.g. pH, others nutrients presents in the medium, amount of ma-
terial to be digest)  (Krajmalnik-Brown et al., 2012). Although a part of the products 
of fermentation (as reported in table 3), are utilized by microorganisms, the majority 
of SCFAs produced are rapidly absorbed by the colonic mucosa. The remaining 
"waste food" and microbial biomass are eliminated via rectum as feces and gases. 
Interestingly, not all gases are excreted as waste. Acetogenic bacteria produce 
acetate from CO2 and H2, while methanogenic bacteria produce CH4 by reduction 
of CO2 with H2 and finally, sulfate reducing bacteria utilise H2 to reduce sulfates and 
produce sulfites or hydrogen sulfide (Gibson et al., 1990). Absorption of SCFA is 
rapid and leads to accumulation of bicarbonates and to an increase of the pH of 
the lumen, especially in the distal colon, where carbohydrate availability, at least for 
people who follow a Western diet, becomes limiting. SCFA stimulate proliferation 
of colonic epithelial cells. Butyrate is the preferred substrate of the colonocytes, 
the epithelial cells lining the colon, providing about 50% of intestinal energy supply. 
Absorbed SCFA which are not metabolized in the mucosa, are oxidized in the liver 
or metabolised in the peripheral tissues. The majority of the butyrate is metabolised 
in the intestine, unlike the propionate, which is eliminated mainly through the liver, 
while about 40% of acetate absorbed in the intestine passes the liver and eventual-
ly enters the circulatory system (Pomare et al. 1985; Cummings et al. 1987; Cum-
mings et al. 1997). Acetate may, under certain conditions, be used as a substrate 
for cholesterol in the liver and also in the brain, which harbours 80% of the bodies 
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cholesterol which must be synthesised in situ as it does not pass through the blood 
brain barrier (BBB). 













































acetate, butyrate, NH3, formate, 
lactate
Verrucomicrobia Verrucomicrobiaceae N.R.
lentisPhaerae Victivallaceae (e.g. Victivallis vadensis) acetate, ethanol, H2
Tab. 1 Human gut fermenting bacteria with important families and fermentation products. Green indicates the metabolites 
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Observations that different dietary fibers appear to be fermented differently or with 
different preferences by the intestinal microbiota and that the human milk oligo-
saccharides selectively stimulate the growth of bifidobacteria within the infant gut 
led to the development of the “prebiotic” concept. A prebiotic was first defined 
as, “a non-digestible food ingredient, that beneficially affects the host, by selecti-
vely stimulating the growth and/or activity of one or a limited number of bacteria 
in the colon,  that can improve the host health” (Roberfriod et al 1998). The most 
widely accepted current definition describes a prebiotic as “a selectively fermen-
ted ingredient that results in specific changes in the composition and/or activity 
of gastrointestinal microbiota, thus conferring benefit(s) upon host health” (Gibson 
et al., 2010). The list of the compounds recognized as prebiotic, has grown from 
compounds like inulin, lactulose, fructooligosaccharides (FOS), and galacto-oli-
gosaccharides (GOS) to include new potential prebiotics, including certain resi-
stant starches, arabinoxylans, and some whole grain products or fractions thereof 
(Bindels et al., 2015). However, to be classed a prebiotic these compounds must be 
evaluated in human studies and shown to have selective modulatory activities on 
the composition of the intestinal microbiota, preferably in a dose response manner 
and reproducibly, and also to generate one (or more) measurable benificial effects 
on human health. 
Inulin, which was the first dietary fiber defined as a prebiotic,  is still one of the most 
studied. It is a naturally occurring oligosaccharide (DP2-60) belonging to a group of 
carbohydrates known as fructans. It occurs naturally in foods such as leek, aspa-
ragus, chicory, Jerusalem artichokes, garlic, onions, wheat, oats, and in the soy-
beans (van Loo et al., 1995). Now considered the “gold standard” prebiotic, inulin 
is undigestible for human enzymes, passing intact through the stomach and small 
intestine, and arrives in the colon where it is extensively fermented by the resident 
microbiota. The selective action on the growth of some bacterial populations by 
inulin intake has been demonstrated repeatably by different researchers and using 
different microbiological approaches. Within the human gut microbiota inulin sti-
mulates the growth of bifidobacteria, and also some commensal species including 
Roseburia and Faecalibacterium prausnitzii (Scott et al., 2011; Ramirez-Farias et 
al., 2009). Both these bacteria are prominent butyrate producing bacteria within the 
human commensal microbiota and F. prausnitzii appears to be reduced in patients 
with inflammatory bowel disease (IBD) and is considered to have anti-inflammatory 




Enhances mineral (Mg2+ and Ca2+) 
uptake by acidification of the intes-
tinal lumen Remineralizing (Hess et al., 2015; Abrams et al., 2005)
Immunomodulation (attenuates 
Cr-induced intestinal inflammation 
through mechanisms affecting NF-
κB and Smad 7 signaling); human 
vaccine adjuvants (increases pro-
duction of activated C3 and thereby 
activate macrophages, stimulates 
cellular (Th1, Th2) immunity)
Immunomodulant, 
protective (GIT and 
systemic)
(Lomax et al., 2015; Franco-Robles 
and López, 2015; Saade et al., 2013; 
Kuo, 2013; Foye et al., 2012; Layton et 
al., 2011; Lobigs et al., 2010; Guarner, 
2005)  
Epigenetic effect by enhanced pro-
duction of SCFA in the colon (mainly 
butyrate), acting on leucocytes, 
intestinal cells, and endothelial 
cells through inhibition of histone 
deacetylase 
(Jung et al., 2015; Canani et al., 2012 
and 2011; Gao et al., 2009; )
Bifidogenic activity (Bifidobacteri-
um longum and Bifidobacterium 
adolescentis) 
Anti-pathogenetic
(Joossens et al., 2011; Falony et al., 
2009; Kolida et al., 2002; Guigoz et al., 
2002: Kruse et al., 1999; Gibson et al., 
1995)  
Stimulate the growth of Lactobacil-
lus strains (Jung et al., 2015)
Lowering of plasma triglycerides 
and LDL cholesterol Lipid-lowering
(Daubioul et al., 2005; Causey et al., 
2000; van Dokkum et al., 1999; Peder-
sen et al., 1997) 
Modulates hyperglycemic and 
insulin resistance (inhibition of glu-
cose absorption from the intestine, 
stimulated glucose uptake into the 
skeletal muscle cells) Antihyperglycemic
(Nishimura et al., 2015; Yun et al., 
2009)
Lowers postprandial appetite, but 
not energy intake Weight control (Heap et al., 2016)
Lowers Plasma p-Cresol in Chronic 
Kidney Disease Antitoxic (Salmean et al., 2015)
    
Tab. 2 Physiological or health effects of dietary inulin and other fructans
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dence support this fructan fiber as a prebiotic.
The main role of prebiotics in the diet is to promote the growth and proliferation 
of beneficial bacteria within the intestinal tract and to improve host health. Since 
our understanding on which bacteria are actually beneficial for the host is still in its 
infancy, most of the studies have focused on bifidobacteria because of their occur-
rence in breast fed infants and their beneficial host-health effects at least confir-
med by animal models (Conlon and Bird, 2014). Prebiotics, have also been shown 
to increase the absorption of certain minerals (e.g. calcium, magnesium and zinc) 
(Scholz-Ahrens et al., 2007), to inhibit the growth of adenomas and carcinomas in 
the intestine, and thus reduce the risk factors involved in colorectal diseases (Liong, 
2008). They may also result in changes in the production of cytokines and chemoki-
nes and exercise anti-inflammatory effects, promote cell growth and differentiation, 
reinforce intestinal barrier function, enhance intestinal motility, inhibit intestinal 
cholesterol synthesis, control body weight by enhancing mitochondrial function, 
and increase insulin sensitivity in type 2 diabetics (Hardy et al., 2013; Tremaroli and 
Bäckhed, 2012) (Table 3). However, most of these beneficial health effects have 
only been demonstrated convincingly in animal models and await confirmation in 
appropriately designed human intervention studies.
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Prebiotics Function source 
Arabic gum  ↑ SCFAs
acacia, carrageenan, guar, 
locust bean and xanthan
Fructooligosaccharide
→ Bifidobacterium and Lactobacillus 
strains, ↑ Ca and Mg absorption, 
↓ triglycerides and has anticarcinogen-
ic effects
jerusalem artichokes, onions, 
leeks, grains and honey
Inulin
→ Bifidobacterium sp. (colon), osmotic 
regulator, has immunomodulatory 
properties ↓ serum cholesterol and 
triglycerides and ↓ calorie value
liliaceae, amaryllidaceae, chico-
ry, onions, leeks, garlic, banan-
as, asparagus, and artichokes
Isomalto-oligosaccharide 
isomalto tetrarose → Bifidobacterium and Lactobacillus strains
isomaltose, panose, and other 
higher branched oligosaccha-
rides
Lactitol Releases constipation and hepatic encephalopathy




produced from lactose and su-
crose by p-fructofuranosidase 
from Arthrobacter sp.
Pyrodextrin → Bifidobacterium sp. (colon)
produced by heat-treating of 
starch
Soy oligosaccharide → Bifidobacterium sp. (colon) soybeans and peas
Trans 
Galacto-oligosaccharide → Bifidobacterium sp. (colon)




↑ Bifidobacterium sp., ↓ blood sugar 
levels and ↑ fat metabolism, restore 
normal intestinal flora, ↑ mineral ab-
sorption and vitamin B production and 
↓ intestinal putrification 
produced from lignocellulosic 
materials by enzymatic hydroly-
sis of xylan
Tab 3. Prebiotics – putative physiological effects and sources  
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Protein is the major nitrogen-containing component of the diet. It is composed of 
long chains of the 20 different amino acids (AA) linked together by peptide bonds. 
Proteins are essential constituents of receptors and cell signaling molecules, 
structural building blocks, enzymes, ion channel pumps, O2 and CO2 transporters 
(hemoglobin), hormones, etc.. Dietary proteins are digested to their constituent ami-
no acids prior to their absorption in the small intestine. In the gastric and pancreatic 
juices, peptidase enzymes hydrolyze peptide bonds to generate small peptides 
and free amino acids. Others enzymes located on the mucosal surface of the small 
bowel, continue protein and polypeptide digestion (Webb, 2012). Like fat and car-
bohydrates, amino acids are also metabolized to form ATP (see equation 2). 
-NH2CHRCOOH (protein) + H2O → H2NCHRCOOH (AA) + NH3 + CO2 →  ATP 
Eq. 2 General equation of proteolytic anaerobic fermentation. 
Amino acids have a similar oxidation state to that of glucose and undergo microbial 
fermentation and their breakdown fosters ATP synthesis. Via the citric acid cycle, 
amino acids, can be oxidised and converted into urea, pyruvate and other keto 
acids, which are used in the anabolic synthesis of other compounds. Amino acid 
degradation follows several pathways, but the Stickland reaction remains the most 
efficient one. Stickland couples the oxidation of one amino acid with the reduction 
of another. Keto acids obtained from amino acid oxidised by deamination (amino 
acid dehydrogenases), leads to ATP synthesis, through loss of CO2 and subsequent 
phosphorylation of the substrate. This reaction is coupled with reductive deamina-
tion (reductase), of the other amino acid. The total amount of C atoms are equal in 
both donor and acceptor amino acid. Usually, the second reaction does not pro-
duce ATP, except if it involves two molecules of glycine. The produced ATP, thus 
depends on the specific pair of amino acids involved in and to the stoichiometry of 
the reaction (e.g. 4 moles of glycine produce 3 moles of ATP) (de Vladar, 2012).
1 glycine + 1 alanine → 1.7 ATP
Fermentation of protein remains with a lower energetic yield compared to the fer-
mentation of carbohydrates:
2 glucose → 5 ATP
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The amino acids play a vital role in maintaining the integrity and mass of the intesti-
nal mucosal, as well as being involved in the synthesis of glutathione, nitric oxide, 
polyamines, purine and pyrimidine nucleotides, and small amino acids (alanine, 
citrulline and proline) (Wu, 1998). Amino acids can be directly incorporated into 
bacterial cells, as building blocks of proteins and some amino acids can also be 
synthesized de novo by the gut microbiota (Neis et al., 2015). The intestinal micro-
biota plays an important role in the synthesis and/or bioavailability of metabolites 
involved in neurotransmission, many of which are derived from amino acidic meta-
bolic pathways (Neis et al., 2015). Competition for peptides and free amino acids 
between actively growing bacteria in the intestinal lumen and colonocytes would 
seem to preclude uptake by the colonic mucosa, which has no specific transport 
systems for them (Bergen and Wu, 2009). Furthermore, the exchange of nutrients 
between the intestinal mucosa/microbiota and host, can proceed in both directions 
making flow prediction difficult. High protein diets and resistant protein intake (e.g. 
glycated protein, formed during food cooking) (Tuohy et al., 2006), could determi-
ne a buildup of undigested protein in the colon skipping previous catabolism (see 
figure no. 4). It has been estimated that about 12–18 g of dietary protein reaches 
the colon each day (Scott et al., 2013). There is also an important contribution of 
endogenous protein sources (e.g. mucin, human/bacterial protein from cell turno-
ver, enzymes, etc.) to colonic protein availability (Moughan et al., 2005). Studies in 
ileostomy patients suggest that endogenous protein can reach about 1852 mg N/
day, thus representing an important contribution to the N economy of the colonic 
microbiota (Moughan and Rutherfurd, 2012).
The microbial catabolism of amino acids may result in competition between diffe-
rent microorganisms as well as on the production of biologically active compounds 
including SCFA, Branched-Chain Fatty Acids (BCFA), phenols, indoles and ammo-
nia (Scott et al., 2013). The main metabolites involved in this pathway are the SCFA 
and BCFA, indicating that dissimilatory reactions are primarily affected through 
reductive deamination (Macferlane et al., 1986). SCFA are important end-products, 
formed during AA fermentation by clostridia and anaerobic gram-positive cocci. 
The ratio of SCFA formation is dependent on the chemical composition of the AA 
involved. Moreover, the time taken for the catabolic reactions changes from a rapid 
fermentation for the basic amino acids, such as lysine and arginine, to a slow and 
sometime incomplete fermentation for the sulfur amino acids (Macfarlane, 1992). 
Acetate and butyrate are formed from glutamate, while acetate and propionate are 
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mainly produced from aspartate (Smith and Macfarlane, 1997). Acetate, is required 
for optimal growth of F. prausnitzii and Roseburia intestinalis / Eubacterium rectale. 
Acetate is also re-absorbed by certain microorganisms and diverted into the butyra-
te production pathway (Duncan et al., 2004). Besides the most studied organic fatty 
acids, acetate, propionate, and butyrate, BCFA, such as isobutyrate and isovale-
rate, are produced by degradation of AA and have been shown to possess anti-
microbial effects against pathogenic species by decreasing the pH in the intestine 
(Williams et al. 2001). Clostridia largely use Stickland reaction for energy production 
from amino acids, which consists as mentioned before of coupled deamination 
between two amino acids, acting as donor and acceptor of hydrogen respectively 
(Nisman, 1954). The principal H-donors involved in this reaction are alanine, leuci-
ne, isoleucine, valine and histidine, while H-acceptors are glycine, proline, ornithine, 
arginine and tryptophan (Davila et al., 2013). 
The main gases produced during protein fermentation include, hydrogen (H2) and 
carbon dioxide (CO2), resulting mainly from urea hydrolysis (Cone and van Gel-
der, 1999). Hydrogenotrophic microorganisms, such as sulfate reducing bacteria, 
methanogenic archaea and acetogenic bacteria, may consume these gases to 
generate hydrogen sulfide (H2S),  methane (CH4) and acetate (Bernalier et al., 1996). 
Methane is a stable end product that is excreted from the gut (Triantafyllou et al., 
2014). H2S is another gas produced by cysteine and methionine breakdown and 
induces hyperproliferation of crypt cells and is therefore thought to predispose to 
colonic carcinomas and ulcerative colitis (Pitcher et al., 2000). Fortunately, it may 
also be further metabolized and thus, detoxified by colonocytes (Barton et al., 
2014). The metabolites derived from commensal microorganisms can have various 
effects on the host immune system (Jacobs et al., 2009). Some of these com-
ponents are generally considered toxic and it is thought they can cause adverse 
effects on the colonic epithelium. The best characterized of these protein endpro-
ducts include phenols and indoles (González-Parra et al., 2013; Evenepoel et al., 
2009), which result from deamination, decarboxylation, fermentation and α or β eli-
mination reactions of protein degradation by colonic bacteria (Hughes et al., 2000). 
Ammonia is a toxic waste product, produced by the deamination of amino acids or 
from hydrolysis of urea via microbial urease activity. It is a very volatile compound 
which can be rapidly absorbed from the intestinal lumen and its concentration in 
faeces also appears to be directly proportional to the consumption of protein in the 
diet. Ammonia causes damage in the intestine and, in patients with end-stage liver 
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disease, it may cause hepatic encephalopathy (Butterworth et al., 1987). This brain 
intoxication can lead to cognitive impairment marking the key role the liver plays in 
the detoxification of compounds absorbed from the gut (Macfarlane et al., 1986). 
The synthesis of lysine by bacteria using free ammonia from urea hydrolysis or 
amino acid fermentation is also possible (Metges, 2000). However, again its signifi-
cance to host nutritional, needs remains to be determined. 
Amino acid metabolism plays an important role in the biosynthesis of metabolites 
involved in neurotransmission and this process, may be influenced by diet and the 
activities of the gut microbiota (Clarke et al., 2014). Also amino acids themselves 
can modify the ability of gut bacteria to utilize other dietary amino acids, as shown 
for L-arginine and L-glutamine, which appear to interfere with the transport, meta-
bolism and utilization of other AA, by gut bacteria (Dai et al., 2013; Dai et al., 2012). 
Additionally, glutamate, glutamine, and aspartate are major metabolic fuels for ente-
rocytes and also regulate intestinal and neurological development and function (Wu, 
2010). Glutamine is essential for ATP production, synthesis of nucleotides, expres-
sion of anti-oxidative genes, and redox signaling in enterocytes. While glutamate, 
activates chemical sensing in the gastrointestinal tract and may inhibit degradation 
of both Essential Amino Acids (EAA) and Non- Essential Amino Acids (NEAA) by in-
testinal microorganisms. Moreover, proline and arginine, which are major sources of 
ornithine for intestinal and placental synthesis of polyamines, are essential for DNA 
and protein synthesis and also participate in protein and DNA methylation, and, 
thus to the genetic and epigenetic regulation of cell growth and development (Wu, 
2014). Similarly, beta-alanine a common amino acid in meat, inhibits the uptake 
of γ-amino butyric acid (GABA) by intestinal cells, such as Caco2 (Aanesen et al., 
1996). 
and peroxidation of dietary fats, which may explain the increased risk of colon 
cancer with diets high in red and processed meats (Bastide et al., 2011). High meat 
consumption seems to be linked to an increased bioavailability of the amino acid 
arginine, which induces nitric oxide synthase to produce nitric oxide (NO) (Rath et 
al., 2014).  However, there was no effect on faecal nitrite on changing from a low to 
high white meat and fish diet in rats (Parnaud et al., 2000). This suggests that, the 
increase in faecal NOC and nitrosating agents, may be due to iron content, whi-
ch is the main difference between red and white meat and links red meat with an 
increased risk of colon cancer characterized by elevated endogenous deamination 
mechanisms (Bingham et al., 1996).
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Currently, we know little about the microbial species or indeed metabolic 
processes involved in amino acid bioavailability and biotransformation by 
the gut microbiota as a community and less about the possible implications 
for neurological function. We also do not know much about how diffe-
rent foods and food components interact to regulate amino acid uptake 
or metabolism by the gut microbiota. Early in vitro studies by Smith and 
Macfarlane showed that amino acid fermentation by the human gut mi-
crobiota is inhibited both by low pH and by the presence of fermentable 
fiber/carbohydrate (Smith and Macfarlane, 1997). However, we have little 
information about how this process translates in vivo or how it changes in 
disease states, upon antibiotic therapy or upon the over-nutrition typical of 
the Western-style diet and likely to radically impact on fermentation in the 
colon.
Many products of the fermentation of amino acids in the colon are con-
sidered harmful to the host (Fig. 5), if availability of organic-N containing 
compounds is high and/or if the supply of carbohydrates, that hinder the 
putrefactive process, is too low. A recent hypothesis proposes heme iron 
in the form of hemin (a ferric form of heme), as catalyst in the endogenous 
formation of N-nitroso compounds  (NOC) and peroxidation of dietary fats, 
which may explain the increased risk of colon cancer with diets high in red 
and processed meats (Bastide et al., 2011). High meat consumption seems 
to be linked to an increased bioavailability of the amino acid arginine, which 
induces nitric oxide synthase to produce nitric oxide (NO) (Rath et al., 
2014).  However, there was no effect on faecal nitrite on changing from a 
low to high white meat and fish diet in rats (Parnaud et al., 2000). This sug-
gests that, the increase in faecal NOC and nitrosating agents, may be due 
to iron content, which is the main difference between red and white meat 
and links red meat with an increased risk of colon cancer characterized by 
elevated endogenous deamination mechanisms (Bingham et al., 1996).
Recentrly, it has been reported that almost 90% of the gastrointestinal 
cancers could be attributed to dietary habits (Anand et al., 2008). The asso-
ciation between red and processed meat consumption, as well as the low 
fiber, calcium, vitamin D and folate intake, with the higher colon cancer risk 
(CRC) is now well established (Cancer Research UK). Metagenomic studies 
have now identified a specific oncogenic microbiome, implicating Strepto-
1.3.4 Pathophysiology implications 
of protein metabolism
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coccus gallolyticus (previously S. bovis), which was one of the first microorganisms 
associated with tumors, although the causative link has not been established. Other 
microorganisms subsequently associated with this disease are: Fusobacterium ne-
crophorum, Enterococcus faecalis, Fusobacteria, Alistipes, Porphyromonadaceae, 
Coriobacteridae, Staphylococcaceae, Akkermansia spp. and Methanobacteriales, 
while Bifidobacterium, Lactobacillus, Ruminococcus,  Faecalibacterium spp., Rose-
buria, and Treponema, are reduced. Nevertheless, whether this represents cause or 
effect remains unknown. A potential causal mechanism proposed lies in the ability 
of these microorganisms to adhere to the colonic epithelium through FadA adhe-
sion and by stimulation of E-cadherin/β-catenin signaling to promote carcinogene-
sis. Significant higher abundance of Bacteroides–Prevotella group in CRC patients, 
with an increased levels of IL-17 immunoreactive cells, suggests the involvement 
of immunological functions in the development of microbiota dysbiosis. The bacte-
rial butyrate producers, who are amongst those most reduced during the intestinal 
dysbiosis, play an important role in the prevention and modulation of the tumor 
process. Butyrate, produced predominantly by Clostridium clusters XIVa and IV, 
exhibits anti-proliferative activity and can induce apoptosis, or programmed cell 
death, in cancer cells. Butyrate, as a histone deacetylase (HDAC) inhibitor activates 
the apoptotic cascade, arresting the growth of tumors via histone hyperacetylation. 
Moreover, butyrate can suppress tumors by potentiating p53 gene expression and 
transforming growth factor-β (TGF-β) signaling, and increase the immunogenicity 
of cancer cells. Proteolytic fermentation of undigested meat by microrganism in the 
gut (mainly Bacteroides spp., and Clostridium spp.), can produce inflammatory and 
procarcinogenic end-products, such as nitrosamines, branched-chain fatty acids, 
phenolic (phenols and p-cresol) and indolic compounds from aromatic amino acids 
catabolism. Red meat moreover, is also rich in sulfur containing amino acids, which 
promote the growth of sulfur-reducing bacteria (SRB) (e.g. Desulfovibrio vulgaris) 
that convert the H2 gas produced, during saccharolytic fermentation, into an inflam-
matory and genotoxic end-product, hydrogen sulfide (H2S). This compound is able 
to impair cytochrome oxidase, inhibit mucin synthesis, suppressing butyrate utiliza-
tion, and promotes methylation of DNA by generating free radicals. Finally, SRB can 
also suppress the growth of methanogens, such as the methanogenic Archaea (e.g. 
Methanobrevibacter smithii), which is involved in the metabolism of H2 through its 
conversion into non-toxic methane, which may be exhaled in the breath (Vipperla 
and O’Keefe, 2016).
42 Fig. 5 Potentially toxic pathways of red meat metabolism
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A number of recent studies have focused also on the role of certain metabolites 
derived from protein fermentation in cardiovascular disease (CVD).  Studies exami-
ning microbial metabolism of phosphatidylcholine, choline and betaine, have linked 
microbial metabolic processes with production of a cardiotoxicant trimethylamine-N 
oxide (TMAO).  Indeed TMAO is becoming recognised as a putative new target for 
the prevention of cardiovascular disease (CVD) risk or at least an early biomarker of 
CVD (Koeth et al., 2013). Pro-atherogenic TMAO is formed by a two step process: 
the first step starts with the gut microbiota, dependent cleavage of a TMA molecule 
from PC/choline/betaine and the second step, takes place in the liver, with the en-
zyme FMO3 mediated oxidation producing TMAO (Brugère et al., 2014). TMAO not 
only promotes atherogenesis through foam cell formation and interferes with ma-
crophage reverse cholesterol transport in atherosclerotic plaques, but recent stu-
dies in mice also suggest that dietary TMA may exacerbate impaired glucose tole-
rance, obstruct hepatic insulin signaling, and promote adipose tissue inflammation 
in animals fed a high-fat diet (Tang and Hazen, 2014). Many of the bacteria involved 
in undigested-protein metabolism, such as clostridia, Bacteroides, sulphate-redu-
cing bacteria, Escherichia coli, Peptostreptococcus, Fusobacterium species, and 
species belonging to the Actinobacteria are recocnized as capable of producing 
TMA (Richardson et al., 2013; Le Leu et al., 2006). Usually Prevotella–dominated 
microbiota, or “enterotype”, is associated with fiber intake, while Bacteroides-do-
minated microbiota is correlated with protein intake (Wu et al., 2011). Nevertheless, 
starvation response of species that derive energy from carbohydrate in the colon, is 
often to switch to AA as a substrate for generating metabolic energy, indicating that 
microbial metabolism may be more relevant than microbioal phylogenetic identity 
under an given environmental  condition (Rinttila and Apajalahti, 2013). 
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1.3.5 TRP in neurogastroenterology
In the rumen, microorganisms play an important role in making dietary amino acids 
bioavailable for the host and also synthesising amino acids, including the essential 
amino acid tryptophan. Although the same metabolic pathways exist within the 
human gut microbiota, colonic TRP production does not appear to contribute signi-
ficantly to hosts needs (estimated dietary requirement of 3.5 mg/kg per day – FAO/
WHO/UNU Expert Consultation, 1991). Tryptophan rich foods include nuts, seeds, 
tofu, cheese, red meat, chicken, turkey, fish, oats, beans, lentils, and eggs. The 
diet-dependent tryptophan, which is a precursor to many neuroactive compounds, 
can follow three different metabolic pathways (Fig. 6) in the human body: (1) kynu-
renine, (2) serotonin, (3) indole ways. 





Kynurenine pathway is the main metabolic route, which involves almost 95% of 
free tryptophan. The enzymes responsible for the initial conversion of tryptophan to 
kynurenine, indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase 
(TDO), are immuno (IFN-γ, TNF and IL-1β) and stress (cortisol and HPA) respon-
sive, respectively. This too highlights the important interconnections between the 
immune system, the brain and host:microbiota co-metabolic processes. While TDO 
is mainly located in the liver, IDO is an extra-hepatic enzyme found in numerous 
cells including macrophages, microglia, neurons and astrocytes (Hwu et al., 2000). 
Activation of both enzymes may impact, by limiting the availability of tryptophan, on 
serotonin synthesis and increase the downstream production of neurotoxic/neuro-
protective metabolites. For exemple, IL-17A and IL-22 cytokines, are regulated by 
the intestinal microbiota, as demonstrated in an in vivo study, where colonization 
of the small intestine of mice with Arthromitus (related to the genus Clostridium), 
segmented filamentous bacterium (SFB), induced the appearance of CD4+ T helper 
cells (Th17 cells) that produce IL-17 and IL-22 in the lamina propria (Ivanov et al., 
2009). Moreover, bacterially produced-ATP can augment Th17 differentiation, whe-
reas commensal microbiota seems to inhibit this pathway via IL-25. How intestinal 
microbiota control RORgt and IL-22 in gut NKp46+ cells remains to be defined, but 
both direct and indirect mechanisms could be operative (Satoh-Takayama et al., 
2008). In the brain, kynurenine (KYN) can be converted to two other componen-
ts of the pathway: the neurotoxic quinolinic acid (QUIN) and the neuroprotective 
kynurenic acid (KYNA). Kynurenic acid, one of the main products of the kynurenine 
pathway, exerts neuroprotective effects via its antagonistic action at glutamate 
receptors (NMDA and AMPA), but also at cholinergic α7nAChR nicotinic receptors, 
that mediate presynaptic release of glutamate (Wu et al., 2010). Moreover through 
its ability to scavenge hydroxyl, superoxide anion and other free radicals, KYNA, is 
also an antioxidant (Lugo-Huitrón et al., 2011). Its potential use in neuroprotection 
has been suggested against complex neurodegenerative processes (e.g. Alzhei-
mer’s disease, lateral amyotrophic sclerosis, Huntington disease and Parkinson 
disease) (Tajti et al., 2015). This action is attributed to its beneficial influence against 
neuroinflammatory processes, cerebral β amyloid peptides (Aβ) accumulation, 
excitotoxicity and apoptosis leading to irreversible histopathological alterations of 
the brain (Klein et al., 2013). Conversely, quinolinic acid, is a neurotoxic metabolite 
which is normally present in small concentrations (nmol) in the human brain and ce-
rebrospinal fluid, but can be increased in patological conditions (Heyes et al., 1996). 
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Macrophages, infected or stimulated with IFN-γ, TNF-α, and IFN-α, have a parti-
cularly high capacity to synthesize quinolinic acid in the brain (Pemberton et al., 
1997). Overactivation of the N-methyl-D-aspartate (NMDA) receptor, a glutamate 
receptor, by quinolinic acid, leads an enhanced recruitment of cytoplasmic Ca2+, as 
well as a mitochondrial dysfunction, massive use of ATP and cytochrome c release. 
Moreover, also the loss of GABAergic synapses and cholinergic neurons, as well as 
the oxidative stress, maybe due to the formation of reactive oxygen and nitrogen 
species (ROS and RNS, respectively) are recognized as toxic effects of quinolinic 
acid (Santamaria et al., 2012). 
Serotonin (5-hydroxytryptophan, 5-HT), is an alternative route-metabolite (around 
1-2%) of tryptophan metabolism. Serotonin has been linked with several functions 
in the human body, including mood, appetite, systemic hemodynamics and ga-
strointestinal motility, in addition to being the precursor for melatonin synthesis in 
pinealocytes. Serotonin is synthesized from tryptophan through hydroxylation – 
tryptophan hydroxylase (TPH) and decarboxylation – aromatic acid decarboxylase 
(AADC), which also catalyzes the synthesis of dopamine from tyrosine (Walther, 
2003; Zhu and Juorio, 1995). AADC enzyme needs vitamin B6 (pyridoxine), naturally 
present in many foods (e.g. rice bran, pistachio nuts, fish – tuna and salmon and 
Liver – Beef), as a cofactor to carryout its decarboxylation activity. These proces-
ses take place in the intestine at enterochromaffin cells mucosal layer, where it has 
been calculated that about 90% of the bodies serotonin is produced. While the re-
maining 10% is largely attributed to serotonergic neurons of the enteric nervous sy-
stem (ENS) (Kim, 2000). Importantly, significant modulatory effect of gut microbiota 
upon 5-HT biosynthesis and GI-activities has been reported. Fecal metabolites may 
increase 5-HT in chromaffin cell cultures (Yano et al., 2015). More recently, Reigstad 
et al (2015) have confirmed that gut microbiota promote serotonin production by 
enterochromaffin cells. Microbial-derived SCFA promotes EC-Tph1 (the rate-limiting 
enzyme for serotonin biosynthesis in EC cells) expression in a concentration-de-
pendent manner, and so 5-HT production. They are also able to increases mRNA 
transcript levels for Tph1 and ChgA (a biomarker of neuroendocrine secretion) in 
the proximal colon (Reigstad et al., 2015). Also α-tocopherol, tyramine, and pa-
ra-aminobenzoic acid (PABA) induce 5-HT release. Some bacteria (Streptococcus 
faecalis, Streptococcus lactis, Micrococcus luteus, Leuconostoc cremoris strains) 
can induce in the gut decarboxylation of tyrosine in tyramine, which stimulates fast 
ileal contractions and neuropeptide Y release (Voigt & Eitenmiller,1977; Gale, 1940). 
49
PABA is an intermediate of folic acid synthesis and essential nutrient for some 
bacteria (genus Lactobacillus). The physiological roles for PABA in the GI tract are 
unclear (Rossi et al., 2011). 
The  indole pathway of tryptophan degradation is mainly dependent on the anae-
robic intestinal bacteria with tryptophanase activity. Lactobacilli (e.g. L. reuteri), are 
typically auxotrophic (unable to synthesize a particular organic compound required 
for its growth), for most of the amino acids. Under carbohydrate starvation condi-
tions, they are able to shift their metabolic activities and produce bioactive indole 
derivatives from tryptophan breakdown, as a energy source (Zelante et al., 2013). 
Many indole-metabolites are able to bind to the aryl hydrocarbon receptor (AhR), 
a ligand–activated transcription factor that controls the expression of a diverse set 
of genes (Beischlag et al., 2008). Indole 3-aldehyde (IAld) is synthesized through 
indole pyruvate (IPyA) route. This compound is a tryptophan metabolite, produced 
by aromatic amino acid aminotransferase (ArAT), a phylogenetically conserved 
enzyme in many bacterial species, including the lactobacilli, which plays a major 
role in the conversion of aromatic amino acids to aromatic compounds (Rijnen et 
al., 1999). Quorum–sensing (QS) autoinducer–molecules are produced and released 
by bacteria in response to fluctuations in cell-population density (Miller and Bassler, 
2001). Indole, is able to modulate intercellular signals in bacteria as a QS molecule. 
It has also been shown (in vitro) to act on the expression of several human genes 
enhancing barrier functions of intestinal epithelial cells (EC) (Shimada et al., 2013). 
Co-metabolite indoxyl sulfate, on the other hand, has been shown to be involved in 
both cardiovascular and renal disease progression. It is an endproduct of bacterial 
tryptophan fermentation in the colon (Viaene et al., 2014). 
A  new tryptophan catabolic pathway which passes over the formation of kynure-
nine and leads to the production of pyruvate, acetaldehyde and acetate as end-
metabolites has been proposed. The main tryptophan-microbial users are Bacillus 
megaterium, Rhodococcus erythropolis, many pseudomonads and Burkholderia 
cepacia. In this pathway, tryptophan is converted to 3-hydroxyanthranilate, using 
the same enzymatic steps for NAD biosynthesis. 3-hydroxyanthranilate, is cleaved 
to 2-amino-3-carboxymuconate semialdehyde (ACMS) and then further degraded 
enzymatically to 2-aminomuconate and then 4-oxalocrotonate. The same enzyma-
tic activities are involved in the degradation of catechols and anthranilatene and 
lead to the production of pyruvate and acetate (Colabroy and Begley, 2005).
Metabolites derived from microbial catabolism of tryptophan, arise from complex 
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processes of co-metabolism which probably stem from the involvement of the diffe-
rent TRP pathways described above. In addition, the metabolic potential of the inte-
stinal microbiota - the metabotype - as well as genetics, gender and lifestyle (eg. 
stress, sleep) of the host and environmental factors within the intestine, in particular 
the amount and the proportions between amino acids, the pH and the presence 
of carbohydrates or other exogenous substrates, can modulate the metabolism of 
tryptophan.
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1.3.6 Gut bacteria-derived bioactive compounds
Many recent studies have shown that the intestinal microbiota may be emitting and 
receiving a multiplicity of signals to and from the brain. These signals, are modu-
lating or regulating a variety of GI functions. It has become increasingly evident 
that this microbe-related bidirectional gut-brain signalling, plays a role in human 
cognitive function and brain development and also brain pathophysiology (Collins 
and Bercik, 2009). Diet has an important role in shaping the gut microbiota and 
also the flux of neurochemicals they produce. As discussed above, certain fibers 
and prebiotics in particular, support a butyrogenic gut microbiota characterised by 
increased relative abundance of Bifidobacterium and sometimes Lactobacillus and 
possibly butyrate producing bacteria, like Roseburia inulinivorans and F. prausnitzii. 
These bacteria appear to be important members of the beneficial gut microbiota 
and induce beneficial host immune effects, improve mucosal integrity and some 
species also produce bioactive compounds other than SCFA, such as folate, sero-
tonin, dopamine and γ-aminobutyric acid (GABA) (Selhub et al., 2014; Asano et al. 
2012). GABA is the main inhibitory neurotransmitter in the brain and regulates many 
physiological and psychological processes. Dysfunction in the GABA system is im-
plicated in anxiety and depression (Cryan, 2005; Schousboe, 2007). Certain strains 
of Lactobacillus and Bifidobacterium can produce GABA from monosodium gluta-
mate and it has been suggested that the microbially produced GABA in the gut may 
have an effect on the gut-brain axis. Screening a number of gut bacteria for GABA 
production has identified L. brevis and B. Dentium as  efficient GABA producer 
species (Barrett, 2012). Another GABA producer tested in rats, Lactobacillus brevis 
FPA3709, was shown to have a similar effect as Fluoxetine, a common antide-
pressant drug, but without the drug side-effects which include loss of appetite and 
body weight (Patterson, et al., 2014). At the level of gene expression, the ingestion 
of L. rhamnosus JB-1, was shown to alter the mRNA expression of both GABA A 
and B receptors, which have been implicated in anxiety and depression (Bravo, 
2011). Strains of both genera are commonly used as probiotics or are present in 
traditional fermented foods, especially dairy products (Selhub et al., 2014). 
Since the early 1950s serotonin has been the subject of intense biological research 
both for its activities, as a neurotransmitter, but also more recently as an immuno-
modulatory in the periphery. It is also involved in the regulation of gastrointestinal 
motility, secretion and sensation, and has served as a basis for development of 
novel treatments for gastrointestinal disorders, such as IBS, besides its involvement 
in mood, appetite and hemodynamics. As previously discussed, almost 90% of the 
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human body's serotonin is produced from TRP by enterochromaffin cells in the gut 
(Oh et al., 2015; Kashyap et al., 2013). The gut microbiota, appears to influence 
serotonin levels, with germ-free mice showing significantly lower 5-HT plasma con-
centrations compared to conventional mice (Wickoff, 2009). In addition, oral inge-
stion of the probiotic B. infantis 35624, increased levels of the serotonin precursor, 
TRP, in the plasma of rats, suggesting that this bacterial strain, may have potential 
modulatory activities on TRP metabolism in the gut and could possibly be investi-
gated as a novel therapy for depression (Desbonnet, 2008). However, the ability to 
produce serotonin or induce serotonin production does not seem to be restricted 
to bifidobacteria and lactobacilli, with strains of the yeast Candida, Streptococ-
cus, Escherichia, and Enterococcus, all shown to produce serotonin (Lyte, 2011). 
As mentioned before, intestinal microbiota can modulate 5-HT levels through the 
production of SCFA (particularly butyrate and acetate), which significantly affects  
TPH1 expression in a concentration-dependent manner (Reigstad et al., 2015). 
Clearly, further studies are urgently needed to explore regulation of TRP metabolism 
by the gut microbiota. 
Catecholamines (CA), such as dopamine (DA), norepinephrine (NE) and epinephrine 
(E), are the major neurotransmitters in the brain. They can modulate a variety of fun-
ctions of nervous system, such as motor control, cognition, emotion, memory pro-
cessing and the endocrine secretions (Kobayashi, 2001). CA might be involved not 
only in pro-absorptive functions and alteration in bacterial pathogenicity, but also in 
a variety of physiological functions, such as gut motility and modulation of immune 
reactions. Substantial levels of free DA and NE were identified in the gut lumen of 
germ free mice after inoculation of with E. coli (Asano et al., 2012). Also Bacillus 
and Saccharomyces strains appear to be involved in the production of endogenous 
CA, while Bacillus and Serratia have the potential to produce dopamine, which 
plays a role in reward-motivated behaviour (Lyte, 2011). Acetylcholine, is a neu-
rotransmitter located both in the central and peripheral nervous systems. It plays 
a critical role in cognitive function, particularly in memory and learning. Previous 
studies have shown that acetylcholine is both a component of bacterial strains, 
including L. plantarum and Bacillus subtilis and a microbial metabolite (Girvin, 1954; 
Rowatt, 1948; Horiuchi, 2003). 
Endocannabinoids are lipid molecules that act as neurotransmitters/neuromodula-
tors in the brain which contain specific endocannabinoid receptors (Piomelli, 2003). 
These receptors also engage with Δ9-tetrahydrocannabinol, the active constituent 
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of cannabis. The endocannabinoid system and the gut microbiota can impact on 
the development of obesity and related disorders (Muccioli, 2010). In addition, a L. 
acidophilus strain has been shown to modulate expression of cannabinoid recep-
tors in the spinal cord (Rousseaux, 2007). 
Diet can have a marked impact on the gut, including gut transit time and pH, while 
the main dietary macronutrients (carbohydrates, proteins and fats) can significantly 
affect the composition of the gut microbiota. It has been suggested that food intake 
could have important effects on behaviour (Bellisle, 2003). Nutritional components, 
such as prebiotics (eg. inulin, GOS, FOS), might play a neuroprotective role against 
white matter injury, through modulation of inflammation and infection, and may 
influence the microbiome-gut-brain axis (Keunen et al., 2015). A dietary supple-
mentation for 3 weeks with GOS/FOS explored the neuroendocrine effects on 45 
healthy human volunteers. Prebiotic GOS intake was associated with decreased 
cortisol levels and altered attentional bias compared to the placebo, while no ef-
fects were found after the administration of FOS (Schmidt et al., 2015). Anxiety and 
depression are highly comorbid in individuals with IBS. Daily administration of pre-
biotic GOS mixture, in patients with chronic fatigue syndrome, decreased anxiety 
scores and had a significant positive impact on quality of life. GOS intake was 
previously shown to increase the numbers of bifidobacteria and lactobacilli (Gopal 
et al., 2001), as well as SCFA (Rodriguez-Colinas et al., 2013), which are well know 
to be associated with an increase of epithelial barrier against potential pathogens 
and toxins, and are also able to modulate the immune system (Vulevic et al., 2008). 
These combined effects could be responsible of the modulation and improvement 
of symptoms related to a state of chronic stress (Schmidt et al., 2015; Silk et al., 
2009). Furter studies are needed to test the ability of prebiotics in the treatment of 
stress-related disorders through modulation of the gut:brain axis.
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The microorganisms which inhabit the colon have a complex and sometimes 
dichotomous relationship with the host. Through their activities, they influence 
many aspects of human physiology. In fact, one could view the human intestine 
as an organ that was largely shaped by the microbiota during evolution and also 
be diet:microbe interactions from birth to old age. The human body influences its 
microbial community by imposing different environments, regulating levels of moi-
sture, oxygen, bile acids, pH, digestive secretions and interactions with the immune 
system (Boon et al., 2014). The gut microbiota protects against enteropathogens, 
extracts nutrients and energy from our diets and contributes to normal immune 
function (Maslowski and Mackay, 2011). Disruptions to the normal balance betwe-
en the gut microbiota and the host have been associated with obesity and type 2 
diabetes (Joost, 2012), malnutrition (Gordon et al., 2012), inflammatory bowel dise-
ase (Sartor and Mazmanian, 2012), neurological disorders (Perlmutter and Loberg, 
2015) and cancer (Poutahidis et al., 2014). Diet can have a marked impact on the 
gut, including gut transit time and pH; the main dietary macronutrients  (carbohy-
drates, proteins and fats), can significantly affect the composition of the gut micro-
biota and importantly, their metabolic output. Furthermore, it has been suggested 
that food intake could have important effects on brain development and cognitive 
function (Bellisle, 2003). The objectives of this PhD project were to (a) examine 
how protein/amino acid metabolism is impacted by the presence of a fermentable 
fiber, the prebiotic inulin; (b) measure the impact of inulin on microbiota tryptophan 
metabolism in vitro; (c) measure in vitro metabolism of different amino acids by the 
gut microbiota, including amino acid precursors of human neurotransmitters; and 
(d) measure the impact of diet on the gut microbiota over the life-course of farmed 
fish in vivo. This study represents an integrated multidisciplinary approach, using in 
vitro model of the human gut microbiota, a dietary intervention in an animal model 
(trout), culture independent microbiology (next generation sequencing and fluo-
rescent in situ hybridization - FISH), metabolomic (NMR) analysis, bioinformatic 
(MICCA) analysis and data integration.
2. Aims of the study
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Abstract
Certain metabolites produced by the colonic microbiota, like the biogenic amine 
trimethylamine (TMA) appear to increase the risk of cardiovascular disease upon 
colonic fermentation of choline, L-carnitine. Anaerobic batch cultures of human fae-
ces (n = 5), were used to measure the microbial ecology of the distal colon upon the 
fermentation of beef (red meat grinded, roasted and predigested simulating gastric 
and duodenal activities). Prebiotic inulin has been included in the study, fermented 
alone or added to beef, to evaluate the cross-feeding relationship between micro-
organism residents in the colon and arisen metabolic profile. Combined high-throu-
ghput pyrosequencing with biofluid NMR-based metabolic profiling allowed the 
measurement of changes in microbial ecology both in terms of diversity measures 
and changes in relative abundance, and also shifts in metabolites produced or 
consumed during the fermentations over a 24 hours period. Inulin improved protein 
metabolism by the distal colonic microbiota by increasing the consumption of ami-
no acids, such as tryptophan and phenylalanine, but at the same time reducing the 
production of potentially toxic metabolites such as TMA, 5-Aminopentanoic acid 
and phenol. Moreover, inulin had an impact on the structure of the distal colonic 
microbiota, shifting relative abundance in favour of Butyricicoccus, Butyricimonas, 
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Coprococcus and Dorea in detriment of others genera, such as Blautia and Lachno-
spiraceae incertae sedis and Clostridium cluster XVIII. However, there was conside-
rable inter-individual variation in response to either digested meat or inulin between 
faecal donors limiting statistical strength of observations. Similarly, inulin did not 
appear to increase the relative abundance of bifidobacteria suggesting a greater 
effect of pH than substrate availability in determining the relative abundance of dif-
ferent bacteria within the distal colon. However, taken together, this study supports 
the notion that increased consumption of fermentable fiber or prebiotics like inulin 
may be one means of reducing the production of harmful metabolites upon protein 
fermentation in the distal colon.
Keywords
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Diets high in protein, especially red meat, have been associated with increased 
risk of cardiovascular disease and colorectal cancer (Lippi et al., 2015; Aykan, 
2015).  It is estimated that about 12–18 g of dietary protein reach the colon each 
day, having escaped digestion by host enzymes and absorption in the stomach 
and small intestine. In the large intestine, this protein comes in contact with the 
colonic microbiota, the single largest collection of microorganisms inhabiting the 
intestinal tract. Dietary protein in the colon serves as a source of amino acids both 
for the microbiota itself (and converted into microbial biomass) and for the host. 
However, dietary protein and derived amino acids can also be fermented by the gut 
microbiota to derive energy, resulting in a range of metabolites including short chain 
fatty acids (acetate, butyrate and propionate), branched chain fatty acids (mainly 
isobutyrate, isovalerate and isocaproate), indoles, sulphides, ammonium, phenols, 
histamine, oxaloacetate and biogenic amines like trimethylamine (TMA) (Scott et al., 
2013). Some of these metabolites are potentially harmful to the host and have been 
suggested to play a role both in colon cancer risk and in cardiovascular disease. 
Some of these compounds have been implicated in the development, function and 
homeostasis of the immune system (Brestoff and Artis, 2013; Jacobs et al., 2009), 
e.g. SCFA, but many also appear to harmful effects on the bowel epithelium (e.g. 
nitrosamines, nitrosamides, and nitrosoguanidines) and/or at systemic level (e.g. 
Trimethylamine N-Oxide – TMAO). Protein fermentation by the colonic microbiota is 
less efficient in terms of energy production (13.4 kJ/g) than carbohydrate (15.7 kJ/g) 
fermentation (Elia and Cummings, 2007). Early observations, recorded a shift in co-
lonic microbiota fermentation patterns, followed the substrate and pH gradient, with 
saccharolytic fermentation predominating in the proximal colon and protein/amino 
acid fermentation in the distal colon. (Cummings and Macfarlane, 1991). The pH of 
the colon changes from proximal (pH 5.5), through the transverse colon (pH 6.2) to 
the distal colon (pH 6.8-7.2). Recent studies have shown that pH can have a signifi-
cant impact on the relative abundance of different bacteria under simulated colonic 
conditions, as for example, bifidobacteria which grow rapidly in the presence of 
prebiotics, like inulin, at pH 5.5, while they are poorly represented, in the presence 
of the same substrate, at pH 6.9 or higher (Chung et al. 2016). Few studies have 
however, examined the impact of protein and/or carbohydrate fermentation on both 
production of fermentation end products and structure of the microbial community 
in the distal colon. 
TMA can derives from choline (Ch) and phosphatidylcholine (PCh), which are found 
3.1 Introduction
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in many different foods, including red meat, fish/sea-food and soy products or 
L-carnitine derived mainly from red meat. Ch is recognized as an essential nu-
trient since it is needed for the synthesis of the neurotransmitter acetylcholine, for 
cell-membrane signaling (phospholipids), lipid transport (lipoproteins), and for its 
role as in methyl-group metabolism (homocysteine reduction) (Zeisel and da Costa, 
2009). It is also the major dietary source of methyl groups via the synthesis of 
S-adenosylmethionine (SAMe) (Penry and Manore, 2008). SAMe, which works with 
vitamin B12 and B9 (folate), plays a important role in the immune system, maintains 
cell membranes, and helps produce and break down brain chemicals, such as 
serotonin, melatonin, and dopamine (Bottiglieri, 2013). Furthermore, choline defi-
ciency may cause diseases such as nonalcoholic fatty liver disease, atherosclerosis 
(via lipoprotein secretion), and neurological disorders (Dumas et al 2006; Zeisel 
and da Costa, 2009; Alpert et al., 2004). L-carnitine is a quaternary ammonium 
compound demonstrated to be involved in the β-oxidation of fatty acids and in 
the transport of long-chain fatty acids through the inner mitochondrial membrane 
of mammals (Krämer et al., 2001). Beef is the third most widely eaten meat in the 
world representing over 22% of meat intake (FAO World Food Outlook 2014). For 
healthy adults - with a default body weight of 70 kg for the european adult popula-
tion - the average requirement (AR) is 0.66 g protein/kg body weight for day based 
on nitrogen required data. In european countries the main dietary protein intake 
come from meat and meat products, grains and grain-based products, and milk 
and dairy products, with a protein intake of 0.8 to 1.25 g/kg body weight for day 
(EFSA, 2012). Although the data are not sufficient to establish a tolerable upper 
intake level (UL) for protein, the over amount of daily animal/resistant protein, can 
be responsible for the production/increase of toxic compounds along bowel, inclu-
ding nitroso compounds (amines and amides), hemin, volatile phenols and indoles 
(Bastide et al., 2011). The International Agency for Research on Cancer (IARC), and 
the cancer agency of the World Health Organization (WHO), have evaluated the 
carcinogenicity of the consumption of red meat and processed meat last October 
(2015).  Pro-atherogenic TMAO is formed by two steps process: the first one starts 
with the bowel microbiota dependent cleavage of a TMA species from PCh/Ch/
betaine/L-carnitine generating the precursor TMA, and the second one in the liver 
with oxidation by FMO3 enzyme to produce TMAO (Brugère et al., 2014). TMAO not 
only promotes atherogenesis, but recent studies in mice also suggest that dietary 
TMAO may exacerbate impaired glucose tolerance, obstruct hepatic insulin signa-
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ling, and promote adipose tissue inflammation when fed a high-fat diet (Tang and 
Hazen, 2014). Nevertheless, TMAO also plays important biological role of slowing 
urea-induced dissociation of multimeric intracellular proteins by diminishing the rate 
of lactate dehydrogenase activity with significant protection of the enzyme against 
urea-induced time-dependent inactivation (Baskakov and Bolen, 1998) and is an 
important osmolyte in the body. A number of recent studies have focused on the 
role of microbial metabolites of phosphatidylcholine, choline and betaine into TMA 
and its oxide form (TMAO) in cardio vascular diseases (CVD) risk. Underlining how 
vegans or vegitarians have much lower levels of TMAO (Koeth et al., 2013). Moreo-
ver, has been acknowledged a partial agonist activity of TMA upon muscle nicotinic 
receptors (Lape et al., 2009). Although TMA administration at high doses has not 
shown to act on locus coeruleus (LC) neurons (Engberg and Hajos, 1994), it is able 
to simulate the effect of nicotine on LC (Hajós and Engberg, 1988). This could be 
another action of TMA, with the opportunity to new studies to confirming the link 
between bowel and neural system. 
Although the link between high red meat intake and both CVD and colon cancer is 
now well accepted, much debate remains concerning the relative contribution of 
TMAO or TMA production in the colon, especially since foods like soy beans and 
fish (both high in PCh and Ch) have been associated with protection from these 
same diseases in epidemiological studies (Rajaie and Esmaillzadeh, 2011) and also 
L-carnitine is a common dietary supplement used to lower the risk of heart disease 
(Lee et al. 2015; DiNicolantonio, 2014; Lee et al. 2014). Host genetics, especially 
polymorphism in the TMAO producing enzyme FMO3 have been suggested to play 
an important role in regulating circulating TMAO concentrations, but few studies 
have examined the impact of different food matrices, or the relative impact of pro-
tein vs carbohydrate fermentation, on TMA production by the gut microbiota, which 
for any given host impacts on circulating TMAO levels (Hartiala et al. 2015).  
In this study, the effects of the prebiotic inulin on colonic dissimilatory protein me-
tabolism was examined, using anaerobic faecal batch cultures. The pH set between 
6.8 and 7.2, represent the environment conditions in the distal colon. Prime ground 
beef was chosen as a PCh, Ch and L-carnitine rich substrate and was cooked 
(roasted) and subjected to simulated gastric and small intestinal digestion, prior to 
use as substrate for faecal batch cultures. Inulin, a polymer (2-60 units) of fructose 
units, with a glucose molecule at the end of the chain, is present in many vege-
tables and fruits including, onions, leeks, garlic, bananas, asparagus, chicory, and 
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Jerusalem artichokes. It is undigestible by human intestinal enzymes and reaches 
the colon intact, where is totally fermented by colonic microbiota (Niness, 1999). 
Inulin is also called the “gold-standard” prebiotic, defined as a selectively fermen-
ted ingredient, that results in specific changes in the composition and/or activities 
of gastrointestinal microbiota, thus conferring benefit(s) upon host health (Gibson et 
al., 2010). Changes in faecal microbial ecology and metabolic output, were studied 
using a combination of 16S rRNA gene sequencing (meta-taxonomics), on the 
Illumina MiSeq platform, fluorescent in situ hybridization with 16S rRNA targeted 
probes, for selected bacteria and a non-targeted 1H NMR-based metabonomics, to 
profile metabolites produced during fermentation experiments.
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3.2 Materials & 
Methods
In vitro digestion
The homemade hamburger, with selecting beef of high-grade, directly from a 
butcher and freshly ground. For simulating all steps followed in a daily meal, the 
hamburger was roasted (10’ for each side) and grinded, as after mastication, and 
then pre-digested by in vitro method, with all enzyme and activities to which the 
food is subjected, during the passage from the oral channel to the duodenal tract. 
Cargill Oliggo-Fiber® inulin DS2 5LB (dietary fiber – 98% and free fructose; glucose 
and saccharose – 2%) (Warcoing Industries S.A. Belgium), composes of short and 
medium length chains with a degree of polymerization average (DPA) of 12 (Gibson 
and Roberfroid, 1995), was pre-digested in the same way of beef. 
The substrates used for batch fermentations was subject to in vitro upper gastroin-
testinal digestion consisting of an initial gastric phase, followed by a duodenal-in-
testinal tract, which simulates the chemical and enzymatic conditions of relevant 
portions of the stomach and small intestine. The protocol was drawn from Manda-
lari (2013) and adapted. The below description of the protocol is considering the 
digestion of 1.5 g starting material.  
Preparation of phospholipid vesicles. The lipid vesicles were prepared by remo-
ving the solvent by 0.28 ml of a stock solution of L-α-phosphatidylcholine (PCh) 
from egg in chloroform (0.235 ml in solution of 100 mg/ml of chloroform) (Grade 1, 
Lipid Products, UK). The organic solvent was removed overnight using a Rota va-
cuum evaporation system, thus producing a thin lipid film on a round bottom flask. 
To avoid oxidation, the lipid film was covered with Argon. The PCh was rehydrated 
with 7.6 ml of 0.15 M NaCl pH 2.5, then 5 2 mm diameter glass beads were added 
and the flask was incubated for 1 hour at 37 °C on a horizontal shaker. The suspen-
sion was then sonicated (Branson mod.) at 30% power for 30 minutes, non-conti-
nuous mode, in order to avoid the excessive increase of the temperature and the 
overheating of the probe. The suspension of liposomes in single layer was finally 
filtered with a 0.22 µm Nalgene filter to remove any deposit of titanium resulting 
from sonication.
Gastric phase. Each test substrate was re-suspended in 6.3 ml of 0.15 M NaCl 
pH 2.5 and the pH was adjusted to 2.5 with HCl (0.5 M) or NaOH (0.5 M). A 6.1 ml 
suspension of lipid vesicles was then added to the solution. The gastric enzymes, 
pepsin and lipase (Sigma-Aldrich) were added at 146 and 60 U/ml concentration 
of reaction respectively, and the samples were incubated at 37 °C for 2 hours on a 
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horizontal shaker.
Duodenal phase. The pH was brought to 6.5 and the following reagents were 
added in such quantities as to reach the respective final concentration: CaCl2 - 
11.7 mmol/l, BIS-TRIS buffer - 0.73 mmol/l and bile acid sodium taurocholate 
and sodium glycodeossicholate - 4 mmol/l. The chemicals were purcased from 
AppliChem. The pH of 6.5 was checked again and the enzymes were then added 
at the respective final concentrations: α-chymotrypsin - 5.9 U/ml, trypsin - 104 U/
ml, colipase - 3.2 U/ml, pancreatic lipase - 54 U/ml and α-amylase - 25 U/ml. The 
chemicals were purchased from Sigma. The digestion was performed by incubating 
the samples at 37 °C for 1 hour on a horizontal shaker.
Dialysis. The digested sample was subjected to dialysis, according to the indica-
tions of Millis et al. (2008). The dialysis membrane, Spectra/Por (Spectrum Labs) 
with a cut-off molecular weight of 1 kDa, which had been previously washed in 
distilled water, was filled with the digested material and closed on both sides. The 
membrane was then placed in dialysis solution (10 mM NaCl), at a volume about 
100 times greater than the volume of the material to be dialyzed and incubated at 4 
°C overnight with slow stirring.
Lyophilization. The dialyzed retentate material were transferred to a round bottom 
flask and placed at -80 °C until frozen. The material was then lyophilized and the 
obtained powder was weighed and stored at -80 °C.
Fecal batch cultures
Faecal fermentations were conducted using the basal nutrient medium, prepa-
red as from the following formula (g/l): starch – 8.0; mucin (porcine gastric) – 4.0; 
casein – 3.0; peptone water – 5.0; tryptone water – 5.0; bile #3 – 0.4; yeast – 4.5; 
FeSO4 – 0.005; NaCl – 4.5; KCl – 4.5; KH2PO4 – 0.5; MgSO4 7H2O – 1.25; CaCl2 
6H2O – 0.15; NaHCO3 – 1.5; tween 80 – 1; hemin – 0.05; cysteine HCl – 0.8. All 
chemicals were purchased from Sigma. The final, working volume of all fermen-
tations was 150 ml. Anaerobic conditions were maintained by O2-free N2 (15 ml/
min) flow overnight. Temperature was held at 37 °C using a circulating water bath, 
and pH was controlled between 6.8 and 7.2 using an automated pH FerMac 260 
controller (Gloucester, England-GL208JH, United Kingdom), which added acid and 
alkali as required (0.5 M HCl and 0.5 M NaOH). Five healthy human donors (2 male, 
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3 female), who had taken no prebiotics, probiotics, or antibiotics within 3 months of 
the study were recruited to provide faecal samples as inocula. Faecal inocula (10% 
w/v) were prepared using pre-reduced phosphate-buffered saline (PBS 0.1 mol/l) 
and used to inoculate each fermentation vessel to a final concentration of 1% fae-
ces w/v. The substrates tested in fermentation, were basal medium (Blank), Inulin 
at 1% (w/v) (Cargill Oliggo-Fiber® inulin DS2 5LB), as positive control, tryptophan 
(5 mmol/l) (Sigma-Aldrich, Germany) and tryptophan added Inulin, with the same 
their respective concentrations. Each fermentation was conducted once with faecal 
inocula from each of the 5 faecal donors (n = 5). Batch cultures were run for 24 hour 
and samples obtained from each vessel at 0, 5, 10, 24 h, were centrifuged at 
13 000 rpm, where the supernatants and pellets were stored at -80 °C for metabo-
lomics and metagenomics analysis respectively. Samples for FISH were prepared 
as described below and stored at -20 °C.
Fluorescence In Situ Hybridization-Flow Cytometry 
(FISH/FC)
Sample fixing and hybridization, were performed as previously described (Ro-
chet et al., 2004; Saulnier et al., 2008). Briefly, 375 μl of culture fluid was diluted 
in 1125 μl of 4% (w/v) paraformaldehyde and fixed overnight at 4 °C. Bacterial 
cells were pelleted by centrifugation at 13 000 rpm for 5 min and washed twice in 
filter-sterilized PBS. Cells were then resuspended in 150 μl PBS and 150 μl ethanol. 
Samples were stored at −20 °C for a minimum of 3 h before further processing. 
Genus-specific 16S rRNA oligonucleotide probes, labelled with the fluorescent dye 
Cy5 (Sigma Aldrich, Italy), were utilized for selected bacterial groups, the nucleic 
acid stain 2-[N-(3-dimethylaminopropyl)-N-propylamino]-4-[2,3-dihydro-3-methyl-
(benzo-1,3-thiazol-2-yl)-methylidene]-1-phenyl-quinolinium - SYBR Green I - (Sig-
ma Aldrich, Italy), for total cell counts. The probes used were as follows: Bif 164, 
specific for Bifidobacterium (Langendijk et al., 1995) and Enterobac D, for Entero-
bacteriaceae (Ootsubo et al., 2002). In 96 well plate, 10 μl of fixed suspension was 
mixed into 190 μl of PBS (pH 7.2) and then centrifuged at 4000 rpm for 15 min at 
4 °C. After one wash in Tris EDTA buffer (TrisHCl – 100 mM; EDTA – 50 mM (pH 8)), 
when requested, pellets were suspended in Tris EDTA buffer, containing 1 mg/ml 
of lysozyme (Sigma Aldrich, Italy) and incubated for 10 min at room temperature. 
Cells were washed in PBS (pH 7.2), to remove lysozyme and were suspended in the 
hybridization solution (NaCl – 900 mM; TrisHCl –20 mM (pH 8.0); Sodium Dodecyl 
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Sulfate – 0.01%; formamide as requested), containing 5 ng/μl of specific probes, 
for a total volume of 55 μl. The hybridization step, was performed overnight at the 
appropriate labelled probe temperature. Following hybridization, a volume of 145 μl 
of hybridization solution, was added in each well, and cells were pelleted at 4000 
rpm for 15 min, at 4 °C. Nonspecific binding of the probe, was removed by incu-
bating the bacterial cell suspension, at the appropriate temperature for 20 min in 
200 μl, of a washing solution (NaCl – 64 mM; TrisHCl – 20 mM (pH 8.0)). Cells were 
suspended in 50 μl of PBS (pH 7.2), containing 1x SYBR Green I and incubated at 
room temperature for 10 min. Following hybridization, a volume of 150 μl of PBS 
(pH 7.2) was added in each well, and cells were centrifuged at 4000 rpm for 15 min, 
at 4 °C. Final pellet was suspended in 100 μl of PBS (pH 7.2) and then subsequent-
ly analyzed.
Data acquisition by flow cytometry (FCM)
The acquisition threshold was set in the side scatter channel using a Guava 
easyCyte 8T flow cytometer (Millipore, Italy). For each sample, a total of 10 000 
events were stored in list mode files. Analyses were made using the inCyte softwa-
re (Millipore, Italy). Cells were enumerated by combining in the same hybridization 
tube, one group Cy5-probe with the SYBR green. An FLG histogram (green fluo-
rescence), was used to evaluate the total number of bacteria stained, with SYBR 
green. A gate was designed, in this histogram representing the total number of 
bacterial cells, in the sample and was used to build an FLR histogram (red fluore-
scence), to estimate the proportion of cells targeted, by the group Cy5-probe in the 
sample. The proportion of group cells, was corrected by eliminating background 
fluorescence. Results were expressed as cells hybridizing with the groupCy5 probe, 
as a proportion of total bacteria stained with SYBR green.
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Real-Time qPCR
Bacterial groups in fecal samples were quantified by qPCR using the LightCycler® 
480 Real-Time PCR System (Roche, Germany) and the primers as shown in the 








Reference (Furet et al., 2009)
Primers for amplification of Bifidobacterium spp. and Enterobacteriaceae were 
designed using 16S rDNA gene sequences, as indicate in references. The qPCR 
reaction mixture (20 µl), was composed of 0.25 µM of each universal primer, 2x 
SensiFAST™ HRM Kit (Cat. No. BIO-32005; Bioline Reagents Ltd. ), and 0.25 ng 
of DNA from 80 samples collected during 24 h fermentation. Nuclease free water 
was add to reach the final volume defined. The Standards (STD), were prepared by 
10-fold serial dilutions starting from the DNA extract of a pure culture of Lactobacil-
lus adolescentis and Escherichia coli  DH 5α, which cells/ml were counted by plate 
count on MRS (LB for E. Coli). The amplification program consisted of one cycle of 
95 °C for 2 min, followed by 45 cycles of 95 °C for 15 s, and 60 °C for 30 sec. Stan-
dard curves were constructed for each experiment using six point of 10- fold serial 
dilutions of bacterial genomic DNA of known concentration. Standard curves were 
created according to LightCycler® 480 software and normalized to the copy number 
of the 16S rRNA gene for each species. 
1H NMR Spectroscopy
For spectroscopic analysis, 400 μL of fermented slurry were diluted with 200 μL 
of phosphate buffer (pH 7.4; 100% D2O), containing 1mM of TSP (3-trimethylsilyl-
1-[2,2,3,3-2H4] propionate) as an external standard and 2mM sodium azide as a 
bacteriocide. Samples were mixed by vortex and centrifuged at 13 000 g for 10 
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min, prior to transferring 550 μL to a 5 mm NMR tube. Spectroscopic analysis were 
carried out on a 500 MHz Bruker NMR spectrometer. For each sample, 8 dummy 
scans were followed by 128 scans and collected into 64 000 data points. A spectral 
widths of 20 ppm was used. Spectra were manually phased, corrected for baseline 
distortions and referenced to the TSP signal at δ 0.00. 1H-NMR spectra (0.2 to 10.0 
ppm) were digitized into consecutive integrated spectral regions (~20.000) of equal 
widths (0.00055 ppm). The regions containing the residual signal from water (4.50 
to 5.00 ppm),  TSP (0.00 ppm) and the large resonance arising from basal medium, 
were removed to minimize the effects of baseline distortion. Each spectrum was 
then normalized to unit area.
NMR data analysis and metabolites identification
Multivariate modeling, including Principal Component Analysis (PCA) and Or-
thogonal Partial Least Squares analysis (OPLS), was performed in MatLab (The 
Mathworks, Inc., Natwick, MA), using scripts provided by Korrigan Sciences Ltd., 
United Kingdom. The 1H-NMR spectroscopic profiles were used as the descriptor 
matrix (X), and donors, sampling time and treatments were used individually as 
response variables (Y). Loading coefficient plots were generated by back-scaling 
transformation to display the covariance between the Y-response matrix and the 
signal intensity of the metabolites in the NMR data (X). Colors projected onto the 
coefficient plot indicate the correlation coefficient (R2) between each metabolite and 
the Y-response variable, with red indicating strong significance and blue indicating 
weak significance. The predictive performance of the model (Q2Y) was calculated 
using a seven-fold cross validation approach. Model validity was established by 
permutation (1000 permutations) and the results are given as p values.
Metabolite identification was performed using HMDB database (http://www.hmdb.
ca/), KEGG (Kyoto Encyclopedia of Genes and Genomes), Chenomix profiler 8.1 
software (Chenomx Inc., Edmonton, Canada).
DNA extraction
The genomic DNA extraction was obtained by FastDNA™ SPIN Kit for Fecesn 
(MP Biomedicals, Santa Ana,CA), following the manufacturer’s protocols. The final 
product was 100 μl of application-ready DNA. Nucleic acid concentration and purity 
were measured using the Nanodrop 8000 spectrophotometer. DNA concentrations 
were in the range 18.2 – 96.6 ng/µL.
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16S rRNA amplicon library preparation and MiSeq se-
quencing
Using the specific bacterial primer set 341F (5’ CCTACGGGNGGCWGCAG 3’) (Klin-
dworth et al. 2013) and 806R (5’ GACTACNVGGGTWTCTAATCC 3’) (Apprill et al. 
2015) with overhang Illumina adapters, total genomic DNA was subjected to PCR 
amplification, by targeting a ~460-bp fragment of the 16S rRNA variable region V3-
V4. PCR amplification of each sample, was carried out using 25 µl reactions with 
1 µM of each primer. Specifically 12.5 µl of 2x KAPA HiFi HotStart ReadyMix, 5 µl 
forward primer, 5 µl reverse primer, were used in combination with 2,5 µl of tem-
plate DNA (5 ng/ul). All PCR amplification was carried out, using a GeneAmp PCR 
System 9700 (Thermo Fisher Scientific) and the following steps: melting step – 95 
°C for 3 minutes (one cycle); annealing step – 95 °C for 30 seconds, 55 °C for 30 
seconds, 72 °C for 30 seconds (25 cycles); extension step – 72 °C for 5 minutes (1 
cycle). The PCR products were checked on 1.5 % agarose gel and cleaned from 
free primers and primer dimer, using the Agencourt AMPure XP system (Beckman 
Coulter, Brea, CA, USA), following the manufacturer’s instructions. Subsequently, 
dual indices and Illumina sequencing adapters Nextera XT Index Primer (Illumina), 
were attached by 7 cycles PCR (16S Metagenomic Sequencing Library Preparation, 
Illumina). The final libraries, after purification by the Agencourt AMPure XP system 
(Beckman), were analysed on a Typestation 2200 platform (Agilent Technologies, 
Santa Clara, CA, USA) and quantified, using the Quant-IT PicoGreen dsDNA assay 
kit (Thermo Fisher Scientific), by the Synergy2 microplate reader (Biotek). Finally, all 
the libraries were pooled in an equimolar way, in a final amplicon library and analy-
sed on a Typestation 2200 platform (Agilent Technologies, Santa Clara, CA, USA). 
Barcoded library were sequenced on an llumina® MiSeq (PE300) platform (MiSeq 
Control Software 2.0.5 and Real-Time Analysis software 1.16.18).
Metagenomic data analysis
The sequences were assigned to samples, according to sample-specific barcodes. 
This allowed to collect FASTQ formatted files. Raw data fastq files were merged 
using micca-mergepairs tool. Raw data will be submitted to the http://www.ebi.
ac.uk/ena/submit/sequence-submission. Reads were processed using the MICCA 
pipeline (version 1.0, http://micca.org/) (Albanese et al., 2015). Forward and reverse 
primers trimming, were performed using micca trim (parameters 5’ CCTACGG-
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GNGGCWGCAG 3’ - 5’ GACTACNVGGGTWTCTAATCC 3’). Quality filtering, were 
performed using micca filter (parameters -e 0.5 -m 400 -t), truncating reads shorter 
than 400 nt and discarding reads, with an expected error (EE) rate > 0.5%. De-novo 
sequence clustering, chimera filtering and taxonomy assignment, were performed 
by micca otu (parameters -d 0.97 -c): operational taxonomic units (OTU) were 
assigned by clustering the sequences, with a threshold of 97% pairwise identity, 
and their representative sequences were classified, using micca classify with the 
RDP classifier version 2.8 (Wang et al., 2007). Template-guided multiple sequence 
alignment (MSA), was performed using micca msa (parameters -m nast), against 
the multiple alignment of the Greengenes (DeSantis et al., 2006) database (release 
13_05) clustered at 97% similarity. Finally, phylogenetic tree was inferred, using 
micca tree (parameters -m fasttree), using FastTree (Price et al., 2010). Sampling 
heterogeneity, was reduced by rarefaction (3,972  sequences per sample). Alpha 
(within-sample richness) and beta-diversity (between-sample dissimilarity) estima-
tes, were computed using the phyloseq R package (McMurdie & Holmes, 2013).
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Metabolomic fingerprint by 1H-NMR and Multivariate 
Data Analysis (MVDA) analysis
OPLS models with one predictive component and no orthogonal components were 
calculated to identify metabolites associated with gut microbial fermentation time 
(0, 5, 10 and 24 h) with Inulin, beef and beef+Inulin, respectively.
A significant model for beef fermentation (Tab. 1), showed an increase over time of 
phenol, TMA, methylamine (MA), 5-aminopentanoic acid, propionate, butyrate and 
acetate (Fig. 2). When combined with inulin (Tab. 1), it seems to inhibit the formation 
of 5-aminopentanoic acid (Fig. 3). 
Figure 4a shows a PCA of metabolite profiles describing the Beef vs Beef+Inulin 
fermentations after 24h. The first two principle components (PCs) explain 38% of 
the total variance within the data comparing Beef and Beef+Inulin, and although 
each donor can be clearly distinguished, the PCA shows a clear and consistent 
separation between the treatments (Fig. 4a). Interestingly, faecal donors 3, 4 and 5, 
appear to group or cluster together indicating that there is a degree of similarity in 
their metabolite profiles at 24 h compared to donor 2 and 1 which show differen-
ce in metabolite profiles after 24 hours of fermentation. The corresponding OPLS 
model (Fig. 4b, Tab. 1) shows that butyrate and ethanol are increased in Beef+Inulin 
treatment compared to Beef alone, while phenylalanine (Phe), tyrosine (Tyr), Betai-
ne, 5-aminopentanoic acid, TMA, and leucine are found in lower amounts, confir-
ming the positive effect of the prebiotic inulin in the reduction of potentially toxic 
compounds generated from meat consumption.
Responses at the OTU level
A total of 80 samples were collected from four treatments (basal medium (Blank), 
Inulin (1% w/v), Beef (0.5% w/v) and Beef+Inulin (1.5% w/v)), four sampling time (0, 
5, 10, 24 hours) and five healthy faecal human donors (No. 1-5), for DNA extraction, 
PCR and sequencing. Using a distance-based similarity of  ≥ 97% for operational 
taxonomic units (OTU) assignment, a total of 204.56 ± 53.48 OTUs were identified 
per sample. For taxonomic alpha diversity (accounting for relative abundances of 
OTUs at each time point), all fermentations showed decrease at 5, 10 and 24 hours 
compared to baseline (0 hours), except for Beef+Inulin, which showed a slight 
increase (Figure 5). The increase in phylotype richness in the Beef+Inulin fermenta-
tion, is significantly from Beef (P = 1.1e-05) and Inulin (P = 0.0047) alone and with 
the blank (P = 1.9e-05) (Tab. 2). There was no statistically difference in α-diversity 
3.3 Results 
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between fermentation of Beef, Inulin or Blank.
UniFrac is a phylogenetically aware measure of beta diversity that can be used 
to compare OTU structure and community diversity, in high resolution 16S rRNA 
gene inventories, of microbial communities. The weighted quantitative measure, 
detects changes present in many sequences from each lineage, as well as changes 
in which taxa present. For describing community changes, the relative abundance 
of different bacteria is critical and here, the scenario appears opposite to that seen 
for α-diversity. All fermentations showed an increase in Weighted Unifrac distance 
beta-diversity over time, compared to baseline (Fig. 6). Beef fermentation, slightly 
increased in β-diversity after 5 hours of fermentation, decreased at time 10 hours 
and increased again by 24 h. This means that although the species or pylotype 
richness decreased over time, the inter-group differences in diversity (e.g. relative 
abundances of different microorganisms), actually increased from starting levels, 
during fermentation of all substrates. Beef+Inulin follows the same trend of Inulin, 
but the magnitude of change in β-diversity appears less, showing a lower degree of 
microbial community change with compared to Inulin alone (Figure 6). 
In Figure 7, individual responses or change in β-diversity, are shown for each faecal 
donor at each time point, relative to the starting level. Weighted UniFrac analysis of 
distance between donors, was calculated for evaluate the inter-individual variability, 
which led to a wide data spread. A lower UniFrac score, indicates more similarity 
between the compared microbiota with a score of 0, representing microbiota profi-
les exactly the same in bacterial presence and abundance. A score of 1 represents 
profiles with no overlapping in bacterial response. Independent of the sex, some 
donors seems to have similar behavior (3,4, 5), while others differ moderately (1, 2) 
both between one another and with donors 3, 4 and 5 (Fig. 7). 
The change in OTU relative abundance from time 0, for the different treatments are 
shown in figure 8. Comparing the treatment effects, Weighted UniFrac distances, 
no significant differences were found, at each sampling time for Beef+Inulin, com-
pared to Beef alone or the Blank fermentation While Inulin appears different betwe-
en Beef and Beef+Inulin, for most sampling times (Fig. 8). Significant differences 
in the relative abundance of different bacteria at genus level were observed both 
between treatments and over the time course of the fermentations. 
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3.4 Conclusion
Alterations in dietary composition result in quantitative and qualitative changes in 
the supply of substrates to the colonic microbiota. In particular, the type and quan-
tity of dietary carbohydrates reaching the colon regulates microbiome energy pro-
duction (through fermentation) and carbon economy (biomass generation). Between 
12 and 18 g dietary protein also reaches the colon every day, although this figure 
depends greatly on the type of dietary protein, the food matrix, how it is processed 
(e.g. cooked, glycated to sugars, fried) and the quantity of protein in the diet (Tuohy 
et al., 2006). Fermentation patterns change along the colon in response to changing 
substrate gradients and resultant changes in pH (Macfarlane et al., 1992). In the 
proximal colon, carbohydrate is plentiful and since its fermentation generates more 
energy than amino acid fermentation (Gest, 1980), it is used preferentially by the re-
sident microbiota. The SCFA produced as a consequence lower pH in the proximal 
colon, typically to about 5.5. However, as the availability of carbohydrate decreases 
along the colon, so to does saccharolytic fermentation giving way to protein or ami-
no acid fermentation in the distal colon, with concommittant production of poten-
tially toxic metabolites like BCFA, amines, phenols, indoles and ammonia. Fermen-
table non-digestible carbohydrates (such as inulin), may decrease the concentration 
of putrefactive compounds that are generated during proteolytic fermentation, by 
providing the microbiota an alternative source of energy and carbon (Macfarlane 
and Macfarlane, 2012; Williams et al. 2001; Swanson et al. 2002). Indeed, non-dige-
stible carbohydrates, fibers and prebiotics, have been shown to reduce production 
of toxic endproducts from proteolytic fermentation in laboraroy animals (Fujiwara 
et al 1991) and in farm animals (Lluis et al. 2014). Few studies have examined how 
supplementation with a prebiotics, such as inulin, impacts on protein fermenta-
tion, subsequent metabolite production and also impacts on microbial community 
structure, in the human distal colon. In this study, we have employed an in vitro 
systems, anaerobic, stirred, faecal batch cultures with pH set at 6.8 to 7.2 to model 
the fermentative environment of the human distal colon. Using fresh faecal samples 
collected from 5 different health donors (male and female), we used a combined 
metabolomics and 16S rRNA profiling approach, in order to track changes both 
in microbiota composition and metabolic output during protein (pre-digested red 
meat/beef) fermentation in the presence or absence of inulin. 
Multivariate statistical analysis of 1H-NMR metabolic profiles was used to identify 
main changes in metabolites over a 24 h fermentation period. Amino acids were 
consumed during inulin fermentation, probably reflecting a conversion into micro-
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bial biomass, as microorganisms grew, during the fermentation. Beef fermentation, 
lead to a significant increases, in the NMR signals, for methylamine (MA) and TMA. 
TMA can also be demethylated into dimethylamine (DMA) and methylamine (MA), 
as well known is putrescine (diamines), a chemical analogue to TMA (Wallraben-
stein et al., 2013). The Beef+Inulin fermentation gave a profile of metabolites with 
NMR signals typical of metabolites form both proteolytic and saccharolytic fermen-
tations. Importantly, TMA production was reduced upon proteolytic fermentation in 
the presence of the prebiotic. Similarly, the BCAA, valine, leucine and isoleucone, 
appeared to be more depleted during the Beef+Inulin fermentation, than in the Beef 
alone. These three amino acids, are important for human physiology because they 
are involved in stress, energy and muscle metabolism (Burrill et al., 2015). Valine, 
has been established as a useful supplemental therapy to liver diseases (Taniguchi 
et al., 1996), while leucine, decreases brain levels of tyrosine, serotonin, but not do-
pamine (Le Masurier et al., 2006). Leucine also stimulates insulin release, which in 
turn stimulates protein synthesis and inhibits protein breakdown. BCAA decreased 
in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahe-
patic biliary atresia or portacaval shunt (Tajiri, 2013; Weisdorf et al., 1987; James, 
2002). Aromatic amino acids (AAA) such as tyrosine, tryptophan and phenylalani-
ne, are more present in Beef alone, perhaps because in the presence of fiber, the 
metabolism is moved to carbohydrate component at the expense of that protein 
which remains undigested. Since BCAA and AAA pass into the brain by a similar 
mechanism, their compete for the brain absorption (Fernstrom, 2005). 5-aminopen-
tanoic acid, whose formation is inhibited in the presence of Inulin, is a lysine degra-
dation product, and can be produced both endogenously, or through Clostridium 
species catabolism (Rodionov et al., 1988). The multi-step reaction, expected the 
production of cadaverine from L-lysine, which is metabolized in L-piperideine and 
then, 5-aminopentanoic acid (Fothergill and Guest, 1977). High levels of 5-amino-
pentanoic acid in biofluids, may indicate bacterial overgrowth or endogenous tissue 
necrosis (Callery and Geelhaar, 1984). Besides being a waste product, 5-amino-
pentanoic acid may act as a methylene homologue of γ-aminobutyric acid (GABA) 
and functions as a weak GABA agonist (Callery and Geelhaar, 1985). Furthermore, 
it shows a weak inhibitory action of route of blood clotting by acting as a similar 
amino acid antifibrinolytic activities (Cole and Castellino, 1984).  
TMA presents a clear decreased profile in the combined metabolism between red 
meat and prebiotic fiber, indicating the possible antibacterial effect, charged to the 
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species involved in the production of these harmful compounds, of highly fermen-
table Inulin. For many compounds, enterohepatic cycling has the effect of rende-
ring the molecules, or its metabolites, more difficult to eliminate from the body, 
contributing or prolonging their toxic effects (Hill, 1995). Importantly, PCA analysis 
showed that although each faecal donor showed different metabolic signatures, the 
combination of Inulin to the Beef fermentations moved these metabolic profiles in 
a consistent manner in the faecal microbiota of all subjects. Moreover, although in 
the same direction, three of the faecal microbiota, behave in a very similar manner, 
clustering closely together in terms of NMR spectra (Fig. 4a), while the faecal mi-
crobiota of donors 1 and 2 were distinct albeit responding in the same direction as 
donors 3, 4 and 5. The present study, while limited in size and number of subjects, 
therefore suggests that although microbiota metabolite production in response to 
different dietary substrates may be unique, certain groupings of “metabotypes” 
may exist, regulated by microbial composition or metagenomic makeup, as sugge-
sted previously (Stella et al. 2006; Vázquez-Fresno et al. 2016). 
Fermentation of Beef, Inulin or Beef+Inulin, had dramatic effects on the architectu-
re of the faecal microbiota, under simulated distal colonic conditions. In terms of 
α-diversity, species or phylotype richness, decreased for the blank fermentation, 
Inulin and Beef fermentations, over the 24 hours, while species richness of Beef+I-
nulin increased significantly, albeit with a small magnitude and a large apparent 
variation between faecal donors. Inulin appeared to have about 10% higher number 
of OTU, compared to the Beef fermentation. The fact that species richness was 
maintained in the Beef+Inulin fermentation, may be due to a more complex and 
diverse substrate availability, including increased metabolic cross-feeding, between 
different bacteria and of course the increased substrate availability in this fermenta-
tion compared to all other fermentations examined. However, the fact that α-divers-
ity decreased even 5 hours, after inoculation, suggests that changes in microbiota 
diversity were likely, due to the composition of the test substrates rather than lack 
of overall energy availability, as previous studies using the same model systems, 
substrates and substrate concentrations showed strong fermentation, as measured 
accumulation of SCFA up to at least 10 hours post inoculation (Gomez et al. 2010; 
Khalil et al. 2014).  
Beta-diversity is a measure of dissimilarity between two communities, it gives a 
quantitive measure of the taxonomic differences between two communities for 
example, and it is usually measured as the amount of species change between the 
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communities (Jiang et al. 2012; Morgan and Huttenhower, 2012; Zinger et al. 2012).  
In this study, using Weighted Unifrac distance of β-diversity from time 0 h, signi-
ficantly increased biodiversity, over the 24 h fermentation, both in the Blank and 
treatments (Beef, Inulin and Beef+Inulin) were observed (Fig. 6). In terms of respon-
se of the faecal microbiota from each of the 5 different healthy donors, weighted 
unifrac distances, showed increased disimmilarity and inter-individual variation, in 
species diversity over the course of the fermentation (Fig. 7). Interestingly, and in 
congruence with the 1H-NMR data, the response of the faecal microbiota of do-
nors 3, 4 and 5 were more similar one to the other, than that of donor 1 or 2, which 
showed more dissimilar microbial diversity. Over the course of the fermentation, the 
response to Inulin, was more dissimilar to Beef and Beef+Inulin, and likewise, Beef 
appeared to be more dissimilar to Inulin than Beef+Inulin. Our hypothesis is that 
these results could be due to the modulatory effect of Inulin on protein metabolism, 
providing a more suitable substrate to the growth of certain bacterial genus  (e.g. 
Butyricicoccus, Butyricimonas, Coprococcus and Dorea – with butyrogenic activity, 
Fig. 9) to the detriment of others. Finally, Beef is the only one that shows a decrea-
se around time 10 h, with an upswing at the end of fermentation (24 h) (Fig. 6). This 
“inverted parabola” trend, hired by the fermentation of Beef, is maybe due to the 
formation of compounds ranging to inhibit bacterial growth, which is then raised 
again, perhaps by the ability of some bacteria to use and metabolize them, making 
the growth environment more accessible. Substantial difference in the biodiversity 
associated with each substrate intake (Beef, Inulin, Beef+Inulin), varied among indi-
viduals (Fig. 5, 6), as confirmed by others studies (Wu et al., 2010; Li et al., 2009). 
Contrary to the recently study published on the effect of resistant fiber (maltodex-
trin) (He et al., 2015) and to the recognized increase of microorganisms tolerant to 
bile, in an animal-based diet (David et al., 2013), all dietary treatments with Inulin 
(alone or added to Beef) showed an increase in relative abundance of the genus 
Alistipes, normally considered degraders of fiber (e.g. fructans) and glucosinolates, 
producing succinic acid as principal metabolic endproduct of glucose fermentation 
(Koropatkin et al., 2012; Li et al., 2009; Song, 2006). Butyrate-producing bacteria 
from the human large bowel such as Butyricicoccus (belonging to Clostridial cluster 
IV) were more abundant in pure Inulin fermentation. Butyricicoccus are generally 
mucosa-associated bacteria, are underrepresented in colonic mucosa of patien-
ts with, active ulcerative colitis (UC) and Crohn’s disease (CD); B. pullicaecorum 
has been investigated as a marker in inflammatory bowel disease (Eeckhaut et al., 
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2013). Enterobacteriaceae, such as Shigella and Escherichia genus, were signi-
ficantly under-represented in samples of human faecal fermentation of protein 
source (Beef). While, Odoribacter and Parabacteroides genus, increased in relative 
abundance when Inulin was fermented. Odoribacter belongs to the Porphyromona-
daceae family and to the Bacteroidetes phylum; O. splanchnus is known to produce 
acetate, propionate, and butyrate, therefore, its growth has been linked to protecti-
ve effects against inflammation in the host via increased SCFA availability (Morgan 
et al., 2012). A shift from Bacteroides to Parabacteroides, can often be observed, 
after fiber intake (Graf et al., 2015). In the inulin fermentations, Parabacteroides 
appeared to increase in relative abundance, while in our experiments no signficiant 
differences in relative abundance of Bacteroides genus was observed, under any of 
the test fermentation conditions. This is consistent with recent studies by Chung et 
al (2016), showing few species of Bacteroides respond in mixed culture, to the pre-
sence of inulin and in a pH dependant manner, suggesting differences in Bacteroi-
des species microbiota composition, between individuals, could explain apparent 
lack of response of these prevalent and dominant member, of the gut microbiota to 
the different fermentation substrates, used in our study. 
Inulin is recognized as the “gold standard” prebiotic and has been shown in many 
in vitro, animal and human studies, to increase the relative abundance of bifido-
bacteria, within the gut microbiota. However, most of these in vitro studies, were 
conducted under conditions simulating the proximal or transverse colon, and few 
studies have examined the response of bifidobacteria to inulin, in mixed culture, 
under the environmental conditions, of the distal colon. Similarly, studies in faeces 
may not faithfully represent microbiota profiles, in any given region of the gut, but 
are seen more as a summation of microbiota profiles, over the combined intestinal 
tract (Tuohy and Scott, 2015). In this current study, small changes were observed in 
relative abundance of bifidobacteria, with significant changes in relative abundan-
ce for Beef, Inulin and Beef+Inulin over the 24 h fermentation, compared to Blank. 
Data from qPCR and FISH (Fig. 10, 11), confirmed high interindiviaul variation, in 
response to the different substrates, and that although bifidobacteria tended to 
increase in 16S rRNa copy number, or relative abundance, according to FISH (Fig. 
10), these changes were small due to interindividual variation. Indeed, very similar 
results were observed by Chung et al (2016), who showed that bifidobacteria re-
spond poorly to fermentable substrates, like inulin or pectin, at near neutral pH ran-
ges, in mixed faecal culture. During Beef fermentation, commensal members of the 
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intestinal community, such as Blautia and Lachnospiraceae incertae sedis (belong 
Lachnospiraceae family), increased significantly, with respect to Beef+Inulin and the 
Blank fermentation. Lachnospiraceae, received in the last years the most attention 
because they are very abundant in the human colon, comprising 10 to 20% of the 
total bacteria (Meehan and Beiko, 2014). Members of this family have been linked 
to obesity, with positive correlation with cholesterol and LDL cholesterol levels (Ko-
ren et al., 2011), but also to an anticancer action at the level of the colon in human 
(Wang et al., 2012), perhaps thanks to the butyrogenic activities of some species.  
Butyricimonas, a member of the family ‘Porphyromonadaceae’, appears stifled by 
the presence of Inulin. The strains, isolated from rat faeces, were related to Odori-
bacter splanchnicus and not growth on medium containing 20 % bile (Sakamoto et 
al., 2009).
Several factors are involved in the onset of a predominant macronutrient-utilizing 
organisms, such as compounds related to partial degradation products, fermenta-
tion products and growth or inhibitory factors, which arise not only by the presence 
of specific compounds, but also competitive or synergistic interaction between 
two or more bacterial populations. Many microbial communities, show significant 
division in metabolic work. Endproducts of some organisms are metabolites for 
others; working together they turn raw resources into fully metabolized nutrients. 
Recent studies have confirmed the important role that pH plays, in determining not 
just relative abundance of different bacteria in the different regions of the gut, but 
also their metabolic activity (Chung et al. 2016). This work has confirmed that the 
presence of a fermentable fiber or prebiotics like inulin, can radically modify me-
tabolic activities, of the gut microbiota in the distal colon, specifically reducing the 
production of potentially harmful metabolites, including TMA, during fermentation of 
digested red meat. Moreover, we have observed that both proteolytic and saccha-
rolytic fermentation in the distal gut, can dramatically remodel microbiota archectu-
re, both in terms of α- and β-diversity, and in the relative abundance of different 
bacteria at the genus level. Some of these microbiota modulations, differ from 
those reported previously for different regions of the colon, and are consistent with 
recent studies, showing the dramatic impact of pH on microbial ecology within the 
colon. Taken together, this current study highlights the value of in vitro models for 
studying diet:microbe interactions in the gut and the importance of using combined 
high-resolution post-genomics methodologies, to derive information on the meta-




Fig. 1 Coefficient plots extracted from the OPLS model constructed from the 1H-NMR profiles of Inulin (1% w/v) in vitro 
fermentation supernatant of five human faecal donor and the corresponding fermentation time (0, 5, 10, and 24 h).
86 Fig. 2 OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of Beef (0.5% w/v) in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
87Fig. 3 OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of Beef+Inulin (1.5% w/v) in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
88 Fig. 4a Principal component analysis (PCA) score plot of 1H-NMR spectra of Beef and Beef+Inulin in vitro fermentations after 24 h of 5 human healthy fecal donors.
89Fig. 4b OPLS coefficient-coded loading plot derived from comparison of 1H-NMR spectra of Beef (0.5% w/v) and Beef+Inulin (1.5% w/v) in vitro fermentation by five human faecal donor, at 24 h.
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blank inulin beeF beeF+inulin beeF  Vs beeF+inulin
R2X 0,19 0,37 0,38 0,34 0,33
Q2Y 0,55 0,67 0,66 0,70 0,54
p value 0,02 0,01  0,01  0,01 0,01
  
Tab. 1 Summary of the parameter values (R2X, Q2Y and p-value) describing the OPLS model.
Fig. 5 Alpha-diversity, ranges from time 0 of each treatments and sampling time. Repeated measure for five different human 
faecal donors, are marked with colored dots.
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beeF beeF+inulin inulin
beeF+inulin 1.1e-05 - -
inulin 0.0047 1.9e-05 -
blank 0.2083 1.9e-05 0.6516
  
Tab. 2 Observed OTU: pairwise comparisons using Wilcoxon rank sum test. P value were adjusted by False Discovery Rate 
(FDR) method.
Fig. 6 Weighed UniFrac distances from hour 0 for hours 5, 10 and 24. Only intra-donor distances were computed.  
92
Fig. 7 Weighted unifrac distances between donors (n = 5), at time 0 and 24h. The donors are shown to the side of the 
frame, while treatments are indicated with a shape.
93
Fig. 8 Weighted unifrac distances between treatments (n = 6), at time 0 and 24h. The treatments are shown to the side of 
the frame, while donors are marked with a color – code dots.
94 Fig. 9 Relative abundance differences from hour 0 estimated at the genus level. Only genera with at least one significant treatment different from the blank are shown in table 2.
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Bilophila Erysipelotrichaceae incertae sedis
Butyricicoccus Faecalibacterium
Butyricimonas Lachnospiracea incertae sedis











Blautia Clostridium sensu stricto





Barnesiella Erysipelotrichaceae incertae sedis

















Tab. 3 Statisticly significant changes at genus level comparing treatmnets and Blank, over 24h.
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Fig. 10 Distribution of the proportion of Bifidobacteria and Enterobacteriaceae in human faeces assessed, over the time (0, 
5, 10, 24 h), by genus-specific 16S rRNA oligonucleotide probes and by relative cell enumeration by FISH combined with 
flow cytometry. Treatments are color – coded: basal medium (blank) - blue, Inulin (1% w/v) - green, Beef (0.5% w/v) - pink 






























































Fig. 11 Distribution of the proportion of Bifidobacteria on Inulin fermentation, between 5 human faecal donors, during the 
time (0, 5, 10, 24 h), by genus-specific 16S rRNA oligonucleotide probes and by relative cell enumeration by FISH combined 
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Abstract
Recent studies have highlighted that different tryptophan metabolic pathways, such 
as the serotonin and kynurenine pathways, may regulate host health/disease, via 
the immune modulation and the gut:brain axis. Little is known about its interactions 
with the gut microbiota and how food compounds, such as fermentable fibers or 
prebiotics, might impact on microbiota TRP interactions. Using anaerobic, stirred 
batch cultures of human, we measured if tryptophan metabolism by gut microbio-
ta changes in the presence of the inulin, using a combination of 1H-NMR based 
metabolomics and 16S rRNA community profiling. Orthogonal projection to latent 
structures (OPLS) analysis shows during TRP fermentation, an increase of indo-
le and indole acetic acid, along to tyrosine and small amounts of the short chain 
fatty acids, particularly acetate. In the presence of inulin, indole metabolites were 
depleted and SCFA enriched with concomitant significant depletion of both inulin 
and TRP over the fermentation. Both TRP and TRP+Inulin fermentation modula-
ted the microbial diversity within the fermentations over time, and at the genus 
level Alistipes, Barnesiella, Clostridium IV, Desulfovibrio, Odoribacter, Oscillibacter, 
Phascolarctobacterium had significantly lower relative abundance (p < 0.0011) in 
the presence of Inulin compared to TRP alone. This in vitro study confirms that the 
presence of a fermentable carbohydrate, in this case the prebiotic inulin, reduces 
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microbial metabolism of TRP into indole metabolites re-directing it towards micro-
bial biomass formation. Diet:microbe interactions in the distal colon may therefore 
play an important role in the bioavailability of TRP and its indole derivatives possibly 
impacting on TRP pathways linked to host health in the gut, periphery and along 
the gut:brain axis.
Keywords
Tryptophan | prebiotics | Inulin | human colon fermentation | next-generation se-
quencing | metabonomics | gut-brain axis
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Tryptophan metabolism contributes to a variety of important (patho)physiologi-
cal processes, including mood and cognitive function, metabolic syndrome and 
immune function, but it is still not fully understood which environmental factors 
regulate its metabolic pathways and how this may impact human health or disea-
se risk (Steinmeyer et al., 2015; Hattersley et al., 2014). Tryptamine, produced by 
decarboxylation of this essential amino acid, is a monoamine compound that is a 
common precursor molecule to many hormones and neurotransmitters (Young and 
Gauthier, 1981). The most well-known tryptamines are, serotonin (5-HT), an impor-
tant neurotransmitter (Fernstrom and Wurtman, 1971), and melatonin, a hormone 
involved in regulating the sleep-wake cycle (Borjigin, 2000). Serotonergic system, is 
involved in a wide range of central and periferal processes. 5-HT, modulates (non-)
photic input to the suprachiasmatic nucleus (SCN), a small group of brain cells 
located in the hypothalamus, that controls mammalian clock, which in turn affect 
cognition and mood, including psychiatric conditions, such as anxiety, autism, up 
to more serious conditions (e.g schizophrenia, bipolar disorders, depression and 
suicidal behavior) (O’Mahony et al., 2015). Acting directly on cardiomyocytes and 
stimulating chemosensitive nerves in the heart, 5-HT regulates also cardiovascu-
lar system (Côté et al., 2004). Over the years, an increasing number of biological 
functions, have been associated to the serotonergic system. This include modula-
tion of appetite, through cross actions on different nuclei within the brain stem and 
hypothalamic regions, as well as on cells containing functional peptides (e.g. neuro-
peptide Y, cholecystokinin) (Lee and Clifton, 2010). Besides being directly involved 
in the regulation of adipose tissues homeostasis. 5-HT, increases glucose uptake 
into brown adipose tissue (BALT), while reduces the diameter of adipocytes in white 
adipose tissue (WAT), suggesting the involvement of serotonin on lipogenesis and 
thermogenesis mechanisms (Oh et al., 2015). In addition to the well recognized 
role of melatonin in regulating sleep patterns, the serotonergic system appears to 
be also involved in the obstructive sleep apnea syndrome (OSAS) (Kokturk and 
Kanbay, 2015). Interesting observation given that an estimated 90% of the bodies 
serotonin is produced in the gut, and its production is directly regulate from entero-
chromaffin cells on the gut wall, via short chain fatty acids (Reigstad et al., 2015).
In vitro 3H-tryptophan binding to proteins (maybe glycoproteins) of cytosols or nu-
clei synthesis, especially in the liver, where activities of nuclear NTPase and protein 
phosphokinase are increase, also in in vivo experimental rats (Cortamira, 1991; 
Sidransky, 2002). Nevertheless, the main way of tryptophan catabolism, consists of 
4.1 Introduction
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the kynurenine pathway; where kynurenine (KYN), is recognized as the first stable 
and the main metabolite of tryptophan (more than 95 %) in mammals (Oxenkrug, 
2010). This degradation pathway includes also the production of quinolinic acid, an 
NMDA antagonist, hypothesized as intermediate in the conversion of tryptophan to 
niacin (St’astný et al., 2004); 3-hydroxyanthranilic acid, a pro-convulsive excitotoxin 
(Luthman, 2000); N-methyl-D-aspartic acid (NMDA) receptor agonist; picolinic acid, 
with neuroprotective activity; finishing the route with the synthesis of Nicotinamide 
Adenosine Dinucleotide (NAD), the biologically active coenzyme form of vitamin B3 
(niacinamide) (Chen, 2009). Metabolites of tryptophan including kynurenine, quino-
linic acid, and picolinic acid, are directly toxic to CD4+ Th1 cells, which promotes 
CD8+ cell survival, memory response, tumor localization and therapy, and also to 
Tumor Infiltrating Lymphocytes (TILs), immunological biomarker, recruited into the 
tumour in an attempt to control its growth (Soliman et al., 2010). Significant cor-
relation between intestinal and portal amino acid concentrations, was found for 
tryptophan. Timing and measured levels of an amino acid in portal plasma reflect 
their concentration in the dietary source, well as its liberation during digestion, and 
the rate and extent of its absorption (Goldberg and Guggenheim, 1962). TRP levels 
in the brain are determined by competitive interactions at the Blood Brain Barrier 
(BBB) (Choi et al., 2009). The transporter responsible for TRP uptake is located 
on capillary endothelial cells of the BBB, and it is saturable and competitive, with 
shared affinities for TRP and  several other amino acids, such as Large Neutral 
Amino Acids – LNAA (e.g. tyrosine and phenylalanine), or Branched-Chain Amino 
Acids – BCAA (e.g. leucine, isoleucine and valine). Brain uptake of tryptophan de-
pends therefore on its blood concentration but also on its relative concentration to 
other amino acids (Fernstrom, 2012). Recently, Hattersley et al (2015) showed that 
in obese individuals, both metabolic risk and plasma BCAA concentrations could 
be altered with different isoenergetic diets, differing in protein, cereal fiber and fat 
content.
Almost 5% of total protein intake from food survives the small intestine, and rea-
ches the colon where it falls under the activities of the colonic microbiota, the most 
metabolically active collection of microorganisms within the human microbiome 
(Sniffen, et al., 1992). In the colon, the main environmental parameters affecting 
tryptophan metabolism, as other aromatic amino acids, are intestinal pH (favored at 
neutral pH), the availability of others nitrogenous compounds, which determine the 
amino acid requirements, and the amount of carbohydrate present and the wide va-
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riability in terms of microbial abundance and biodiversity between subjects (Davila 
et al., 2013). Carbohydrates intake stimulates insulin secretion, which causes a re-
duction of amino acids plasma levels, due to the dissociation of non-esterified fatty 
acid molecules from albumin, with the entrance of the firsts in adipocyte cells and 
an increase bioavailability of the seconds, which can bind to the free amino acids in 
the blood. (Felig et al., 1969).
Anaerobic degradation of L-tryptophan, leads mainly to indole, pyruvate, and am-
monia, via pyridoxal phosphate-dependent tryptophanase (Kurnasov et al., 2003). 
In the colon, asaccharolytic obligately amino acid-fermenting bacteria, include 
Clostridium spp. (e.g. C. perfringens), Enterococcus, Shigella and Escherichia coli   
(Richardson et al., 2013). The proteolytic activity differs between the dependent 
protease bound to cell membranes, described for Bacteroides fragilis-type organi-
sms, and extra-cytosol proteases, for Streptococcus faecalis ST6, Propionibacte-
rium acnes P6, Clostridium perfringens C16, C. bifermentans C21 and C. sporoge-
nes C25 (Macfarlane et al., 1988). However, not all of these organisms are able to 
metabolize tryptophan; Macfarlane by direct plate counting methods, enumerated 
the fermenting bacteria in faeces obtained from three healthy donors, highlighting 
the predominance of Peptostreptococcus indolicus, Bacteroides putredinis, Clo-
stridium sporogenes, Peptostreptococcus asaccharolyticus, as TRP consumers 
(Macfarlane et al., 1988). Other reserchers report Peptostreptococcus indolicus, 
Bacteroides putredinis, Clostridium sporogenes, Peptostreptococcus asaccharolyti-
cus, Xenorhabdus nematophilus and Bacillus atrophaeus, as producers of trypta-
mine, and Lactobacillus bulgaricus, which is able to excrete tryptamine (Williams et 
al., 2014).
Evidence on the brain availability change of TRP in the cross-feed interaction, was 
well described by Choi in 2009. The transporter located on capillary endothelial 
cells, of the blood–brain barrier, is saturable and competitive, well as shares with 
several other amino acids, such as LNAA - tyrosine and phenylalanine, and the 
BCAA - leucine, isoleucine and valine. The brain uptake of tryptophan, depends 
therefore on its blood concentration. Recently, Hattersley et al (2015) showed that 
in obese individuals, both metabolic risk and plasma BCAA concentrations, could 
be altered with different isoenergetic diets, differing in protein, cereal fiber and fat 
content (Hattersley et al., 2015). Moreover, using a combined metabolomics and 
metagenomics approach, Zhang et al. (2015) showed at a radical dietary shift to 
a high fiber, high polyphenol and low fat/sugar diet, improved metabolic health in 
109
both genetic and diet-lifestyle associated obesity in children (Zhang et al., 2015). 
Together with reduced body weight, improved BMI, insulin sensitivity and markers 
of liver and immune function, microbiota re-modelling, including a reduction in mi-
crobiota TRP metabolic pathways, was observed together with reduced production 
of TRP metabolites, such as indoxyl sulfate, which had been previously linked to 
heart disease. Similarly, other cell based work has recently shown that, the indole, a 
microbial metabolite of dissimilatory TRP metabolism, regulates production of glu-
cagon-like peptide-1 (Glp-1), an important anoretic incretin produced by intestinal 
enteroendocrine L cells (Chimerel et al., 2014). The following experiment, was desi-
gned to measure the impact of the prebiotic inulin on microbial TRP metabolism, in 
the distal colon, and its modulation on the TRP availability and absorption, and then 
subsequent conversion into neurotransmitters (like serotonin), or catabolism into 
metabolites like indole and indoxyl-sulfate, which appear to play a pathophysiolo-
gical role in metabolic disease, and may have important consequences for under-
standing the role of the gut microbiota in obesity and the metabolic diseases.
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4.2 Materials & 
Methods
Tryptophan stock solution
Tryptophan (Sigma-Aldrich), was added to the basal medium in the form of a stock 
solution as described by Smith and Macfarlane (1997), with a concentration of 5 
mmol/l in the final volume (150 ml). Wait the restoration of pH, before procededing 
with the faecal inoculum.
In vitro digestion
Cargill Oliggo-Fiber® inulin DS2 5LB (dietary fiber – 98% and free fructose, gluco-
se and saccharose – 2%) (Warcoing Industries S.A. Belgium), underwent in vitro 
upper gastrointestinal digestion, consisting of an initial gastric phase, followed by a 
duodenal-intestinal phase, which simulated the chemical and enzymatic conditions 
of relevant portions of the stomach and small intestine. The protocol was drawn 
from Mandalari et al. (2013) and adapted. The below description of the protocol is 
relative the digestion of 1.5 g starting material.  
Preparation of phospholipid vesicles. The lipid vesicles were prepared by remo-
ving the solvent by 0.28 ml of a stock solution of L-α-phosphatidylcholine (PCh) 
from egg in chloroform (0.235 ml in solution of 100 mg/ml of chloroform) (Grade 1, 
Lipid Products, UK). The organic solvent was removed overnight using a Rota va-
cuum evaporation system, thus producing a thin lipid film on a round bottom flask. 
To avoid oxidation, the lipid film was covered with Argon. The PCh was rehydrated 
with 7.6 ml of 0.15 M NaCl pH 2.5, then 5 2 mm diameter glass beads were added 
and the flask was incubated for 1 hour at 37 °C on a horizontal shaker. The suspen-
sion was then sonicated (Branson mod.) at 30% power for 30 minutes, non-conti-
nuous mode, in order to avoid the excessive increase of the temperature and the 
overheating of the probe. The suspension of liposomes in single layer was finally 
filtered with a 0.22 µm Nalgene filter to remove any deposit of titanium resulting 
from sonication.
Gastric phase. Each test substrate was re-suspended in 6.3 ml of 0.15 M NaCl 
pH 2.5 and the pH was adjusted to 2.5 with HCl (0.5 M) or NaOH (0.5 M). A 6.1 ml 
suspension of lipid vesicles was then added to the solution. The gastric enzymes, 
pepsin and lipase (Sigma-Aldrich) were added at 146 and 60 U/ml concentration 
of reaction respectively, and the samples were incubated at 37 °C for 2 hours on a 
horizontal shaker.
Duodenal phase. The pH was brought to 6.5 and the following reagents were 
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added in such quantities as to reach the respective final concentration: CaCl2 - 
11.7 mmol/l, BIS-TRIS buffer - 0.73 mmol/l and bile acid sodium taurocholate 
and sodium glycodeossicholate - 4 mmol/l. The chemicals were purcased from 
AppliChem. The pH of 6.5 was checked again and the enzymes were then added 
at the respective final concentrations: α-chymotrypsin - 5.9 U/ml, trypsin - 104 U/
ml, colipase - 3.2 U/ml, pancreatic lipase - 54 U/ml and α-amylase - 25 U/ml. The 
chemicals were purchased from Sigma. The digestion was performed by incubating 
the samples at 37 °C for 1 hour on a horizontal shaker.
Dialysis. The digested sample was subjected to dialysis, according to the indica-
tions of Millis et al. (2008). The dialysis membrane, Spectra/Por (Spectrum Labs) 
with a cut-off molecular weight of 1 kDa, which had been previously washed in 
distilled water, was filled with the digested material and closed on both sides. The 
membrane was then placed in dialysis solution (10 mM NaCl), at a volume about 
100 times greater than the volume of the material to be dialyzed and incubated at 4 
°C overnight with slow stirring.
Lyophilization. The dialyzed retentate material were transferred to a round bottom 
flask and placed at -80 °C until frozen. The material was then lyophilized and the 
obtained powder was weighed and stored at -80 °C.
Fecal batch cultures
Faecal fermentations were conducted using the basal nutrient medium, prepa-
red as from the following formula (g/l): starch – 8.0; mucin (porcine gastric) – 4.0; 
casein – 3.0; peptone water – 5.0; tryptone water – 5.0; bile #3 – 0.4; yeast – 4.5; 
FeSO4 – 0.005; NaCl – 4.5; KCl – 4.5; KH2PO4 – 0.5; MgSO4 7H2O – 1.25; CaCl2 
6H2O – 0.15; NaHCO3 – 1.5; tween 80 – 1; hemin – 0.05; cysteine HCl – 0.8. All 
chemicals were purchased from Sigma. The final, working volume of all fermen-
tations was 150 ml. Anaerobic conditions were maintained by O2-free N2 (15 ml/
min) flow overnight. Temperature was held at 37 °C using a circulating water bath, 
and pH was controlled between 6.8 and 7.2 using an automated pH FerMac 260 
controller (Gloucester, England-GL208JH, United Kingdom), which added acid and 
alkali as required (0.5 M HCl and 0.5 M NaOH). Five healthy human donors (2 male, 
3 female), who had taken no prebiotics, probiotics, or antibiotics within 3 months of 
the study were recruited to provide faecal samples as inocula. Faecal inocula (10% 
w/v) were prepared  using pre-reduced phosphate-buffered saline (PBS 0.1 mol/l) 
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and used to inoculate each fermentation vessel to a final concentration of 1% fae-
ces w/v. The substrates tested in fermentation, were basal medium (Blank), Inulin 
at 1% (w/v) (Cargill Oliggo-Fiber® inulin DS2 5LB), as positive control, tryptophan 
(5 mmol/l) (Sigma-Aldrich, Germany) and tryptophan added Inulin, with the same 
their respective concentrations. Each fermentation was conducted once with faecal 
inocula from each of the 5 faecal donors (n = 5). Batch cultures were run for 24 hour 
and samples obtained from each vessel at 0, 5, 10, 24 h, were centrifuged at 13 
000 rpm, where the supernatants and pellets were stored at -80 °C for metabolo-
mics and metagenomics analysis respectively. Samples for FISH were prepared as 
described below and stored at -20 °C.
Fluorescence In Situ Hybridization-Flow Cytometry 
(FISH/FC)
Sample fixing and hybridization, were performed as previously described (Rochet 
et al., 2004; Saulnier et al., 2008). Briefly, 375 μl of culture fluid was diluted in 1125 
μl of 4% (w/v) paraformaldehyde and fixed overnight at 4 °C. Bacterial cells were 
pelleted by centrifugation at 13 000 rpm for 5 min and washed twice in filter-sterili-
zed PBS. Cells were then resuspended in 150 μl PBS and 150 μl ethanol. Samples 
were stored at −20 °C for a minimum of 3 h before further processing. Genus-spe-
cific 16S rRNA oligonucleotide probes, labelled with the fluorescent dye Cy5 (Sigma 
Aldrich, Italy), were utilized for selected bacterial groups, the nucleic acid stain 
2-[N-(3-dimethylaminopropyl)-N-propylamino]-4-[2,3-dihydro-3-methyl-(benzo-1,3-
thiazol-2-yl)-methylidene]-1-phenyl-quinolinium - SYBR Green I - (Sigma Aldrich, 
Italy), for total cell counts. The probes used were as follows: Bif 164, specific for 
Bifidobacterium  (Langendijk et al., 1995) and Enterobac D, for Enterobacterua-
ceae (Ootsubo et al., 2002). In 96 well plate, 10 μl of fixed suspension was mixed 
into 190 μl of PBS (pH 7.2) and then centrifuged at 4000 rpm for 15 min at 4 °C. 
After one wash in Tris EDTA buffer (TrisHCl – 100 mM; EDTA – 50 mM (pH 8)), 
when requested, pellets were suspended in Tris EDTA buffer, containing 1 mg/ml 
of lysozyme (Sigma Aldrich, Italy) and incubated for 10 min at room temperature. 
Cells were washed in PBS (pH 7.2), to remove lysozyme and were suspended in the 
hybridization solution (NaCl – 900 mM; TrisHCl – 20 mM (pH 8.0); Sodium Dodecyl 
Sulfate – 0.01%; formamide as requested), containing 5 ng/μl of specific probes, 
for a total volume of 55 μl. The hybridization step, was performed overnight at the 
appropriate labelled probe temperature. Following hybridization, a volume of 145 μl 
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of hybridization solution, was added in each well, and cells were pelleted at 4000 
rpm for 15 min, at 4 °C. Nonspecific binding of the probe, was removed by incu-
bating the bacterial cell suspension, at the appropriate temperature for 20 min in 
200 μl, of a washing solution (NaCl – 64 mM; TrisHCl – 20 mM (pH 8.0)). Cells were 
suspended in 50 μl of PBS (pH 7.2), containing 1x SYBR Green I and incubated at 
room temperature for 10 min. Following hybridization, a volume of 150 μl of PBS 
(pH 7.2) was added in each well, and cells were centrifuged at 4000 rpm for 15 min, 
at 4 °C. Final pellet was suspended in 100 μl of PBS (pH 7.2) and then subsequent-
ly analyzed.
Data acquisition by flow cytometry (FCM)
The acquisition threshold was set in the side scatter channel using a Guava 
easyCyte 8T flow cytometer (Millipore, Italy). For each sample, a total of 10 000 
events were stored in list mode files. Analyses were made using the inCyte softwa-
re (Millipore, Italy). Cells were enumerated by combining in the same hybridization 
tube, one group Cy5-probe with the SYBR green. An FLG histogram (green fluo-
rescence), was used to evaluate the total number of bacteria stained, with SYBR 
green. A gate was designed, in this histogram representing the total number of 
bacterial cells, in the sample and was used to build an FLR histogram (red fluore-
scence), to estimate the proportion of cells targeted, by the group Cy5-probe in the 
sample. The proportion of group cells, was corrected by eliminating background 
fluorescence. Results were expressed as cells hybridizing with the groupCy5 probe, 
as a proportion of total bacteria stained with SYBR green.
1H NMR Spectroscopy
For spectroscopic analysis, 400 μL of fermented slurry were diluted with 200 μL 
of phosphate buffer (pH 7.4; 100% D2O), containing 1 mM of TSP (3-trimethylsilyl-
1-[2,2,3,3-2H4] propionate) as an external standard and 2 mM sodium azide as a 
bacteriocide. Samples were mixed by vortex and centrifuged at 13 000 g for 10 
min, prior to transferring 550 μL to a 5 mm NMR tube. Spectroscopic analysis were 
carried out on a 500 MHz Bruker NMR spectrometer. For each sample, 8 dummy 
scans were followed by 128 scans and collected into 64 000 data points. A spectral 
widths of 20 ppm was used. Spectra were manually phased, corrected for baseline 
distortions and referenced to the TSP signal at δ 0.00. 1H-NMR spectra (0.2 to 10.0 
ppm) were digitized into consecutive integrated spectral regions (~20.000) of equal 
114
widths (0.00055 ppm). The regions containing the residual signal from water (4.50 
to 5.00 ppm), TSP (0.00 ppm) and the large resonance arising from basal medium, 
were removed to minimize the effects of baseline distortion. Each spectrum was 
then normalized to unit area.
NMR data analysis and metabolites identification
Multivariate modeling, including Principal Component Analysis (PCA) and Or-
thogonal Partial Least Squares analysis (OPLS), was performed in MatLab (The 
Mathworks, Inc., Natwick, MA), using scripts provided by Korrigan Sciences Ltd., 
United Kingdom. The 1H-NMR spectroscopic profiles were used as the descriptor 
matrix (X), and donors, sampling time and treatments were used individually as 
response variables (Y). Loading coefficient plots were generated by back-scaling 
transformation to display the covariance between the Y-response matrix and the 
signal intensity of the metabolites in the NMR data (X). Colors projected onto the 
coefficient plot indicate the correlation coefficient (R2) between each metabolite and 
the Y-response variable, with red indicating strong significance and blue indicating 
weak significance. The predictive performance of the model (Q2Y) was calculated 
using a seven-fold cross validation approach. Model validity was established by 
permutation (1000 permutations) and the results are given as p values.
Metabolite identification was performed using HMDB database (http://www.hmdb.
ca/), KEGG (Kyoto Encyclopedia of Genes and Genomes), Chenomix profiler 8.1 
software (Chenomx Inc., Edmonton, Canada).
DNA extraction
The genomic DNA extraction was obtained by FastDNA™ SPIN Kit for Fecesn 
(MP Biomedicals, Santa Ana,CA), following the manufacturer’s protocols. The final 
product was 100 μl of application-ready DNA. Nucleic acid concentration and purity 
were measured using the Nanodrop 8000 spectrophotometer. DNA concentrations 
were in the range 25.03 ± 11.01ng/µL.
16S rRNA amplicon library preparation and MiSeq se-
quencing
Using the specific bacterial primer set 341F (5’ CCTACGGGNGGCWGCAG 3’) (Klin-
dworth et al. 2013) and 806R (5’ GACTACNVGGGTWTCTAATCC 3’) (Apprill et al. 
2015) with overhang Illumina adapters, total genomic DNA was subjected to PCR 
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amplification, by targeting a ~460-bp fragment of the 16S rRNA variable region V3-
V4. PCR amplification of each sample, was carried out using 25 µl reactions with 
1 µM of each primer. Specifically 12.5 µl of 2x KAPA HiFi HotStart ReadyMix, 5 µl 
forward primer, 5 µl reverse primer, were used in combination with 2,5 µl of tem-
plate DNA (5 ng/ul). All PCR amplification was carried out, using a GeneAmp PCR 
System 9700 (Thermo Fisher Scientific) and the following steps: melting step – 95 
°C for 3 minutes (one cycle); annealing step – 95 °C for 30 seconds, 55 °C for 30 
seconds, 72 °C for 30 seconds (25 cycles); extension step – 72 °C for 5 minutes (1 
cycle). The PCR products were checked on 1.5 % agarose gel and cleaned from 
free primers and primer dimer, using the Agencourt AMPure XP system (Beckman 
Coulter, Brea, CA, USA), following the manufacturer’s instructions. Subsequently, 
dual indices and Illumina sequencing adapters Nextera XT Index Primer (Illumina), 
were attached by 7 cycles PCR (16S Metagenomic Sequencing Library Preparation, 
Illumina). The final libraries, after purification by the Agencourt AMPure XP system 
(Beckman), were analysed on a Typestation 2200 platform (Agilent Technologies, 
Santa Clara, CA, USA) and quantified, using the Quant-IT PicoGreen dsDNA assay 
kit (Thermo Fisher Scientific), by the Synergy2 microplate reader (Biotek). Finally, all 
the libraries were pooled in an equimolar way, in a final amplicon library and analy-
sed on a Typestation 2200 platform (Agilent Technologies, Santa Clara, CA, USA). 
Barcoded library were sequenced on an llumina® MiSeq (PE300) platform (MiSeq 
Control Software 2.0.5 and Real-Time Analysis software 1.16.18).
Metagenomic data analysis
The sequences were assigned to samples, according to sample-specific barcodes. 
This allowed to collect FASTQ formatted files. Raw data fastq files were merged 
using micca-mergepairs tool. Raw data will be submitted to the http://www.ebi.
ac.uk/ena/submit/sequence-submission. Reads were processed using the MICCA 
pipeline (version 1.0, http://micca.org/) (Albanese et al., 2015). Forward and reverse 
primers trimming, were performed using micca trim (parameters -w CCTACGG-
GNGGCWGCAG -r GACTACNVGGGTWTCTAATCC -W -c). Quality filtering, were 
performed using micca filter (parameters -e 0.5 -m 400 -t), truncating reads shorter 
than 400 nt and discarding reads, with an expected error (EE) rate > 0.5%. De-novo 
sequence clustering, chimera filtering and taxonomy assignment, were performed 
by micca otu (parameters -d 0.97 -c): operational taxonomic units (OTU) were 
assigned by clustering the sequences, with a threshold of 97% pairwise identity, 
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and their representative sequences were classified, using micca classify with the 
RDP classifier version 2.8 (Wang et al., 2007). Template-guided multiple sequence 
alignment (MSA), was performed using micca msa (parameters -m nast), against 
the multiple alignment of the Greengenes (DeSantis et al., 2006) database (release 
13_05) clustered at 97% similarity. Finally, phylogenetic tree was inferred, using 
micca tree (parameters -m fasttree), using FastTree (Price et al., 2010). Sampling 
heterogeneity, was reduced by rarefaction (3,972 sequences per sample). Alpha 
(within-sample richness) and beta-diversity (between-sample dissimilarity) estima-
tes, were computed using the phyloseq R package (McMurdie & Holmes, 2013). 
micca tree (parameters -m fasttree), using FastTree (Price et al., 2010). Sampling 
heterogeneity, was reduced by rarefaction (3,972  sequences per sample). Alpha 
(within-sample richness) and beta-diversity (between-sample dissimilarity) estima-
tes, were computed using the phyloseq R package (McMurdie & Holmes, 2013).
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1H-NMR-based Inulin-changed metabolites of tryp-
tophan metabolism
Differences in faecal slurry metabolites between time 0 and time 24 of Inulin fer-
mentation were detected by principal component analysis (PCA) of 1H-NMR pro-
files (Fig. 1a). The two first principal components accounted for 74% of the total 
variation in the data. The corresponding loading plots results, in the prebiotic fiber 
consumption, with the simultaneous formation of SCFA, such as butyrate, propio-
nate and acetate, in addition to ethanol production and small amount of valerate. 
Lactate appers with a  high peaks, but no significant as a target of fermentation 
(Fig. 1b). 
The first two PCs, obtained from TRP samples, explain 49% of the total varian-
ce within the data and shows a similar, but independent metabolic trend for each 
donor, indicating that the TRP fermentation followed a similar metabolic pattern for 
all faecal fermentations but that the metabolites produced by colonic microbiota is 
subject to interindividual variation. Over the 24 hours, a small but significant incre-
ase in indole, indole acetic acid and acetate was observed during TRP fermenta-
tion by OPLS model (Tab. 1, red colour-code in Fig. 2b). Also tyrosine, propionate, 
acetate and isoleucine tended to increase, but these changes were not statistically 
significant over the 24 hour fermentation. In the TRP+Inulin fermentations, two 
different metabolic trajectories were observed, one for faecal donor 1 and 5, and 
the second for donors 3 and 4. These trends were observed in the first 2 PC and 
explained 63% of the total variance within the data (Fig. 3a). Corresponding loading 
plot (Tab. 1), shows an increase of Indole-3-lactate, 3-indoxyl sulphate, indole-3-a-
cetate, propionate, butyrate, acetate, lactate, ethanol and a decreased of tryp-
tophan (Fig. 3b). 
Finally both PCA (Fig. 4a) (explained 48% of the total variance) and OPLS (Fig. 4b; 
Tab. 1) discriminated analysis of TRP from TRP+Inulin treatments over the time, 
showed a marked difference in tryptophan, BCAA (valine, leucine, isoleucine), indo-
le-3-lactate and tyrosine for TRP treatment alone, while inulin, acetate, ethanol and 
lactate (although not significant) characterize TRP+Inulin fermentated substrate. 
Investigating on the metabolic profiles of these two groups, it was possible highli-
ght, a few differences (Fig. 5a,b). As shown in the two spectra related to the TRP + 
Inulin treatment at 24 h of fermentation, the main difference, lies of the one hand, in 
the formation of lactate for group 2 (donor 3 and 4), compared to group 1 (donor 1 
and 5), whose spectrum shows a weak signal for this compound, while on the other 
4.3 Results 
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hand the group 1 presents a more intense signal for propionate and in the aromatic 
region, only this group shows the formation of 3-indoxyl sulfate in a small amount.
Microbial diversity of bowel microbiota
A total of 80 samples were collected from four treatments: basal medium (Blank), 
Inulin, TRP  and TRP+Inulin, four sampling time (0, 5, 10, 24 hours) and five healthy 
human faecal donors, for 16R rRNA gene community profiling, using the Illumina 
sequencing platform. Using a distance-based similarity of  ≥ 97% for operational ta-
xonomic units (OTU) assignment, a total of 15087 OTUs  were identified. Taxonomic 
alpha diversity (accounting for relative abundances of OTU), was significantly diffe-
rent between TRP and TRP+Inulin treatments (p < 0.0011) (Fig. 6, Tab. 2). TRP and 
Blank fermentation, seem to have a similar trend, with no changes over the course 
of the fermentations, except for donor 5 in the TRP fermentation, which showed 
exceptionally high increase in α-diversity. Although the α-diversity of the Blank 
and TRP alone fermentations remained more or less constant over the 24 hour 
fermentation period, during fermentations of TRP+Inulin and Inulin alone showed a 
reduction in species richness of about 30% (OTU %) between time 5 h to time 24 h 
(Fig. 7). Bacterial community composition was analyzed by statistical comparisons, 
as indicated in the methods section, of each sampling time, respect to time 0 h. 
Figure 10, shows the change, with respect to time 0 h, in relative abundance of 
bacteria at genus level over the course of the fermentation. Only genus level chan-
ges which showed statistically significant differences between TRP and TRP+Inulin 
fermentations compared to the control Blank fermentation are shown. Since data 
are presented as relative abundances, an increase in any given genus for example, 
may be due either to an increase in its actual population level or cell number or a 
decrease on other bacteria within the same community. According to these prelimi-
nary considerations, we can say that although with a strong interindividual variabili-
ty, Inulin (alone or in addition to tryptophan), seems enriched of Escherichia/Shigella 
(about 5%), and slightly above the zero appears the genus Phascolarctobacterium. 
While with greater homogeneity among donors, a slight positive trend was found for 
Dorea. Instead, during fermentation of pure TRP, an increase of about 1% and 2% 
in Alistipes, compared with Inulin and TRP+Inulin respectively, were found. Final-
ly TRP shows for Desulfovibrio, Oscillibacter and Phascolarctobacterium a slight 
positive stimulation. Compare with the other treatments, a negative trend (over the 
time) of the genus Clostridium XVIa (about -3%), was measured when Inulin was 
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present in the medium. The high variability between donors and over the time, 
prevents an understanding of how the genus Ruminococcus, behaves during Inulin 
fermentation. Inulin alone, leads to a reduction of Barnesiella genus (about -1%), 
Clostridium IV (about - 0.5%), Clostridium XVIa (about -3%), and even shows a sli-
ght negative trend for Flavonifractor (about -0.5%) and Odoribacter (about -0.25%). 
A fluorescence in situ hybridization-flow cytometry (FISH/FC)-based method, was 
also used to enumerate the relative abundance of Enterobacteriaceae and Bifido-
bacteria, of all 80 samples collected during this experiment. As shown in figure 11, 
TRP is characterized with the higher level of Enterobacteriaceae, while not allowing 
a suitable medium for the growth of Bifidobacterium. Moreover Inulin, as expected, 
has been an ideal substrate for the growth of Bifidobacteria and also in association 
with TRP, showed a remarkable growth of this bacterial population.
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4.4 Discussion 
This study was designed firstly, to measure the impact of TRP metabolism on 
metabolite profiles produced by the human faecal microbiota using anaerobic pH 
controlled and stirred batch cultures simulating the fermentation conditions of the 
distal colon. A range of known TRP metabolites were formed during TRP fermen-
tation over 24 h. We also examined whether the presence of a fermentable fiber, 
the prebiotic inulin, could modulate both microbiota composition and their meta-
bolic output during TRP metabolism. Metabolism of TRP by the faecal microbiota 
resulted in the production of a range of known TRP metabolites including indole, 
indole acetic acid (IAA) and Branched-Chain Amino Acids (BCAA), such as valine, 
leucine and isoleucine. Low correlation of acetate, was also found over the course 
of the fermentation, although this is likely to have been derived from either residual 
carbohydrate in the growth medium or organic matter delivered with the faecal 
inoculum (e.g. residual dietary fiber).
Similarly, acetate and lactate are the main end products of carbohydrate fermenta-
tion by Bifidobacterium and Lactobacillus (Pokusaeva et al., 2011); while lactobacilli 
and other Firmicutes such as certain clostridia produce ethanol during fermentation 
of carbohydrates (Krajmalnik-Brown et al., 2012). 
The results obtained through high-throughput sequencing, have showed a re-
duction of bifidobacteria in terms of relative abundance, during fermentation of 
Inulin. Being well known the bifidogenic activity of inulin, reported in many in vitro 
and in vivo studies, quantification fluorescent in situ hybridization have been inte-
grate. The results obtained through high-throughput sequencing, have showed a 
reduction of bifidobacteria in terms of relative abundance, during fermentation of 
Inulin. Being well known the bifidogenic activity of inulin, fluorescent in situ hybri-
dization quantitative method, has been integrated. Measure of microbial absolu-
te abundance, have confirmed, as aspected, the ability of Inulin to stimulate the 
growth of bifidobacteria. However, the relative abundance may give an important 
contribution to understanding the dynamics that regulate the growth of more taxa in 
a specific substrate. During fermentation of prebiotic fiber, the absolute increase of 
bifidobacteria, may have been joined the growth of other populations, in relative ter-
ms, which have grown more and then led to the results observed for metagenomi-
cs. Moreover, early work by McBain and Mcfarlane (1997), showed by three stage 
continuous in vitro gut model system, that prebiotic inulin has a specific bifidogenic 
stimulation in the proximal colon stage (with a pH 5.5), while no significant effects 
were reported for the other two tract (transverse and distal colon, with more neutral 
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pH). Furthermore in all conditions, nitroreductase and azoreductase activities were 
increased and at the same time it was stimulate the growth of Enterobacteria and 
C. perfringens (McBain and Macfarlane, 1997). More recently, Chung and collea-
gues, described the observed pH effect on bifidobacteria relative abundance by 
four stage continuous in vitro gut model. The best result, in terms of promotion of 
bifidobacteria by inulin, was observed at pH 5.5, while at higher pH it was inhibited, 
maybe due to a competition between several co-use of this fiber microorganisms 
as an energy source (Chung et al., 2016).
In this paper Illumina MiSeq sequencing and quantitative FISH and real-time PCR 
were used to monitoring the specific effect of inulin on the bacterial growth and the 
impact of colonic pH on this modulatory activity of prebiotic fiber. An hypothesis 
upon investigation limits of microbial changes during nutritional intervention, lies 
in the possible conversion of some phyla that, once phylogenetically distant, find 
themselves to share more characteristics, gained during the evolution, as the use of 
the same substrates, as dietary sources, for the their survival within a given envi-
ronment.
Prebiotic addition of Inulin during faecal microbiota metabolism of TRP appears 
to have had a positive impact on the consumption of tryptophan, which is more 
closely related to TRP treatment alone, after 24 h. This is in good agreement with 
the know metabolism of inulin, especially by bifidobacteria, and also the suggests 
growth of the microbiota in response to the fermentable carbohydrate resulted in 
TRP being incorporated into microbial biomass. Decreased levels of tryptophan 
occurs without the formation of characteristic breakdown metabolites such as 
the indoles, suggesting that the presence of inulin, microbial growth increases the 
demand for this essential amino acid. This is in contrast to the TRP fermentation, 
where NMR signals for indole-3-lactate, BCAA valine, leucine and isoleucine increa-
sed over the 24 h fermentation period. In the TRP+Inulin fermentations, BCAA, may 
have been consumed by a more metabolically active microbiota in the presence of 
the fermentable substrate Inulin (Neis et al., 2015). 
As shown in figure 3a, each donor appear to have the same start condition (score 
plot overlap in one point), however, as confirmed by weighted UniFrac phylogenetic 
distances between donors (Fig. 8), two groups have split up along diverging trajec-
tories, during fermentation.
OPLS and PCA modeling were performed on all 80 samples collected during this 
experiment. The metabolic profiles observed, have inevitably influenced the re-
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sults obtained and have made more difficult the interpretation of the data, due to 
the overlap of several peaks of metabolites linked to different donor-response at 
the same dietary intervention (like inulin substrate) interfering with the subsequent 
multivariate data analysis. Nevertheless, we were able to identify and interpret the 
differences emerged between donors in response to the tested substrates, confir-
ming previously published findings, as that inulin stimulates the growth of bifido-
bacteria via formation of SCFA and that carbohydrate availability may reduced the 
aromatic amino acid metabolism by some microorganisms, but may stimulated this 
process by others.
Thus, even if genera Alistipes and Barnesiella, are defined saccharolytic, while spe-
cies belonging to Odoribacter are predominantly asaccharolytic (Rajilić-Stojanović 
and de Vos, 2014), only Alistipes results more abundant in tryptophan metabolism, 
while the others appear not affected by the treatments (Barnesiella decrease slightly 
over the time in all treatments except for the Blank). Barnesiella, which is a member 
of the family Porphyromonadaceae, order Bacteroidales, is a common members 
of the human intestinal and oral microbiota (Morotomi et al., 2009) and it contri-
butes to carbohydrate degradation and prevents the colonisation of the intestine 
by pathogenic bacteria (Kulagina et al., 2012). Although it is difficult to precisely 
define the preferred substrates of fermentation, as shown in figure 10, Oscillibacter, 
includes bacteria starch degraders, which increase both on the resistant starch that 
carbohydrate starvation, suggesting that other factors must be involved in their re-
sponse to diet. Summing, Inulin (alone or in addition to tryptophan), seems increase 
the abundance of Escherichia/Shigella, Dorea and in a less amount Phascolarcto-
bacterium; TRP shows a positive influence on Alistipes, Desulfovibrio, Oscillibacter 
and Phascolarctobacterium; Clostridium XVIa was inhibited by Inulin substrate (alo-
ne or added to TRP), while alone, inulin leads to a reduction of Barnesiella genus, 




TRP bioavailability and conversion into indole metabolites in particular appears to 
have important consequences for human health, impacting on the pathophysiology 
of immune and metabolic diseases, including obesity and on brain function. Althou-
gh 90% of the bodies serotonin is produced at the gut wall from dietary TRP, little 
is know about how the gut microbiota impact on TRP metabolism and subsequent 
systemic TRP pathways involving kynurenine, neurotransmitters like serotonin and 
indole compounds. Similarly, little is known about how diet, especially the presence 
or absence of fermentable carbohydrates and prebiotics, known to modulate the 
gut microbiota, impacts on these interactions. In this present study, focusing on the 
distal colon as a typical proteolytic environment in the gut, we examined the ability 
of the faecal microbiota of 5 health individuals to metabolise TRP in the presence or 
absence of inulin. Inulin had a dramatic impact not only on the production of indole 
TRP catabolites, but also apparently on the bioavailability of TRP itself. Both were 
reduced in the presence of the fermentable carbohydrate, indicating that diet:mi-
crobta interactions might play an important role in TRP availability and associated 
biological activities in vivo. Similarly, this study also supports the recent findings 
that pH as well as the type and quantity of growth substrate can have a dramatic 
impact on both the composition and metabolic activity or growth of bacteria as ob-
served by Chung et al. (2016) and in this case illustrating that the bifidogenic effect 




Fig. 1a Principal component analysis (PCA) score plot of 1H NMR spectra of Inulin in vitro fermentation, over the time (0, 5, 
10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
125Fig. 1b Coefficient plots extracted from the OPLS model constructed from the 1H-NMR profiles of Inulin (1% w/v) in vitro fermentation supernatant of five human faecal donor and the corresponding fermentation time (0, 5, 10, and 24 h).
126 Fig. 2a Principal component analysis (PCA) score plot of 1H NMR spectra of TRP in vitro fermentation, over the time (0, 5, 10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
127Fig. 2b Coefficient plots extracted from the OPLS model constructed from the 1H-NMR profiles of TRP (5 mmol/l) in vitro fermentation supernatant of five human faecal donor and the corresponding fermentation time (0, 5, 10, and 24 h).
128 Fig. 3a Principal component analysis (PCA) score plot of TRP+Inulin in vitro fermentation over the time (0, 5, 10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
129Fig. 3b Coefficient plots extracted from the OPLS model constructed from the 1H-NMR profiles of TRP+Inulin in vitro fer-mentation supernatant of five human faecal donor and the corresponding fermentation time (0, 5, 10, and 24 h).
130 Fig. 4a Principal component analysis (PCA) score plot of 1H NMR spectra of TRP vs TRP+Inulin in vitro fermentation after 24 h and for 4 human healthy faecal donors.
131Fig. 4b OPLS coefficient-coded loading plot derived from comparison of 1H-NMR spectra of TRP (5 mmol/l) and TRP+Inulin (1% w/v) in vitro fermentation by five human faecal donor, at 24 h.
132 Fig. 5a 1H-NMR spectrum of TRP+Inulin of donors 1 and 5
133
134 Fig. 5b 1H-NMR spectrum of TRP+Inulin of donors 3 and 4
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Tab. 1 Summary of the parameter values (R2X, Q2Y and p-value) describing the OPLS model.
Fig. 6 Alpha-diversity, ranges from time 0 of each treatments and sampling time. Repeated measure for five different human 
faecal donors, are marked with colored dots.
Blank inulin trp trp+inulin trp  vs trp+inulin
R2X - 0,19 0,16 0,21 0,45
Q2Y - 0,75 0,44 0,73 0,71
p value > 0.05 0,01  0,01  0,01 0,01
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Tab. 2 Observed OTU: pairwise comparisons using Wilcoxon rank sum test. P value were adjusted by False Discovery Rate 
(FDR) method.
Blank inulin trp
trp+inulin 0.0037  0.2364 0.0011  
trp 0.5189 3.0e-05 -
Blank - 3.6e-05 -
Fig. 7 Weighed UniFrac distances from hour 0 for hours 5, 10 and 24. Only intra-donor distances were computed.  
138
Fig. 8 Weighted unifrac distances between donors (n = 5), at time 0 and 24h. The donors are shown to the side of the 
frame, while treatments are indicated with a shape.
139
Fig. 9 Weighted unifrac distances between treatments (n = 6), at time 0 and 24h. The treatments are shown to the side of 
the frame, while donors are marked with a color – code dots.
140 Fig. 10 Relative abundance differences from hour 0 estimated at the genus level. Only genera with at least one significant treatment different from the blank are shown in table 2.
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Bacteria enriched Bacteria depleted
inulin
Clostridium XlVa Barnesiella
Clostridium XVIII Clostridium IV


















Tab. 3 Statisticly significant changes at genus level comparing treatmnets and Blank, over 24h.
142
Fig. 11 Distribution of the proportion of Bifidobacteria and Enterobacteriaceae in human faeces assessed, over the time (0, 
5, 10, 24 h), by genus-specific 16S rRNA oligonucleotide probes and by relative cell enumeration by FISH combined with 
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Abstract 
There are many potential signaling mechanisms by which the gut microbiota could 
influence brain activity, including changes in microbiota-produced signaling mo-
lecules, such as neurotransmitters, neuroactive phenolic compounds, short chain 
fatty acids and amino acid (AA)-metabolites. This current work, tested the fer-
mentation of selected neuroactive compounds (dopamine, tyrosine, tryptophan, 
phenylalanine, glutamate and methionine), using in vitro anaerobic batch cultu-
re, designed to simulate fermentation in the human distal colon. Using 1H-NMR 
spectroscopy based metabolic profiling, we measured changes in levels of meta-
bolites associated to the selected neuroactive compound and identified recognized 
metabolic derivatives which might potentially impact on human physiology through 
the gut:brain axis. Significant changes over time in bacterial populations were 
observed, using fluorescence in situ hybridization (FISH), with 16S rRNA targeted 
oligonucleotide probes for bifidobatteria, Lattobacillus/Enterococcus, Bacteroides, 
Desulfuvibrio and total bacteria. While no statistically significant changes, in alpha 
– or beta-diversity, based on OTU obtained from Illumina 16S sequencing, over the 
course of any of the fermentations, were observed. However, considerable interindi-
vidual variation in response to different fermentation substrates, between the faecal 
microbiota of different donors, may account for the lack of statistical significance.  
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Indeed, for the aromatic amino acids and dopamine, changes in metabolite profiles, 
appeared to cluster into two distinct groups, suggesting the existence of meta-
botypes or signature metabolic responses dependent on microbiome structure. In-
triguingly, comparative analysis of 16S rRNA community structures, between these 
two “metabotypes”, revealed statistically significant differences, between important 
groups of gut bacteria, at the family level. Including organism already suspected, of 
forming alternative community structures, within the human microbiome, specifical-
ly the Prevotellaceae and Bacteroidaceae.
Keywords
gut-brain axis | metabonomics | neuroactive compounds | human colonic fermenta-
tion | amino acids
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Nutrients and gut microbiota, can activate physiological pathways and modulate 
the central nervous system, by acting on flow of neuroactive compounds, between 
gastrointestinal environment and neural system. Nutrients derived from food and 
followed digestion by gut microbiota, by regulating the flow of neuroactive com-
pounds, between the gut and neuronal system, could modulate the physiological 
activities of the central nervous system, including the brain. Similarly, signals from 
the brain regulate important gut functions, including food intake (Farr et al., 2016), 
peristalsis (Schemann, 2005), enzyme/chemical secretions (Konturek, 2003) and 
maybe the enterohepatic circulation of bile acids (Hofmann, 2011). It is estimated 
that there are between 200 and 600 million neurons in the human enteric nervous 
system (ENS) (Mayer, 2011), which has led to it being defined, as a second brain. 
This “gut brain” receives information and sends impulses, records emotional expe-
riences and responds to them. Its nerve cells, are signaling routes and are stimu-
lated by the same brain-neurotransmitters. ENS and enterochromaffin (EC) cells 
on the gut wall, produces about 10% and 80% of human body’s total serotonin, 
respectively (Resnick and Gray, 1961), while about 50% of the dopamine measured 
in human body, is produced by mesenteric organs (Eisenhofer et al., 1997). The 
much-studied gut-brain axis includes the central nervous system (CNS), the neuro-
endocrine and neuroimmune systems, the sympathetic and parasympathetic arms 
of the autonomic nervous system (ANS), the enteric nervous system (ENS) and 
the intestinal microbiota (Grenham et al., 2011). Visceral messages from the gut, 
can influence brain function and, the possibility of regulating the gut microbiota, 
is opening up as a tractable therapeutic target, for a host health disorders. There 
are many potential signaling mechanisms, by which gut microbiota could influence 
brain activity. Including changes in microbiota-produced signaling molecules, such 
as short chain fatty acids and ketone bodies (Cummings and Macfarlane, 1991; 
Kimura et al., 2011), phenolic acids (Russell et al., 2013), steroids (Gérard, 2013), 
amino acids and their derivatives (Fernstrom, 2012; Dai et al., 2011), catecholami-
nes (Rhee et al., 2009), incretins  (Cani, 2015; Cani et al., 2009), mucosal immune 
mechanisms (Sherman et al., 2015; El Aidy et al., 2014), and enterochromaffin 
cell-mediated vagal activation (Rhee et al., 2009; Raybould, 2010). Food intake, 
changes the composition of the blood plasma, which affects the release of amine 
neurotransmitters. For example, changes in plasma levels of choline, lead to chan-
ges in brain levels of the neurotransmitter acetylcholine; tryptophan levels absorbed 
from the gut, lead to serotonin; and tyrosine, is used to produce catecholamines. 
5.1 Introduction
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The relationship between precursors and neurotransmitters, in addition to control-
ling food intake, can of course influence  neurotransmission and thus mental and 
physical performance, with possible physiological and medical implications, which 
are only now coming to light (Marriott, 1994).
Phenylalanine (PHE), is an essential amino acid and given its hydrophobicity, it is 
mainly found within protein (Institute of Medicine (U.S.), 1999). Although the meta-
bolic pathway for PHE, is well recognized and many gut bacteria, possess genes 
involved in this pathway (especially the Proteobacteria), we still do not fully under-
stand either, the biochemistry or microbial ecology of PHE metabolism, by the gut 
microbiota (Teufel et al., 2010). Phenylalanine plays a key role in the biosynthesis of 
protein and nonessential amino acid tyrosine. 
Tyrosine (TYR), is in turn responsible for the synthesis of monoamine neurotran-
smitters dopamine, norepinephrine, and epinephrine, as well as the skin pigment, 
melanin (Daubner et al., 2011).  The peptide tyrosine–tyrosine, better know as 
peptide PYY, plays an important role in regulating appetite and energy metabolism, 
in modulating gut motility and in reducing harvest of energy, from the diet. Recently, 
homologous AA sequences, between these neuropeptides and proteins belonging 
to certain commensal bacteria, suggest that the gut microbiota may have the ca-
pability to influence  production of gut hormones, like PYY and, therefore regulate 
human eating behaviour (Samuel et al., 2008; Wynne and Bloom, 2006). 
Meals with high concentration of tyrosine, stimulate tyrosine hydroxylation rate, the 
rate-limiting enzyme for the synthesis of dopamine (Fernstrom, 2012). An alternative 
dopamine biosynthesis route, involves tyramine oxidization by Cyp2D. Tyramine 
comes in turn directly from decarboxylation, by aromatic amino acid decarboxylase 
(AADC), of L-tyrosine, or from phenylethylamine, which derives from decarboxyla-
tion of L-phenylalanine, by the same AADC enzyme (Meiser et al., 2013).  
Dopamine (DA), is now recognized as an important neurotransmitter and not just 
as a precursor of epinephrine or, an intermediate of tyrosine degradation. It stimu-
lates  exocrine secretions, modulates sodium absorption and gut mucosal blood 
flow, inhibits gut motility and is protective against gastroduodenal ulcer (Eisenhofer 
et al., 1997). In the gastrointestinal tract, the extent of dopaminergic innervation, is 
not well documented and there is still much debate, concerning the relative impor-
tance, of neuronal and/or non-neuronal sources, of enteric dopamine. 
Trypthophan (TRP), on the other hand, is probably one of the most studied essen-
tial amino acids of recent years, is abundantly present in dietary proteins and is the 
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main precursur of serotonin. Serotonin, is a monoamine neurotransmitter and a key 
signalling molecule in both the enteric and central nervous systems. Tryptophan hy-
droxylase (TPH), the rate limiting step, uses tetrahydrobiopterin cofactor to convert 
tryptophan to 5-hydroxytryptophan (5-HTP); while amino acid decarboxylase, the 
second enzyme involved in serotonin biosynthesis, converts 5-HTP into serotonin 
(Nakamura and Hasegawa, 2009). Approximately 4–6% of total amount of TRP, 
undergoes bacterial degradation, which leads to the release of the metabolites 
including  indole, indican, and indole acid derivatives, which have an important role 
in host gut immune homeostasis (Keszthelyi et al., 2009; Zelante et al., 2013). The 
impact of a meal, can indirectly affect brain TRP uptake (and serotonin synthesis), 
depending on blood concentration of large neutral amino acids (LNAA) and tryp-
tophan, which are transport competitors in the BBB (Fernstrom, 2012). 
Glutamate (GLU), is one of the most abundant amino acids, isolated from protein 
matrices (Giacometti,1979). It is converted to glutamine, by cells lining the intestinal 
tract. Studies show that glutamate, is an energy source for enterocytes and drives 
our digestion, sending signals to the stomach, small intestine, and liver. Besides 
its role in digestive health and function, glutamate is the major excitatory neuro-
transmitter in the brain. It plays an essential role in learning and memory (Uneyama 
et al., 2008; Reeds et al., 2000). Decarboxylation of the C-1 carboxylic group of 
glutamate, leads to the biosynthesis of GABA (gamma-aminobutyric acid), which is 
the main inhibitory or calming neurotransmitter in adult human brain (Roberts and 
Frankel, 1950). A build-up of glutamate with a deficiency of GABA, has been linked 
to serious brain disorders, like autism (Horder et al., 2013), alzheimer’s disease 
(Lanctôt et al., 2004), stiff man syndrome (Manto et al., 2015) and diabetes (Wang 
et al., 2015). 
Methionine (MET), is required during brain development and for mantaining brain 
function throughout life. Classified as sulfur-containing amino acid (SAA), it sup-
plies sulfur and other compounds required by the body for normal metabolism and 
growth and it constitutes one of the nine essential amino acids. In addition to die-
tary sources, methionine is commonly found in sulfated polysaccharides, including 
mucin and chondroitin sulfate produced endogenously by the gastrointestinal tract 
(Magee et al., 2000). Methionine was discovered and isolated in 1922 from casein 
and belongs to a group of compounds called lipotropics, which includes choline, 
inositol, and betaine (trimethylglycine), all of which assist lipid breakdown in the 
liver. Physiological increases in brain methionine, are directly related to its serum 
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concentration and thus, factors regulating methionine levels in the circulation, 
will also regulate methionine in the brain. Brain methionine appears to be utilized, 
mainly for protein synthesis and increases the rate of S-adenosyl methionine (SAM) 
synthesis (Rubin et al., 1974). SAM, is involved in the biosynthesis of serotonin, me-
latonin, and dopamine in the brain, as well as plays an important role in the immune 
system, has a protective effect on cellular and mitochondrial membranes and is 
able to inhibit of inflammatory response (Baldessarini and Kopin, 1966). As for other 
sulfur-containing amino acids, methionin metabolism in the gut has been shown 
to be influenced by the presence of specific lactobacilli and other closely related 
Gram-positive bacteria, including Bacillus subtilis, Lactococcus lactis, Streptococ-
cus mutans (Liu et al., 2012). Methionine and cysteine are involved, as precursors, 
in the biosynthesis of numerous bioactive compounds, including glutathione, 
polyamines, and taurine (Brosnan and Brosnan, 2006). In numerous cells within the 
body, methionine, is metabolized via transamethylation to homocysteine and in the 
process produces S-adenosylmethionine, which donates an aminopropyl moiety, 
in the formation of the polyamines, spermidine and spermine. Homocysteine is con-
verted to cysteine via transsulfuration. Cysteine, is one of three constituent amino 
acids of glutathione (GSH), along with glutamate and glycine. Moreover, cysteine is 
metabolized to form taurine. Glutathione is a major cellular antioxidant in cells and 
forms, an important part of the bodies defence mechanism against oxidative stress. 
Cysteine and taurine can also function as cellular antioxidants. The quantitative 
significance of these functional endproducts to splanchnic methionine, cysteine 
and glutamate utilization, is unknown however. Early studies in humans, suggested 
that splanchnic tissues, are an important site of transsulfuration. Studies in piglets, 
indicate that first-pass utilization of dietary methionine ranged from 30% to 40% 
(Bauchart-Thevret et al., 2009). 
However, we still know little about what regulates the flux of amino acids or their 
bioactive derivatives, including neurotransmitters from the gut. In particular, few 
studies have examined how amino acids are handled by the gut microbiota and 
what influence amino acids have in turn on gut microbiota composition and meta-
bolic activity. Although direct absorption of amino acids from the distal colon, may 
not contribute significantly to circulating amino acid concentrations, their metaboli-
sm and production of bioactive derivatives, not least neurotransmitters may have a 
direct effect on the ENS, colonic mucosal metabolism and health, and the microbial 
ecology of this region of the colon. Here, using in vitro anaerobic model of human 
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distal colon, with pH set at 6.8-7.2 and repeted by five human faecal donor, we 
measured the influence of different amino acids (dopamine, tyrosine, tryptophan, 
phenylalanine, glutamate and methionine), on metabolites production and microbial 
populations, using metabolomics and culture-independent microbiological approa-
ches. 
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5.2 Materials & 
Methods
Neuroactive compound stock solution
Dopamine, tyrosine, tryptophan, phenylalanine, glutamate and methionine were 
added to the basal medium in the form of a stock solution, made in a weakly acid 
or basic solution (to increase their solubility) to give final concentrations, in the ba-
tch culture vessels (200 ml) of 10 mmol/l for the linear compounds (glutamate and 
methionine), or 5 mmol/l for the aromatic compounds (dopamine, tyrosine, tryp-
tophan and phenylalanine) as described by Smith and Macfarlane (1997). 
Fecal batch cultures
Faecal fermentations were conducted using the basal nutrient medium of Smith 
and Macfarlane, (1997) which contained no added amino acids. The medium, was 
prepared as from the following formula (g/l): CaCl2  2H2O – 0.02; MgSO4 7H2O – 
0.02; K2HPO4 – 0.08; KH2PO4 – 0.08; NaHCO3 – 0.8; NaCl – 0.2; haemin – 0.01; 
Tween 80 – 2.0. Moreover, trace element solution and vitamin solutions, were ad-
ded at 8 and 20 ml/l respectively. Mineral solution contained the following amounts 
(g/l) of salts: ‎C2H3NO4 – 1.5; MgSO4 – 3.0; MnSO4 – 0.5; NaCl – 1.0; FeSO4 – 0.1; 
CaCl2 –0.1; CoC12 – 0.1; ZnSO4 – 0.1; CuSO4 – 0.01; AlK(SO4)2 – 0.01; H3BO3 – 0.01; 
Na2MoO4 – 0.01. While Vitamin solution contained (mg/l): biotin – 2.0; folic acid – 
2.0; pyridoxine hydrocgloride – 10.0; riboflavin – 5.0; thiamine – 5.0; nicotinic acid 
– 5; pantothenic acid – 5.0; vitamin B12 – 0.1; p-aminobenzoic acid – 5.0; thioctic 
acid – 5.0 (Wolin et al., 1963). All chemicals were purchased from Sigma. The final, 
working volume of all fermentations was 150 ml. Anaerobic conditions were main-
tained by O2-free N2 (15 ml/min) flow overnight. Temperature was held at 37 °C 
using a circulating water bath, and pH was controlled between 6.8 and 7.2 using 
an automated pH FerMac 260 controller (Gloucester, England-GL208JH, United 
Kingdom), which added acid and alkali as required (0.5 M HCl and 0.5 M NaOH). 
Five healthy human donors (2 male, 3 female), who had taken no prebiotics, pro-
biotics, or antibiotics within 3 months of the study were recruited to provide faecal 
samples as inocula. Faecal inocula (10% w/v) were prepared using pre-reduced 
phosphate-buffered saline (PBS 0,1 mol/l) and used to inoculate each fermentation 
vessel to a final concentration of 1% faeces w/v. The test fermentations were basal 
medium (Blank), Inulin at 1% (w/v) (Cargill Oliggo-Fiber® inulin DS2 5LB), as positive 
control, TRP (Sigma-Aldrich, Germany) (5 mmol/l) and TRP (5 mmol/l) with Inulin 
(1% w/v). Each fermentation was conducted once with faecal inocula from each 
of the 5 faecal donors (n = 5). Batch cultures were run for 24 hour and samples 
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obtained from each vessel at 0, 5, 10, 24 h, were centrifuged at 13 000 rpm, where 
the supernatants and pellets were stored at -80 °C for metabolomics and metage-
nomics analysis respectively. Samples for FISH were prepared as described below 
and stored at -20oC. 
Fluorescence In Situ Hybridization (FISH)
Sample fixing and hybridization were performed as previously described (Rochet 
et al., 2004; Saulnier et al., 2008). Briefly, 375 μl of culture fluid was diluted in 1125 
μl of 4% (w/v) paraformaldehyde and fixed overnight at 4 °C. Bacterial cells were 
pelleted by centrifugation at 13 000 rpm for 5 min and washed twice in filter-sterili-
zed PBS. Cells were then resuspended in 150 μl PBS and 150 μl ethanol. Samples 
were stored at −20 °C for a minimum of 3 h before further processing. The probes 
used were as follows: Eub 338 (I, II, III) – specific for the total bacteria (Daims et 
al., 1999); Bif 164 – specific for Bifidobacterium (Langendijk et al., 1995); Bac 303 
– specific for the Bacteroides and Prevotella group (Manz et al., 1996); Lab 158 – 
specific for Lactobacillus and Enterococcus (Harmsen et al., 1999); DSV 687 – for 
Desulfovibrionales and Desulfomonales (Devereux et al., 1992). Probes sequences 
and their respective hybridization temperatures were previously described (Saulnier 
et al., 2008). To permeabilize the cells for use with probe Lab158, samples were 
treated with 50 μl of lysozyme (1 mg/ml in 100 mM TrisHCl, pH 8.0) at 37°C for 15 
min before being washed (2–3 s) in water and were finally dehydrated in the ethanol 
series (50%, 80% and 96% v/v ethanol, 3 min each). A probe/hybridization buffer 
mixture (5 ng/5 μl of a 50 ng/μl probe in stock solution plus 45 μl of hybridization 
buffer), was applied onto the surface of each well. Hybridizations were performed 
for 4 h in an oven. For the washing step, slides were placed in 50 ml of wash buffer 
containing 20 μl of 4, 6-diamidino-2-phenylindole di-hydrochloride (DAPI; 50 ng/μl; 
Sigma, UK) for 15 min. They were then washed (2–3 s) in ice-cold water and dried 
under a stream of compressed air. Five μl of antifade reagent (polyvinyl alcohol 
mounting medium, with DABCOTM antifading, Sigma), was added to each well and 
a coverslip was applied. Slides were stored in the dark at 4°C (for a maximum of 3 
days) until cells were counted under a microscope. DAPI slides were visualized with 
the aid of a DM 400 filter and probe slides with the aid of a DM 575 filter.
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NMR spectra acquisition and processing
Batch culture samples (400 μl) were combined with 200 μl of phosphate buffer (pH 
7.4; 100 % D2O) containing 1 mM of the internal standard, TSP (3-trimethylsilyl-1-
[2,2,3,3-2H4] propionate). Samples were mixed by vortex and centrifuged (10 000 
g for 10 min) before transfer to a 5 mm diameter NMR tube. Spectroscopic analysis 
was carried out on a 500 MHz Bruker NMR spectrometer. Standard one dimensio-
nal 1H-NMR spectra of the batch culture samples were acquired with water, TSP 
and basal medium peacks suppression using a standard pulse sequence. For each 
sample, 8 dummy scans were followed by 128 scans and collected into 64 000 
data points. A spectral widths of 20 ppm was used. Chemical shifts in the spectra 
were referenced to the TSP singlet at 0.0 ppm. Spectra were manually phased and 
corrected for baseline distortions. The 1H-NMR spectra (0.2 to 10.0 ppm) were 
digitized into consecutive integrated spectral regions (~20 000) of equal widths 
(0.00055 ppm). The regions containing the residual signal from water (4.50 to 5.00 
ppm) and the large resonance arising from polyethylene glycol (3.70 ppm) were re-
moved to minimize the effects of baseline distortion. Each spectrum was then nor-
malized using a total option. Multivariate modeling, including Principal Component 
Analysis (PCA) and Orthogonal projection to latent structes (OPLS) analysis, was 
performed in MatLab (The Mathworks, Inc., Natwick, MA) using scripts provided by 
Korrigan Sciences Ltd., United Kingdom. The predictive performance of the model 
(Q2Y) was calculated using a seven-fold cross validation approach. Model validity 
was established by permutation (1000 permutations) and the results are given as p 
values.
Metabolite identification was performed using HMDB database (http://www.hmdb.
ca/), KEGG (Kyoto Encyclopedia of Genes and Genomes), Chenomix profiler 8.1 
software (Chenomx Inc., Edmonton, Canada). 
DNA extraction
The genomic DNA extraction was obtained by FastDNA™ SPIN Kit for Feces (MP 
Biomedicals, Santa Ana,CA), following the manufacturer’s protocols. The final 
product was 100 μl of application-ready DNA. Nucleic acid concentration and purity 
were measured using the Nanodrop 8000 spectrophotometer. Nucleic acid con-
centration and purity were measured using the Nanodrop 8000 spectrophotometer. 
DNA concentrations were in the range 25,77 ± 15,97 ng/µL.
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16S rRNA amplicon library preparation and MiSeq se-
quencing
Using the specific bacterial primer set 341F (5’ CCTACGGGNGGCWGCAG 3’) (Klin-
dworth et al. 2013) and 806R (5’ GACTACNVGGGTWTCTAATCC 3’) (Apprill et al. 
2015), with overhang Illumina adapters, total genomic DNA was subjected to PCR 
amplification, by targeting a ~460-bp fragment of the 16S rRNA variable region V3-
V4. PCR amplification of each sample, was carried out using 25 µl reactions with 
1 µM of each primer. Specifically 12.5 µl of 2x KAPA HiFi HotStart ReadyMix, 5 µl 
forward primer, 5 µl reverse primer, were used in combination with 2.5 µl of tem-
plate DNA (5 ng/ul). All PCR amplification was carried out, using a GeneAmp PCR 
System 9700 (Thermo Fisher Scientific) and the following steps: melting step – 95 
°C for 3 minutes (one cycle); annealing step – 95 °C for 30 seconds, 55 °C for 30 
seconds, 72 °C for 30 seconds (25 cycles); extension step – 72 °C for 5 minutes (1 
cycle). The PCR products were checked on 1.5 % agarose gel and cleaned from 
free primers and primer dimer, using the Agencourt AMPure XP system (Beckman 
Coulter, Brea, CA, USA), following the manufacturer’s instructions. Subsequently, 
dual indices and Illumina sequencing adapters Nextera XT Index Primer (Illumina), 
were attached by 7 cycles PCR (16S Metagenomic Sequencing Library Preparation, 
Illumina). The final libraries, after purification by the Agencourt AMPure XP system 
(Beckman), were analysed on a Typestation 2200 platform (Agilent Technologies, 
Santa Clara, CA, USA) and quantified, using the Quant-IT PicoGreen dsDNA assay 
kit (Thermo Fisher Scientific), by the Synergy2 microplate reader (Biotek). Finally, all 
the libraries were pooled in an equimolar way, in a final amplicon library and analy-
sed on a Typestation 2200 platform (Agilent Technologies, Santa Clara, CA, USA). 
Barcoded library were sequenced on an llumina® MiSeq (PE300) platform (MiSeq 
Control Software 2.0.5 and Real-Time Analysis software 1.16.18).
Data analysis
The sequences were assigned to samples, according to sample-specific barcodes. 
This allowed to collect FASTQ formatted files. Raw data fastq files were merged 
using micca-mergepairs tool. Raw data will be submitted to the http://www.ebi.
ac.uk/ena/submit/sequence-submission. Reads were processed using the MICCA 
pipeline (version 1.0, http://micca.org/) (Albanese et al., 2015). Forward and reverse 
primers trimming, were performed using micca trim (parameters -w CCTACGG-
GNGGCWGCAG -r GACTACNVGGGTWTCTAATCC -W -c). Quality filtering, were 
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performed using micca filter (parameters -e 0.5 -m 400 -t), truncating reads shorter 
than 400 nt and discarding reads, with an expected error (EE) rate > 0.5%. De-novo 
sequence clustering, chimera filtering and taxonomy assignment, were performed 
by micca otu (parameters -d 0.97 -c): operational taxonomic units (OTU) were 
assigned by clustering the sequences, with a threshold of 97% pairwise identity, 
and their representative sequences were classified, using micca classify with the 
RDP classifier version 2.8 (Wang et al., 2007). Template-guided multiple sequence 
alignment (MSA), was performed using micca msa (parameters -m nast), against 
the multiple alignment of the Greengenes (DeSantis et al., 2006) database (release 
13_05) clustered at 97% similarity. Finally, phylogenetic tree was inferred, using 
micca tree (parameters -m fasttree), using FastTree (Price et al., 2010). Sampling 
heterogeneity, was reduced by rarefaction (3,972  sequences per sample). Alpha 
(within-sample richness) and beta-diversity (between-sample dissimilarity) estima-
tes, were computed using the phyloseq R package (McMurdie & Holmes, 2013). 
micca tree (parameters -m fasttree), using FastTree (Price et al., 2010). Sampling 
heterogeneity, was reduced by rarefaction (3,972  sequences per sample). Alpha 
(within-sample richness) and beta-diversity (between-sample dissimilarity) estima-
tes, were computed using the phyloseq R package (McMurdie & Holmes, 2013).
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NMR-based metabolites profiling data 
Phenylalanine (PHE). During PHE fermentation, two individuals-class were ob-
served, by PC2  (with 15% of the total variance within the data) and described as 
group A  = donor 1 and 2; group B = donor 3, 4, 5. Wide spread of samples scores 
were obtained only for group A , while more closed was the trajectory of group B 
(Fig. 1a). Fermentation of phenylalanine, yields mainly phenylacetate after 24 h. 
Other compounds identified included hydroxypropyl derivatives, like hydroxypropyl 
pyruvate (HPPA), propionate, butyrate, acetate, valerate and isovalerate (all statisti-
cally significant, except for the last one) (Fig. 1b).
Tyrosine (TYR). OPLS analysis during the time, shows a reduction of tyrosine con-
centration and an increase of acetate as the main product of fermentation (Fig. 2b). 
The lack of recognition of other secondary metabolites is confirmed by the PCA, 
which sees a shorter path along time, compared with DA (Fig. 2a). Other meta-
bolites produced by human colonic bacteria, but not statistically significant, are: 
m-hydroxyphenyl propionyl sulfate (m-HPPS), p-hydroxyphenylacetate (4-HPA), 
p-hydroxyphenylacetate (2-HPA), phenol, in the aromatic region and cresol, propio-
nate, butyrate, isovalerate, acetate and ethanol, in the aliphatic region, as shown in 
figure 2b. 
Dopamine (DA). PCA score plot of 1H-NMR spectra of DA in vitro fermentation 
(Fig. 3a), shows a logical evolutive trend, over the time, of metabolite profile origi-
nated from each donors. However, samples at time 0 have a dissimilarity origin and 
class-separation by PC1 for groups A and B, were observed too. The correspon-
ding loading plots (Fig. 3b), shows that the donors are distinguishable by indepen-
dent metabolic patterns, but follow the same trend, during the fermentation time. 
The values of the parameters (R2X, Q2Y and permutation test) describing the OPLS 
model are statistically significant, as reported in table 1. Metabolites identified 
after 24 h from DA fermentation are SCFA, such as propionate, acetate, butyrate 
and isovalerate. Other compounds identified, but not statistically significant are: 
phenylacetate, m-hydroxyphenylacetate (3-HPA), o-hydroxyphenylacetate (2-HPA), 
p-hydroxyphenylacetate (4-HPA). Significant microbial metabolism was hypnotized 
by depletion of initial DA concentrations during the time. Dopamine spectra, in the 
region of δ 6.9–3.0, show a different profile respect to the chemical shift reported 
from HMBC database. Proton NMR chemical shift found from by us includes dou-
blet of doublet at δ 3.06, doublet of doublet at δ 3.16, doublet of doublet at δ 3.93, 
5.3 Results 
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doublet at δ 6.74, singlet at δ 6.84, and doublet at δ 6.91. While, triplet at δ 2.88, 
triplet at δ 3.23, doublet at δ 6.76, singlet at δ 6.87, and doublet at δ 6.91 is repor-
ted in HMBC database. 
Tryptophan (TRP). The first PC explain 53% of the total variance within the data, 
showing a separation between samples at time 0 and 24, but with independent 
metabolic trend for each donor (Fig. 4a). Two donor groups (A and B), as from DA 
results, clusterized respects to PC2, which explains 13% of the variation across 
all samples. Tryptophan, as expected, was converted to Indole, indole-3-aceta-
te, indoleacetate (IAA), propionate, butyrate and acetate (Fig. 4b). Nevertheless, 
production of indole, propionate, butyrate and acetate showed a strong statistical 
significance over 24 h, corresponding with a significant depletion of TRP (Fig. 4b).
Glutamate (GLU). Differently from the fermentation of all aromatic AA and DA, 
the principal analysis obtained from GLU fermentation, shows a clear separa-
tion between time 0 and 24 of all donors (PC1 with 69% of variation). Moreover a 
dissimilarity responses for only donor 5 was observed (PC2 with 10% of variation), 
compare with the other donors (Fig. 5a). As shown in figure 5b, SCFA, as propio-
nate, butyrate and acetate have been significantly produced, while no N-containing 
compounds were observed after 24 h.
Methionine (MET). Changes in metabolites over time for the MET fermentations 
are visualized in PCA (Figure 6a). A wide spread of score was observed, despi-
te 1H-NMR spectral profiling was not possible for faecal microbiota derived from 
donors 4 and 5 because of poor spectral resolution, and these data were excluded 
from analyses. The metabolite profiles for the remaining three faecal microbiota 
(D1-3) behaved in a similar manner, clustering closely together (Fig. 6a). 24 h-fer-
mentation of methionine resulted in the formation of metabolites including phenyla-
lanine, tyrosine, 4-hydroxyphenylacetate (4-HPA), scyllo-inositol, 5-aminolevulinate, 
propionate, butyrate, propionate, acetate, alanine, leucine and valine. Despite this, 
only few of them were recognised to make a significant contribution towards fer-
mentation, as SCFA propionate and butyrate, BCAA  leucine and valine and scyl-
lo-inositol (Fig. 6b).
Faecal microbiota composition and community structu-
re.
A total of 60 samples were collected from four treatments (Blank, DA, TYR, TRP, 
PHE, GLU, MET), two sampling time (0 and 24 hours) and five healthy human faecal 
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donors, for 16R rRNA gene community profiling using the Illumina sequencing pla-
tform. Using a distance-based similarity of  ≥ 97% for operational taxonomic units 
(OTU) assignment, a total of 12 303 OTU were identified. Taxonomic alpha diver-
sity (accounting for relative abundances of OTU) shows no significant differences 
between treatments (Fig. 7). The same result was obtained calculating weighted 
UniFrac distance, related to time 0, of each treatments, despite all of them are 
significantly distant from time 0 (Fig. 9). 
Exempt for methionine, the treatments appeared reduce the biodiversity, from the 
start of fermentation to the end. However, considerable variations in response, were 
observed between donors and there were no statistically significant overall chan-
ge in alpha-diversity. Similarly, for beta-diversity, measuring how different types or 
bacterial sequence are distributed amongst different fermentations, no statistically 
significant changes were observed after 24 h fermentation compared to 0 hours, 
probably due to large variation in response to amino acid/dopamine fermentations 
of the microbiota, form the 5 different faecal donors (Fig. 8). The weighted UniFrac 
analysis of distance between each donor, before (0 h) and after (24 h) fermentation, 
is shown in figure 9. Although, clear differences between 0 h and 24 h can be seen 
for each substrate, these differences were not statistically significant, compared 
to the blank/control, due to inter-individual variation. In contrast, there were con-
sistent differences between bacterial counts, obtained by FISH for total bacteria, 
TRP from T10-T24 (p = 0,04), PHE from T0-T10 (p = 0,002) and Blank from T0-T10 
(p = 0,002); bifidobacteria, only for TYR from T0-T10 (p = 0,016), Bacteroides/Pre-
votella, GLU from T5-T24 (p= 0,010), Blank from T5-T24 (p = 0,041) and MET from 
T0-T5 (p = 0,016); lactobacilli/enterococci, PHE from T0-T24 (p = 0,031) and TYR 
from T0-T24 (p = 0,039) and finally Desulfobacteraceae, with only GLU from T5-T24 
(p = 0,039) (Fig. 12). However, clear trends in response of given groups of bacteria, 
e.g. between similar substrates, like the aromatic amino acids, were not evident 
and high interindividual variation in bacterial counts, as illustrated by large standard 
errors around the mean, hinder useful interpretation of the data.
In order to visualize better the interindividual variation in microbiota composition 
between each donor, Figure 9 shows the weighted UniFrac distance between 
microbiota of faecal donors. Donors 1 and 2, although presenting with different 
microbiota compositions at time 0, showed very similar response to the different 
substrates at time 24 hours. The microbiota of these two donors changed in a simi-
lar manner at time 24 h. Similarly, the change in weighted UniFrac distances of the 
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microbiota of donors 3, 4 and 5, appeared to behave in a more similar manner, one 
another than to the microbiota of donors 1 and 2. However, inter-substrate differen-
ces meant these trends were not statistically significant.
These trends however, do appear to support the clear separation obtained with 
respect to the second principal component in the PCA of 1H NMR metabolomic 
fingerprint for the aromatic amino acids and dopamine (Fig. 1a, 2a, 3a and 4a). Divi-
ding these donors according to NMR “metabotype” or differences in aromatic ami-
no acid metabolic profiles we formed two groups, Group A (D1 and D2) and Group 
B (D3, D4 and D5). Using one-way ANOSIM, Bray-Curtis distance measure, 9999 
permutations, and pair-wise comparisons, with Bonferroni correction (using PAST 
software, http://nhm2.uio.no/norlex/past/download.html), we observed a significant 
difference between Group A and B in terms of microbiota relative abundance. Exa-
mining individual differences in relative abundance at the family level Desulfovibrio-
naceae, Enterobacteriaceae, Bifidobacteriaceae, Prevotellaceae, Bacteroidaceae, 
Hyphomicrobiaceae, Victivallaceae, Lachnospiraceae, Peptococcaceae 1, Acida-
minococcaceae, Actinomycetaceae, Porphyromonadaceae,  were all statistically 
different (P value < 0.01) as was Comamonadaceae (P = 0.02) (Table 3).
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5.4 Discussion 
Unexpected mechanisms are involved in the complex two-way communication that 
links the brain and intestine. Despite considerable progress for identify and follow 
the microbial metabolic pathways and for characterize their roles upon human 
physiology, we are only at the beginning of them understanding. The semi-perme-
ability of the enteric epithelium, allows the huge interchange of metabolite, many of 
whom come from dependent metabolism of the microbiota, that inhabits the last 
part of the large bowel. Interactions within the supraorganism (mibrobioma-host), 
are largely caused by the circulating level of neurotransmitters and other neuroacti-
ve substances. Many of these substances come directly from the diet, or indirectly 
by the bacterial metabolism in the intestine. Through studies on the metabolism of 
these compounds (e.g. dopamine, tryptophan and glutamate), we shall be able to 
predict the formation and thus bioavailability levels, of secondary metabolites, able 
to modulate peripheral and central neuronal functions. To this end, we used an in 
vivo model, capable of simulating the environment of the human colon (37 °C, pH 
6.8–7.2, basal medium mimic–intestinal content) and thanks to healthy fecal donors 
of both genders, we carried out 5 different fermentations containing the same, se-
lected, substrates (DA, TYR, TRP, PHE, GLU and MET). Through the metabolic (by 
1H NMR analysis), and microbial (by FISH and Illumina sequencing) characteriza-
tions, we have tried to shed light on the dynamics that develop in the colon, during 
fermentation of these biologically active compounds.
The mainly phenylalanine degradation product, is phenylacetate. Aerobic phenyla-
cetate-metabolizing bacteria pathway, is still under scrutiny, due to accumulation 
of active intermediate (e.g. CoA thioesters, ring epoxy, and possibly oxepin inter-
mediates as well as a hydrolytic ring cleavage), of phenylacetate, which could be 
toxic for the host. It was hypotized a connection between expression of genes 
leads, with reactive pathway intermediates of phenylacetate and virulence of some 
bacteria, such as Burkholderia cenocepacia and Mycobacterium abscessus. These 
microorganisms can cause serious infections and immune responses, compromi-
sing the life of the host (Teufel et al., 2010). Many gut bacteria are involved in this 
pathway, such as members of Proteobacteria, (e.g Escherichia coli, Pseudomonas 
putida), pathogens (e.g. Bordetella pertussis, Shigella dysenteriae), or opportunistic 
pathogens (e.g. Burkholderia cenocepacia), as well as, gram positive (e.g. Rho-
dococcus spp.) and members of the Deinococcus/Thermus phylum (Teufel et al., 
2010).
Amino acid tyrosine, is the precursor for the catecholamines (CA) (dopamine, epine-
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phrine and norepinephrine) biosynthesis, which take their name from the catechol 
moiety coming from the tyrosine. Local tyrosine concentrations, after food inge-
stion, could stimulate DOPA synthesis (Fernstrom and Faller, 1978). Nevertheless, 
no catecholamine production was recorded by our in vitro gut model; other in vivo 
studies instead have measured, in a biologically active- free form, an high level of 
dopamine at the cecum level (the higher among the three CA) (Asano et al., 2012). 
On the other hand, secondary metabolites, without statistical significances, were 
identified: m-HPPS, phenol, cresol, 4 and 2-HPA. These compounds are recognized 
as discriminating key metabolites of human healthy gut and reflects the alterations 
on gut microbial co-metabolic activities (Garcia-Perez et al., 2012; Windey et al., 
2012; Bone et al., 1976). Clostridium species, has been defined as bacteria-derived 
alpha-glucuronidase activity (GUS), as necessary for the production of free CA in 
the large bowel (Asano et al., 2012). Various species of Clostridium, Bifidobacte-
rium, and Bacteroides fragilis has been attributed to the production of cresols from 
tyrosine; while other bacteria such as E. coli are associated with phenol production 
(Nicholson et al., 2012).
Sample preparation, with change of pH and/or interaction between chemicals, may 
affect chemical shifts and the mathematical alignment of peaks detected by NMR 
(Defernez and Colquhoun, 2003), as happened for dopamine (Fig. 3b). In our case 
dopamine stock solution, was prepared by dissolving DA powder (Sigma Aldrich), in 
HCl 1N, to increase the solubility of the compound. This preparation step perhaps, 
caused this change in the DA spectra. The general distribution of proton chemical 
shifts, associated to the main compounds identified in this study, are reported in 
table 1. Spread of dopamine samples score at time 0, suggests two loose clusters 
of metabolite profiles based on faecal donor at the beginning of fermentation. 
Metabolites produced by colonic microbiota are also subject to interindividual va-
riation, as observed for all treatments after 24 h. Propionate, butyrate, and acetate 
are the most important SCFA, which were identified, as key compounds produced, 
after 24 h DA fermentation. In the last years, SCFA have been shown to have neu-
roactive properties. SCFA are able to activate intestinal gluconeogenesis (IGN gene) 
expression, via a gut-brain neural circuit and through the activation of the fatty acid 
receptor FFAR3 (De Vadder et al., 2014) and/or their blood circulation, are able to 
acting on the brain regions, where activate G-protein-coupled receptors (GPCRs), 
which are linked to the regulation of metabolism, inflammation, but also pathologi-
cal conditions (den Besten et al., 2013).
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Tryptophan feed intake, may be involved in mood and behavior regulations (Jen-
kins et al., 2016), and in the modulation of immune response (Moffett and Nambo-
odiri, 2003). In the gastrointestinal tract, tryptophan can takes several metabolic 
pathways as, synthesis of protein or serotonin, or bacterial degradation, even if 
kynurenine pathway, remains the preferred route (Palego et al., 2016). Bacterial 
tryptophanase enzyme, is the principal responsable of tryptophan catabolism in 
the gut (DeMoss and Moser, 1969). Indole and their metabolites, who are the main 
metabolites from this metabolic activity, would seem to be indirectly linked to the 
kynurenine pathway, and able to modify neuronal function and animal behaviour by 
interacting with voltage-dependent Na+ channels (Moroni, 1999).
Compared to just discussed aromatic compounds, the main rapresentative meta-
bolites originated from the glutamate and methionine fermentations are SCFA, pro-
prionate, butyrate and acetate. Acetate compare with the other SCFA, shows a less 
change during the fermentation process of methionine. The absence of detection 
of nitrogen compounds, afer 24 h fermentation of glutamate and methionine, may 
be due to their incorporated into microbial biomass without accumulating in the 
medium, or more likely formed small, with similar NMR chemical shifts like water 
(Fig. 5b).  However this result, despite require further confirmation, it remains in line 
with preceding literature reported that no dietary glutamate appeared in the portal 
circulation after protein (or other source of glutamate) intake (Bauchart-Thevret et 
al., 2013; Reeds et al., 1996). Glutamate, which about 95% derives from food inta-
ke, is a metabolic intermediates and key links between carbon (from both carbohy-
drate  and protein surces) and nitrogen metabolism and it is used as energy source 
by the enterocytes of the intestinal mucosa (Beyreuther et al., 2007). Furthermore 
methionine, a sulfur-containing amino acid, is a dietary indispensable amino acid, 
which leads to the formation of scyllo-inositol (Fig. 5b), one of the promising inositol 
isomers tested, as a treatment in Alzheimer’s disease (AD) (Choi et al., 2010). 
The weighted UniFrac analysis of distance for microbiota from each donor before 
(0 h) and after (24 h) fermentation of the different substrates is shown in figure 9. 
Although, clear differences between 0 h and 24 h can be seen for each substrate, 
these differences were not statistically significant, compared to the Blank, due to 
interindividual variation. All the aromatic amino acid fermentations and DA, lead 
to different metabolite patterns (more or less evident), formed depending on the 
gut microibota. Unexpectedly PCA analysis, as well as weighted UniFrac distan-
ce between donors, showed a distinct donor-dependent clustering, indicating the 
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effect of donor upon amino acids and dopamine fermentations. Figure 11a,b show 
the distribution of the main families in each sample and the % value calculated from 
the global community composition. It can be seen a certain level of between-sam-
ple variability, which gives rise to two groups (A and B). The main dissimilarity its 
rapresents by the Prevotellaceae family, which is dominant in the group A (Fig. 11a), 
while appears almost missing in the second one (Fig. 11b). This family, belonging 
to the phylum Bacteroidetes, contains carbohydrate-fermenting and H2-producing 
bacteria implicated in energy production (Kovatcheva-Datchary et al., 2009). On the 
other hand the group B, shows richness in terms of relative abundance of Bacteroi-
daceae, which growth well in the neutral pH of colonic environment, compared to 
the low pH required for the growth of both bifidobacteria and lactobacilli (Dalland 
and Hofstad, 1974). The family Hyphomicrobiaceae, with a lower abundance, it is 
more represented in the group B as well. It was associated to omnivorous feeding 
in non invasive fish model by metabolic and microbial analysis after nutritional in-
tervention (Asakura et al., 2014). A recent work identified, as member of this family, 
the genera Gemmiger, which shows high sequence homology of 16S  rRNA gene, 
with some of the bacteria included in Ruminococcaceae family (Firmicutes), that 
could reveal an incorrect taxonomic assignment (Garrity et al., 2015). The Lachno-
spiraceae family, which was closely related to the genus Blautia, and it is one of the 
most abundant human fecal bacterial phylotype (Newton et al., 2011). It appears 
6% more representative in the second group. Lachnospiraceae are able to produce 
butyric acid, and then, through environmental changes (e.g. pH, availables nutrien-




Metabolites arising from the microbial metabolism in the intestine, have been 
recently recognized to have a key role in the inter-communication between brains 
(located in the head and belly). The changes in these processes are underlie of im-
portant brain disorders, and it is increasingly clear that the answer to some of most 
feared brain disorders, may actually reside outside of the brain. Diet is an often 
overwhelming decision that people face every meal of every day. Intestinal bacteria 
modulate several metabolic reactions of the host and through digestion and fer-
mentation of food metabolize and in turn synthesize many neurotransmitters and 
neuromodulators. This metabolites released through gut lumen may induce epithe-
lial cells and modulate neural signalling acting directly on primary afferent axons or 
indirectly within the enteric nervous system. Physiologic factors that influence brain 
pools of these amino acids, notably diet, influence their rates of conversion to neu-
rotransmitter products, with functional consequences. Using NMR based metabo-
nomics, as well as 16S metagenomic sequencing, with multivariate data analysis, 
this study want to remark the importance of omics methodologies to examining 
questions related to gut microbiota metabolism and their roles in the host (pato)
physiology. Although this is an in vitro study, with its natural limitations, it offered 
food for thought on how gut microbioma could be involved in the metabolism and 
production of several compounds, which could be involved in several pathwey. Fur-
thermore the division, both in terms of metabolomic and metagenomic profile, of 5 
subjects here examined, revealed an association between specific metabolic profile 
and gut microbiota composition. Future studies should be conducted to confirm the 
possibility to classify “metabotype”, shared between subjects, able to respond in a 




Fig. 1a Principal component analysis (PCA) score plot of PHE in vitro fermentation over the time (0, 5, 10, 24h) and for 4 
human healthy faecal donors (D1, D2, D3, D4).
169Fig. 1b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of PHE in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
170 Fig. 2a Principal component analysis (PCA) score plot of TYR in vitro fermentation over the time (0, 5, 10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
171Fig. 2b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of TYR in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
172 Fig. 3a  Principal component analysis (PCA) score plot of DA in vitro fermentation over the time (0, 5, 10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
173
Fig. 3b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of DA in vitro fermentation by five human 
faecal donor, over the time (time points 0-5-10-24 h).
174
Fig. 4a Principal component analysis (PCA) score plot of TRP in vitro fermentation over the time (0, 5, 10, 24h) and for 4 
human healthy faecal donors (D1, D2, D3, D4).
175
Fig. 4b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of TRP in vitro fermentation by five human 
faecal donor, over the time (time points 0-5-10-24 h).
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Fig. 5a Principal component analysis (PCA) score plot of GLU in vitro fermentation over the time (0, 5, 10, 24h) and for 4 
human healthy faecal donors (D1, D2, D3, D4).
177Fig. 5b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of GLU in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
178 Fig. 6a Principal component analysis (PCA) score plot of MET in vitro fermentation over the time (0, 5, 10, 24h) and for 4 human healthy faecal donors (D1, D2, D3, D4).
179Fig. 6b OPLS coefficient-coded loading plot derived from the 1H-NMR spectra of MET in vitro fermentation by five human faecal donor, over the time (time points 0-5-10-24 h).
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MetaBolite cheMical shifts (δ)
Dopamine 2.88(t), 3.23(t), 6.76(d), 6.87(s), 6.91(d)
Tyrosine 3.06(dd), 3.20(dd), 3.94(dd), 6.89(d), 7.18(d)
Tryptophan 3.30(dd), 3.48(dd), 4.05(dd), 7.19(t), 7.27(t), 7.31(s), 7.53(d), 7.72(d)
Phenylalanine 3.13(dd), 3.28(dd), 4.0(dd), 7.34(d), 7.39(m), 7.44(m)
Glutamate 2.08(m), 2.34(m), 3.75(t)
Methionine 2.14(s), 2.16(m), 2.65(t), 3.86(t)
Phenylacetate 3.54(s), 7.31(t), 7.39(t)
3-Hydroxyphenylacetate 
(3-HPA)
3.48(s), 6.79(d), 6.81(s), 6.86(d), 7.26(t) = 3.48(s), 
6.79(m), 6.81(m), 6.86(dd), 7.26(t)
o-Hydroxyphenylacetate 
(2-HPA)
3.54(s), 6.91(d), 6.93(d), 7.18(dd), 7.21(td) = 3.54(s), 
6.93(m), 7.21(m)
p-Hydroxyphenylacetate 
(4-HPA) 3.45(s), 6.87(d), 7.17(d)
Propionate 1.06(t), 2.19(q)
Isovalerate 0.92(d), 1.94(m), 2.05(d)
Acetate 1.92(s)
Butyrate 0.90(t), 1.56(m), 2.16(t)
m-hydroxyphenylpropionyl-
sulfate (m-HPPS) 7.38 (t), 7.21 (m), 2.91 (t), 2.51 (t), 7.16 (dd)
Phenol 7.3 (t/m), 6.93 (t/m), 6.84 (d/m), 5.34 (s)
Ethanol 1.19(t), 3.66(q)
Valerate 0.89(t), 1.30(m), 1.55(m), 2.19(t)
Indole 6.61(s), 7.18(t), 7.27(t), 7.42(s), 7.56(d), 7.72(d)
Indole-3-acetate 3.66(s), 7.17(t), 7.24(t), 7.5(d), 7.63(d)
Indoleacetate (IAA) 7.62 (d), 7.50 (d), 7.24 (m), 7.15 (dd), 3.65 (s)
Phenylacetate 3.54(s), 7.31(t), 7.39(t)
Tab. 1 Proton NMR chemical shifts of main compounds found during in vitro colonic fermentation of neuroactive com-
pounds.
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MetaBolite cheMical shifts (δ)
Hydroxypropyl propionate 
(HPP) 4.5 (d), 3.8 (m), 2.28 (q), 1.2 (d), 1.05 (t)
3-phenyllactate 7.33 (m), 4.26 (dd), 3.09 (dd), 2.87 (dd)
scyllo-inositol 3.36(s)
5-aminolevulinate 4.06 (s), 2.8 (t), 2.5 (t)
Alanine 1.48(d), 3.79(q)
Leucine 0.95(t), 1.71(m), 3.73(t) or 0.94(d), 0.96(d), 1.71(m), 3.73(t)
Valine 0.99(d), 1.04(d), 2.28(m), 3.62(d)
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 dopaMine tyrosine tryptophan phenylalanine GlutaMate Methionine
R2X 0,41 0,14 0,1 0,1 0,1 0,17
Q2Y 0,41 0,45 0,45 0,48 0,16 0,51
p value 0,004 0,01 0,001 0,001 0,15 0,006
metabolites
acetate acetate acetate acetate acetate acetate
butyrate butyrate butyrate butyrate butyrate alanine
3-HPA cresol Indole hydroxypropyl pyruvate propionate 5-aminolevulinate
2-HPA ethanol indole-3-acetate isovalerate butyrate
4-HPA m-HPPS indoleacetate phenylacetate  4-HPA
isovalerate 2-HPA propionate propionate  leucine 
phenylacetate 4-HPA  valerate  phenylalanine
propionate isovalerate    propionate
 phenol    propionate
 propionate    scyllo-inositol
    tyrosine
     valine
Tab. 2 Summary of the parameter values (R2X, Q2Y and p-value) describing the OPLS model and significantly representative 
metabolites found during fermentation of each treatment.
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 dopaMine tyrosine tryptophan phenylalanine GlutaMate Methionine
R2X 0,41 0,14 0,1 0,1 0,1 0,17
Q2Y 0,41 0,45 0,45 0,48 0,16 0,51
p value 0,004 0,01 0,001 0,001 0,15 0,006
metabolites
acetate acetate acetate acetate acetate acetate
butyrate butyrate butyrate butyrate butyrate alanine
3-HPA cresol Indole hydroxypropyl pyruvate propionate 5-aminolevulinate
2-HPA ethanol indole-3-acetate isovalerate butyrate
4-HPA m-HPPS indoleacetate phenylacetate  4-HPA
isovalerate 2-HPA propionate propionate  leucine 
phenylacetate 4-HPA  valerate  phenylalanine
propionate isovalerate    propionate
 phenol    propionate
 propionate    scyllo-inositol
    tyrosine
     valine
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Fig. 7 Deviation of richness from hour 0 in terms of percentage of number of OTU. Repeated measure for five different 
human faecal donors, are marked with colored dots.
Fig. 8 Weighed UniFrac distances from hour 0 for hours 5, 10 and 24. Only intra-donor distances were computed.  
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Fig. 9 Weighted unifrac distances between donors (n = 5), at time 0 and 24h. The donors are shown to the side of the 
frame, while treatments are indicated with a color – code dots.
186 Fig. 10 Weighted unifrac distances between treatments (n = 6), at time 0 and 24 h. The treatments are shown to the side of the frame, while donors are marked with a color – code dots.
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Group a Group B st.dev a st.dev B p value
Hyphomicrobiaceae 1,57 3,58 1,12 1,09 1,68E-05
Desulfovibrionaceae 0,53 0,04 0,28 0,06 1,86E-05
Oxalobacteraceae 0,03 0,00 0,03 0,00 9,00E-03
Comamonadaceae 0,01 0,00 0,01 0,00 3,46E-02
Pasteurellaceae 0,01 0,07 0,01 0,09 5,60E-03
Enterobacteriaceae 0,06 0,44 0,08 0,28 8,56E-06
Verrucomicrobiaceae 2,97 3,59 0,02 0,04 9,05E-03
Victivallaceae 0,07 0,00 0,07 0,00 2,59E-03
Lachnospiraceae 16,53 22,76 1,83 7,22 1,24E-03
Peptococcaceae 1 0,02 0,00 0,02 0,00 1,01E-02
Acidaminococcaceae 0,77 0,14 0,31 0,19 9,88E-07
Enterococcaceae 0,06 0,00 0,07 0,00 8,36E-03
Synergistaceae 0,57 0,00 0,66 0,00 6,08E-03
Bifidobacteriaceae 1,85 5,76 0,40 3,59 1,04E-04
Actinomycetaceae 0,02 0,00 0,01 0,00 5,28E-04
Prevotellaceae 14,72 0,00 15,08 0,00 2,92E-03
Bacteroidaceae 9,09 37,35 3,25 6,83 6,01E-16
Porphyromonadaceae 1,75 0,18 0,99 0,26 4,52E-05
Tab. 3 Differences in relative abundance at family taxonomic level between Group A (D1 and D2) and Group B (D3, D4 and 









































Fig. 11a Relative abundance, calculated using OTU table and relative bacterial species composition (%) based on DNA 
























Fig. 11b Relative abundance, calculated using OTU table and relative bacterial species composition (%) based on DNA 




Fig. 12 Total bacteria, Bifidobacteria, Bacteroides/Prevotella, Lactobacilli/Enterococci and Desulfobacteraceae enumerated 
by FISH coupled with microscopy. Bacterial populations (log10 cells ml−1) in pH-controlled batch cultures at 0, 5, 10 and 24 
h of fermentation with basal medium (Blank), DA, TYR, TRP, PHE (5 mmol/l), and GLU, MET (10 mmol/l). 
Values are the average of five healty human donors. Total bacterial and bacterial groups count was quantified using the 
following FISH probes: EUB 338 (I,II,III), Bif 164, Bac 303, Lab 158 and DSV 687.
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Abstract 
Developing fish farming, to meet the demands of food security and sustainability in 
the 21st century, will require new farming systems and improved feeds. High ranges 
of physical and environmental variables, can affect rainbow trout tolerance to the 
intensive aquaculture, and determine animal health and production yield. The re-
cent recognition of key role played by the gut microbiota in regulating host physio-
logy and response to diet in particular, identifies diet:microbe interactions in the gut, 
as an important modifiable variable, with potential to make a significant impact, on 
future fish farming diets and production systems. Here, we monitored the gut mi-
crobiota of farmed rainbow trout (Oncorhynchus mykiss), using 16S rRNA profiling, 
over 75 weeks, during standard rearing conditions and dietary regimes and during 
dietary supplementation of feed modified, with antioxidant rich essential oils. Rain-
bow trout, from an initial body weight of 10.2 ± 2.5 g, were reared. From 24 weeks 
of age (T0), intestinal contents were collected after 4 (T1), 8 (T2), 18 (T3), 22 (T4), 
27 (T5), 32 (T6) and 51 (T7) weeks. The gut microibota 16S rRNA profiling indicated 
that, the fish gut was dominated by Actinobacteria, Proteobacteria, Bacteroidetes 
and Firmicutes. Although, the dietary supplementation with plant derived essential 
oil, had little impact on either the composition or architecture of the gut microbiota, 
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significant changes in alpha and beta diversity and relative abundance of important 
groups of gut bacteria, were evident during different growth stages and standard 
feed, especially upon prolonged growth on finishing feed. Our results show that, 
dietary supplementation with essential oil, can have subtle effects on final fish fillet 
quality. We have also observed, significant differences within the gut microbiota of 
juvenile and adult rainbow trout, under the same rearing conditions, highlighting the 
need for further studies, examining how dietary microbiome modulation, at different 
life stages, can influence animal health, production yields and final product quality.
Keywords
Rainbow trout | essential oils | growth performance | gut microbiota | 16S rRNA 
profilingg | fillet quality
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Since 1871 rainbow trout constitute one of the main species, used for fish farming 
(Halverson, 2010) and trout, is one of the most efficient species of fish, at conver-
ting macronutrients into biomass. However, it requires high-quality feed ingredients. 
Under standard production systems, the high proportion of animal protein (predo-
minantly fishmeal), commonly used to support growth and health in the juvenile 
stage, is progressively reduced during the grow-out stage (from 12 to 24 months) 
(Naylor et al., 2009). Due to shortages and indeed collapse of wild fish stocks, the 
cost of fishmeal as a feed ingredient has risen sharply, promoting innovation in feed 
development towards use of cheaper plant-based protein sources (Gaylord and 
Barrows, 2009). Plant proteins derived from soybean, canola and peas, are used as 
ingredients of various aquaculture diets (Gatlin et al., 2007; Mundheim et al., 2004; 
Thiessen et al., 2003). However, plant protein ingredients contain also significant 
anti-nutrient factors, such as saponins, glucosinolates, phytate and trypsin inhibi-
tors, which at high doses, have been associated with intestinal disorders, in farmed 
fish, including meal–induced enteritis (Francis et al., 2001; Refstie et al., 2000). 
Much current work focuses on optimal fish diet compositional development, to 
provide optimal dietary protein, from economically viable protein sources (e.g. ve-
getable food waste streams, poultry waste streams and alternative protein sources 
from farmed insects), but which also support animal health, especially gastrointesti-
nal health and disease resistance.
In aquaculture, as well as in other animal husbandry, the misuse and over reliance 
on antibiotics, has lead to increased risk of resistant pathogenic or pest species 
and the spread of antibiotic resistance determinants (Guardabassi et al., 2008). 
Current use of antimicrobials, as growth promoters, is now banned in the EU and 
strict regulations control to use of pesticides and medicinal antibiotic are implemen-
ted in fish farming (Park et al., 2012; Giannenas et al., 2012). Essential oils, have 
recognized antimicrobial potential and also may have flavour traits, of potential 
interest from an organoleptic perspective, which has raised interest in their use as 
an innovative functional ingredient in fish feed. They also have recognized antioxi-
dant activities and are used successfully, in other animal production systems, as 
alternatives to antibiotic growth promoters and to improve final food quality. Some 
of these bioactive effects, appear to be mediated through interactions within the 
gut, especially with the gut microbiota (Yang et al., 2015). Essential oils were found 
to exert antioxidant and antibacterial activities and to show beneficial effects on im-
mune system and intestinal microbiota of fish (Giannenas et al., 2012). Other rese-
6.1 Introduction
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arch has demonstrated that essential oils, when added at the feed as preservatives, 
improves shelf life of fish fillets, by inhibiting lipid oxidation and bacterial spoilage 
(Burt, 2004; Kykkidou et al., 2009; Tironi et al., 2010; Erkan et al., 2011). 
An influence of the intestinal microbiota on animal nutrition and health status of 
rainbow trout, was recently been suggested (Ingerslev et al., 2014). The gut mi-
crobiota plays an important role in animal host physiology, including digestion and 
absorption of nutrients, synthesis of vitamins, as well as development of intestinal 
mucosal and systemic immune system and assisting detoxification processes. 
Changes in the fish gut resident community, directly affect the growth and health 
of the animals, by influencing the nutritional status and the capability to build an 
efficacious immune defense, from pathogens (Kotzamanis et al., 2007; Abid et al., 
2013). The close interaction between the animal host and gut symbiotic bacterial 
community, suggests that the host metabolism is the result of metabolic processes, 
involving the systemic organism in intimate collaboration, with its gut microbiota. 
Many exogenous and endogenous factors, may alter the composition of the gut 
microbiota of fish, including the environment (e.g. temperature, pH, salinity), the 
developmental age, fish species and individual genetics, use of antibiotics, during 
farming and diet (Pérez et al., 2010). In aquaculture, several dietary supplements 
for fish, including probiotic yeasts and bacteria, as well as a wide range of microal-
gae, have been shown to positively impact on the gut microbiota and, indirectly, to 
improve fish health, growth, survival and protection from disease (Hernández et al., 
2016; Kiron, 2015; Navarrete and Tovar-Ramrez, 2014). In this study, we tested the 
hypothesis that dietary supplementation with essential oils, would induce a positive 
modulation of the fish gut microbiota and thus beneficially affect fish quality. To this 
aim, we used 16S rRNA profiling by pyrosequencing, to characterize the composi-
tion and structure of the gut microbiota over time and, in response to different diets, 
standard/control rearing diets and diets supplemented with essential oil. We also 
evaluated physical and chemical quality characteristics, of trout fillets.
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6.2 Materials & 
Methods
Fish, diets and culture conditions
A total number of 1296 selected parr (6 months old) of rainbow trout with an avera-
ge weight of 10.2 ± 2.5 g were randomly distributed into 2 squared fiberglass tanks 
(0.7 m3) and assigned to 2 different treatments (Control and MixOil added diet) for a 
51 weeks feeding trial (T0 or week 0). The fish were acclimatized for six days prior 
to the start of the trial. During the trial fish were fed manually, 5 days a week, and 
water temperature and dissolved O2 (in the water outlet) were measured weekly. 
Feed was given and mortality recorded daily for each tank. The total biomass of 
each tank was assessed at different times during the trial at three stages of growth, 
Stage 1–8 weeks after start of test feed (end of 1st stage), end of stage 2–25 weeks 
after start of test feed and end of stage 3–51 weeks after start of the test feed. Wa-
ter flow and size tanks, were increased accordingly with the growing fish biomass. 
Two different diets (Control–C and Treated–MO) were formulated to evaluate the 
effect of GrowNat-MixOil Aqua (an essential oils blend), at 200 ppm concentration, 
on growth performances of rainbow trout. The coating method, was used to com-
bine GrowNat-MixOil Aqua (MixOil), with a commercial feed. To ease the coating 
process, the oils blend was diluted in fish oil (for control diet, C, pellets were coated 
with 1% fish oil (w/w), for MixOil diet, MO, pellets were coated with 0.99% fish oil 
(w/w) plus 0.1% MixOil (w/w)). The diets were iso-energetic and iso-lipidic. Pellet si-
zes and proximate composition of the commercial feed, are given in table 1, at each 
of the three stages of growth. Pellet size and feeding ratio were adjusted, according 
to manufacturer recommendations, as the fish grew. To insure growth performance, 
according to the manufacturer’s specifications, the use of the feeds, were evaluated 
at the end of each stage, using the following parameters calculated from the data 
collected:
Specific Growth Rates (SGR, %/day) = [(Ln Wf – Ln Wi)/days] *100
Feed Conversion Ratio (FCR) = Total feed consumption / Weight gain.
Gut sampling and DNA extraction
The metagenomic analysis, was performed on samples obtained throughout the 
life stages of the fish, i.e. at time 0 (T0) and after 4 (T1), 8 (T2), 18 (T3), 22 (T4), 27 
(T5), 32 (T6), 51 (T7) weeks of rearing. A total of 6 fish at each time was sampled, 
from the fiberglass tanks containing the fish fed control diet (C, n=3) and fish fed 
the same diet supplemented, with 200 ppm of Grownat-MixOil Aqua (MO, n = 3). 
203
For the last time point (T7), the double of samples, was collected (C, n = 6 and MO, 
n = 6). Sampling, was performed at each time point, in order to obtain fish from 
two groups, with similar body weight, to avoid the influence of this last parameter 
on the metagenomics analysis results. The genomic DNA extraction from intestinal 
content, was carried out using FastDNA™ SPIN Kit for Feces (MP Biomedicals, 
USA), following the manufacturers’ instructions. Total intestinal content (foregut, 
midgut and hindgut, excluding the stomach), was collected from each fish, imme-
diately after sacrificing the animal, then stored in RNAlater® (Ambion, Life Techno-
logies) at -80 °C. Genomic DNA, was extracted from 500 mg aliquots of intestinal 
content sample, after thawing and removal of RNAlater. DNA quality and quantity 
were assessed, by gel electrophoresis and NanoDrop spectrophotometer (Thermo 
Fisher). Only samples with Aλ260/Aλ280 within the range 1.8-2.0 were processed 
for analysis. Extracted DNA was stored at -20 °C.
PCR amplification of the V1-V3 region of bacterial 16S 
rRNA genes
For each sample, the 16S rRNA gene was amplified, by using special fusion primer 
set specific for V1-V3 hypervariable regions (27-Forward: 5’-AGAGTTTGATCMTG-
GCTCAG-3’ (Lane et al. 1991) and 533-Reverse: 5’-TTACCGCGGCTGCTGGCAC-3’ 
(Muyzer et al. 1993) ). The forward primer contained: the “LIB-L” primer A sequence 
specific for the “Lib-L” chemistry and the “One-Way Reads” sequencing methods 
(Roche, Branford, CT, USA), the key sequence TCAG, the barcode (Multiple IDen-
tifier) sequence (specific for any sample) and the 8-forward sequence. The reverse 
primer contained the “Lib-L” primer B sequence, the key sequence TCAG and the 
533-reverse sequence. For each sample, a PCR mix of 25 µl was prepared contai-
ning 1X PCR buffer, 1.25 U of FastStart High Fidelity polymerase blend (Roche) and 
dNTPs from the FastStart High Fidelity PCR system (Roche), 0,4 µM of each primer 
(PRIMM, Milano, Italy) and 10 ng of gDNA. Thermal cycling consisted of initial 
denaturation at 95 °C for 5 minutes followed by 35 cycles of denaturation at 95 °C 
for 30 seconds, annealing at 58 °C for 30 seconds, and extension at 72 °C for 1 
minute, with a final extension of 8 minutes at 72 °C.
Library construction and pyrosequencing
The PCR products, were analysed by gel electrophoresis and cleaned using the 
AMPure XP beads kit (Beckman Coulter, Brea, CA, USA), following the manufactu-
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rer’s instructions. The products of the 54 samples, were quantitated via quantitative 
PCR, using the Library quantification kit – Roche 454 titanium (KAPA Biosystems, 
Boston, MA, USA) and pooled in equimolar way, in a final amplicon library. The 454 
pyrosequencing, was carried out on the GS FLX+ system, using the XL+ chemistry, 
following the manufacturer’s recommendations.
Data analysis
The pyrosequencing produced a total of 919,936 high quality reads of 16S rDNA 
reads. The sequences were assigned to samples, according to sample-specific 
barcodes. This allowed to collect FASTQ formatted files containing an average of 
18,398 sequences per sample. Raw 454 files were demultiplexed using the Ro-
che’s sff file software. Raw data were submitted to the http://www.ebi.ac.uk/ena/
submit/sequence-submission. Reads were processed using the MICCA pipeline 
(version 1.0, http://micca.org/) (Albanese et al., 2015). Forward and reverse primers 
trimming, were performed using micca trim (parameters -w AGAGTTTGATCMTG-
GCTCAG -r TTACCGCGGCTGCTGGCAC -W -c). Quality filtering, were performed 
using micca filter (parameters -e 0.5 -m 400 -t), truncating reads shorter than 400 nt 
and discarding reads, with an expected error (EE) rate > 0.5%. De-novo sequence 
clustering, chimera filtering and taxonomy assignment, were performed by micca 
otu (parameters -d 0.97 -c): operational taxonomic units (OTU) were assigned by 
clustering the sequences, with a threshold of 97% pairwise identity, and their re-
presentative sequences were classified, using micca classify with the RDP classi-
fier version 2.8 (Wang et al., 2007). Template-guided multiple sequence alignment 
(MSA), was performed using micca msa (parameters -m nast), against the multi-
ple alignment of the Greengenes (DeSantis et al., 2006) database (release 13_05) 
clustered at 97% similarity. Finally, phylogenetic tree was inferred, using micca tree 
(parameters -m fasttree), using FastTree (Price et al., 2010). Sampling heterogeneity, 
was reduced by rarefaction (3,972  sequences per sample). Alpha (within-sample 
richness) and beta-diversity (between-sample dissimilarity) estimates, were compu-
ted using the phyloseq R package (McMurdie & Holmes, 2013).
Experimental set-up for fillet quality characteristics
To test of the effect of the essential MixOil added in the diet, on quality characteri-
stics of fillets, a total of 15 fish were sampled, from the fiberglass tanks containing, 
the fish C and the fish MO. The sampling was performed, in order to obtain fish 
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from two groups, with similar body weight, to avoid the influence of this last para-
meter, on the selected quality indicators.
All 30 fish were filleted immediately, after slaughter and sent to DISPAA laboratories 
in Florence, where the fillets were stored in a refrigerated room, at 1 °C on ice until 
analyses. A number of 5 fillets per diet (i.e. n. 10 fillets in total), were analyzed at the 
1st, 4th and 7th day of storage. The physical-chemical analyses, were carried out on 
the left fillets, while the microbiological ones on the right fillets. All analyses sche-
duled for the samples at each time of storage, were performed at the same time. 
The physical-chemical determinations, on the left fillets, were the followings:
Drip loss (DL). Drip loss was determined for each fillet. The initial weight of the left 
fillets was recorded (Wi), in the day of slaughtering. Fillets were re-weighed at each 
storage time (1st, 4th and 7th; n = 10 at each storage time), to register the final weight 
(Wf). Drip loss, was then calculated as follows: DL (%) = [(Wi−Wf) /Wi] × 100.
Water Holding Capacity (WHC). It was determined, by a low speed centrifugation 
at 210 g for 5 minutes (Eide et al., 1982 modified by Hultmann and Rustad, 2002), 
on a sample withdrawn from the epaxial site of the fillet (Figure 1). The moisture of 
the sample, was determined by drying 2 g of flesh in an oven at 105 °C for 24 h.
Colour. The colorimetric attributes lightness (L*), redness index (a*), yellowness 
index (b*), saturation (Chroma) and hue (Hue), according to the method of the Com-
mission Internationale de l’Éclairage (CIE, 1976), were registered by the Spectro-co-
lor® colorimeter (software: Spectral qc 3.6). The measurements were done on three 
sites for each fillet (epaxial, ventral and caudal; Figure 1), with three replicates for 
each site.
Texture. Textural parameters were obtained by instrumental analysis, using the 
Zwick Roell® texturometer (software: Text Expert II) . A cyclic compression test 
was performed twice on the epaxial region (Figure 1). The parameters of the test 
were the followings: Probe: cylindric (length: 12 cm, diameter: 1 cm); Load cell: 1 
kN; Number of cycles: 2; Constant speed: 100 mm/min; Deformation: 50% of the 
original length.
Total lipids. Total lipids were determined, by the Bligh and Dyer (1959 mod.) 
method. Five grams of muscle, were weighed and homogenized by adding chlo-
roform, methanol and distilled water, to a final ratio of 2:2:1.8. Each homogenized 
sample, was centrifuged at 5000 rpm per 10 minutes, to allow the two phases 
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separation. One millilitre of the lower phase, was collected and transferred to a 
crucible. Solvents were left to evaporate and the net weight of the crucible was 
registered. Total lipids were calculated, according the formula:
g of lipid/100 of muscle = [net weight (g) x chloroform (ml)] / [g of muscle / evapora-
ted chloroform (ml)]
of which:
Chloroform (ml) = 20 ml
Evaporated chloroform (ml) = 1 ml
Malondialdheyde (MDA). MDA was determined as reactive substances to 2-thio-
barbituric acid (TBARs) according to the method of Siu and Draper (1978), modified 
by Luciano et al. (2013). A quantity of 2.5 g of muscle was homogenized in 5% 
(w/v) TCA (trichloroacetic acid) and then centrifuged at 5000 rpm for 30 minutes. 
The supernatant was filtered and 2 ml of the extract was collected to react with 2 
ml of 40 mM TBA (2-thiobarbituric acid). Samples were incubated at 90 °C for 20 
minutes. Absorbance was read at 532 nm by the spectrophotometer. MDA content 
was calculated by using a calibration curve of TEP standard solutions (TEP concen-
trations from 0.8 to 8 μM).
Vitamin E. Tocopherols concentration in rainbow trout muscle, previously submit-
ted to the saponification and extraction phases, was determined by reverse phase 
chromatography and quantified by FID detection. The saponification procedure 
was performed according to Liu et al. (1996). Saponification solution was prepared 
fresh each day and comprised 11% KOH (wt/vol), 55% EtOH (vol/vol), and 45% 
deionized distilled water (vol/vol). One gram of frozen sample was weighed into a 
20- x 150-mm test tube, in duplicate for each muscle sample. Ascorbic acid (0.25 
g) and saponification solution (7.3 ml) were added to each tube. Tubes were briefly 
vortexed until the ascorbic acid was dissolved. Tubes were then placed into a test 
tube rack and incubated in a 80 °C shaking water bath for 15 min at 200 rpm. After 
the incubation, test tubes were cooled in ice and 4 ml of isooctane was delivered 
to each tube. Tubes were vortexed for 2 min and allowed to stand briefly to allow 
separation of aqueous and isooctane phases. The concentrations and volumes of 
the saponification solution and isooctane were designed to provide the final propor-
tions of H2O - 4 ml, EtOH - 4 ml, isooctane - 4 ml, the muscle sample was assumed 
to contribute 0.7 ml of H2O.
The chromatographic separation of tocopherols was performed by HPLC, on a 150 
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mm x 4,6 mm i.d., 5 µm Cosmosil π NAP column (Nacalai-Tesque, Kyoto, Japan). 
The mobile phase used was methanol-water with 0.2% phosphoric acid (90:10 
v/v), prepared fresh daily. The flow rate was 1.0 ml/min, and analyses were made at 
room temperature. The injection volume was 20 µl. The total run time was 25 minu-
tes. The separated tocopherols were quantified with FID detector (Agilent mod. HP 
050) at emission wavelenght λem = 295 nm and excitation wavelenght λexc= 330 
nm. An external calibration curve was calculated by using α-tocopherols (DL-al-
pha-tocopherol, Sigma Aldrich) at different concentrations. Results were expressed 
as mg of α- and γ- tocopherol per kg of muscle.
On the right fillets the followings determinations were performed:
Activity of water (Aw) and pH. Aw and pH (pHmeter Mettler Toledo, Milan, Italy) 
were performed by using the official methods ISO (2004a) and MFHPB-03 (2003), 
respectively.
Microbial counts. Fillets were examined for total mesophilic count (CMT), Entero-
bacteriaceae and Pseudomonadaceae, to whichthe Specific Spoilage Organisms 
(SSOs) belong, deriving from gut, water, ice and skin and responsible for fish quality 
deterioration (Gram and Dalgaard, 2002). Strain typing of Enterobacteriaceae and 
Pseudomonadaceae was performed. CMT, Enterobacteriaceae and Pseudomona-
daceae counts were performed by using the official methods ISO (2003a, 2004b 
and 2009). Fillets were also examined for the pathogens Yersinia enterocolitica and 
Salmonella spp., according to the methods ISO (2003b and 2004c), and Listeria 
monocytogenes by using the qualitative and quantitative methods according to 
UNI EN ISO (2005a and 2005b). Staphylococcus coagulase positive bacteria were 
determined according to ISO (1999) and the lactic bacteria according to ISO (1998).
Statistical analysis
Data related to fillet quality characterization were analysed using the General Linear 
Model procedures of the statistical analysis software SAS (2004) for Windows. 
A two-ways ANOVA tested the diet (D, with two levels: Control and MixOil diets) 
and the day of storage (S, with three levels: 1st, 4th and 7th day of storage) as fixed 





During the whole trial, the rearing conditions remained within a range optimal, for 
the fish growth. The mean dissolved oxygen (DO), measured in the tank water 
outlet, was 8.10 mg/l ± 1.03 and the water temperature fluctuated close to 12.58 
°C ± 0.78. The maximum rearing density in the experimental tanks, was limited to: 
21.4 kg/m3 during the first stage, 41.4 kg/m3 in the second one, and 37.4 kg/m3 in 
the third growth stage. Fish live weight, increased from 9 g to 1000 g, within the 51 
weeks period on the test diets. Similarly, the total biomass increased a hundredfold. 
Survival at the end of the trial, was high and no relevant differences were noted 
amongst the diets, in mortality rates. Limited differences in terms of total biomass 
are observed, between the control tank and the MO treated tank one, as show in 
the Figure 2.  
The overall Feed Conversion Ratio (FCR) and Specific Growth Rates (SGR), were 
very similar but the MO group, showed a faster growth ratio and a better feed 
conversion, in the whole trial period. In the first stage the fish, 6–8 months  old, 
show similar performances and the gap between control and treated group, beco-
me more evident in the second stage, when the fish are 30–150 g and 8–12 months  
old. On the other hand, the control group partially makes up, for the gap in the third 
stage.
      
Gut microbiota
The characterization, of the gut microbiota 16S rRNA gene community profiling 
(using the V1-V3 hypervariable regions), was carried out using Roche 454 GS-FLX 
Titanium and produced 186.791 high-quality sequences. The primer set employed 
in this study, prevented overestimation of species richness, which was observed 
previously by Youssef et al. (2009), by using primers targeting the V1-V2 regions 
of 16S rRNA. Average sequence lengths, were 501 nt (length SD 56 nt). Over the 
course of the intervention period and especially between growth stage 3 and the 
earlier growth stages, microbiota species richness and diversity, increased sign-
ficiantly over time (observed OUT’s, Chao 1 and Shannon Index), with P value < 
0.05 (Figure 3). The only exceptions was at T6, two weeks after the initiation of the 
growth stage 3, or finishing diet. Over the following 24 weeks, alpha-diversity incre-
ased dramatically in both groups of fish, irrespective of the presence of essential 
oil. A similar shift in beta-diversity, Unweighted UniFrac measure, of phylogenetic 
209
distances between the gut microbiota of individual trout from, diets C and MO, over 
time-points T3 to T7, clear separation of samples from T7, upon principle compo-
nents analysis (PCoA), with PC 1 explaining 41.6% of the variation, within the data-
set and clearly separating T7, from the other time points (Figure 4). The second and 
third components of the PCoA, show a separation of microbiota phylogenetic di-
stances, roughly according to time, from T3 (week 18) to T6 (week 32) and T7 (week 
51). Examining changes in relative abundance, at different phylogenetic levels, 
according to diet and time, no significant differences were observed, between the 
control diet and MO diet. However, the distribution of predominant bacteria at the 
Class level, with respect to sampling time, revealed significant changes in dominant 
members of the Actinobacteria, Bacilli and Clostridia within the Firmicutes, and the 
α- and γ-Proteobacteria into gut of over the course of the experiment (Figure 5). 
After the 51st week (T7), the microbiota appeared to reach its maximum diversity, in 
terms of species richness, as observed by the number of OTU. Up until T6, or week 
32 after the initiation of the dietary intervention, the gut microbiota of all fish, was 
dominated by the Corynebacteria, a member of the Actinobacteria Phylum. The 
fish were about 21 months of age and weighted about 350g at this stage. They had 
undergone shifts in feed at week 25. Two weeks later, all animals were placed on a 
diet lower in protein, with three times the dietary fiber. By week 51, the microbiota 
had experienced radical alterations both in α- and β-diversity. Major shifts in relative 
abundance, were also observed and manifest as statistically significant changes 
in Actinobacteria. Genus Corynebacteria decreased dramatically, becoming a 
sub-dominant genus, concomitantly with a small, but significant increase in genus 
Propionibacterium (Figure 6). Within the Firmicutes, genus Bacillus, Lactobacillus, 
Carnobacterium, Pediococcus and especially Oenococus all increased significantly 
in relative abundance. Oenococcus became a dominant member of the microbiota, 
representing about 15% of the microbiota. Changes occurred in both the α- and 
γ-Proteobacteria. Enterobacteria and Pseudomonas increased in relative abundan-
ce to 6.2% and 4.5%, respectively, and a small, but significant increase in Serratia 
relative abundance, was also observed within the γ-Proteobacteria. α-Proteobacter-
ia became the dominant class of bacteria in the fish gut, with several predominant 
genera: Acetobacter (1.1%), Gluconacetobacter (30.1%), Sphingomonas (19.1%) 
and Glucobacter (11.3%) and is in start contrast to the Actinobacteria dominated 
gut microbiota of the juvenile animal.
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Fillet quality characteristics
Dietary supplementation with Mixed Essential oils (MO diet) did not significantly 
affect the fillet yields (Fig. 7). The storage time but not the test diets significantly 
increased drip loss (p < 0.01) (Fig. 8). The two groups of fish had a different beha-
viour during the storage, since differences were detected only over storage time 
in relation with diet (Fig. 8): fish fed control diet showed higher water losses from 
the 1st to the 4th storage day, while fish fed MixOil diet released a greater amount of 
water at the 7th day.
The muscle colour measurements did not show significant differences between 
fish fed two diets, except in the case of values registered at caudal region (Tab. 2;). 
In this site, fillets from MixOil had higher L* and Hue and lower redness index (a*) 
values, presumably due to the influence of the diet in pigmentation and indicating a 
tendency towards a slightly more yellowish shade. In all the sites where the measu-
rements were carried out, the lightness was systematically higher in MixOil fillets. 
The storage time markedly influenced the behaviour of the colour parameters, that 
highlighted at the 4th day of storage L* values significantly (p < 0.001) higher, while 
a* and b* values, chroma and hue were lower than in the other storage days.
Concerning textural parameters (Tab. 3), no differences were found between diet 
groups except for hardness. Fillets from MixOil were softer than those from fish fed 
control diet. No differences were detected over the storage time but by the signi-
ficant interaction resulted for cohesiveness and adhesiveness showed a different 
trend during storage in relation with diet, in the case of these textural parameters 
(Fig. 9).
No significant differences, were found in lipid content, between the diet groups 
(5.32 vs 5.57%), while there were significant differences in MDA content, between 
control and MixOil (1.230 vs 0.917 mg/kg of sample) fish. The lower MDA values, 
registered in the MixOil group, could suggest that the essential oils, included in 
feed, exerted an antioxidant effect, preventing the MDA formation. However, no 
significant differences were found, over storage time, in MDA content. As shown 
in Tab. 4, the tocopherol isomers α- and γ- were detected in fillet samples and 
α-tocopherols, generally, the most widespread in marine lipids (Parazo et al., 1998; 
Ortiz et al., 2013), were the most abundant in the muscle. The amount of tocophe-
rols was similar to what was found by other authors on rainbow trout (Baron et al., 
2009; Ortiz et al., 2013; Timm-Heinrich et al., 2013).
Differences between diets, were found in α-tocopherol, and fish fed MixOil showed 
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a significant lower amount of α-tocopherols. The amount of α- and γ- tocopherol 
significantly differed in samples analysed at different storage time.
No differences were found in pH values between the groups differently fed (Table 4) 
while this parameter significantly (p < 0.01) increased from the 1st to the 4th storage 
day and decreased from the 4th to the 7th storage day. In this study, the antibacte-
rial effect attributed to the essential oils supplemented to the farmed animals diet 
(Govaris et al., 2007; Nieto et al., 2010; Álvarez et al., 2012) was not evidenced, 
since no significant differences were detected in microbial growth between the two 
groups of trouts (Tab. 5). Consequently the storage of fillets on ice, the CMT growth 
was significant for both groups of fish and yielded values of approximately 2.0-4.5 
log cfu g-1, while the variations of the Enterobacteriaceae and Pseudomonadaceae 
counts with the storage time were not significant (Tab. 5). By the microbiological 
characterization, resulted that in fish fed control diet, the type of Enterobacteria-
ceae detected at the 4th day of storage, were Pantoea spp., while in fish fed MixOil 
were Pantoea spp. and Hafnia alvei. At the 7th day of storage the type of Entero-
bacteriaceae was Pantoea spp. and the type of Pseudomonadaceae was Pseudo-




In this study, we examined the impact of a novel feed for rainbow trout, containing 
200 ppm GrowNat-MixOil Aqua (an essential oils blend), compared to standard 
commercial feed alone as control, on fish production yield over 51 weeks, fillet qua-
lity and the composition of the intestinal microbiota. There is a clear and present 
need for improved aquaculture practices and feed innovation, to meet the food 
security and sustainability demands of the 21st century. Essential oils, have a long 
history as functional ingredients, in animal production, providing useful alternatives 
to antibiotic growth promoters, now banned in the EU, improving production animal 
yield and health, and reducing infectious disease, through pathogen inhibition. 
They have also been shown to impact on meat quality, including physiochemical 
characteristics of fish fillet texture, colour and taste, often through their antioxi-
dative activities. In this study, although supplementation with essential oil mix, 
did not mediate any obvious change in fish yield (neither biomass nor calculated 
mean weight), it did improve trout fillet quality. The MixOil diet had a modest, but 
statistically significant influence, on certain qualitative parameters of fillets. FY, pH, 
WHC, colorimetric attributes in dorsal and ventral region, cohesiveness, resilience, 
gumminess and adhesiveness, lipid content and spoilage microorganisms, were 
not influenced by diet added with antioxidants. Fillets from fish fed MixOil, resulted 
in improved oxidative stability, since the MDA content was lower than the fish fed 
Control. Oxidative stability is an important physiochemical chatacteristic for fish 
storage, especially fish fillets, as it impacts significanty on organoleptic properties.  
They also had a smaller tendency to loose more water from the 4th to the 7th storage 
day at 1 °C, that can be considered a positive aspect for marketability. MixOil fillets, 
also showed higher tenderness and cohesiveness and lower adhesiveness, by 
increasing storage time, again important product characteristics for fillet quality.
The intestinal microbiota is emerging, as an important metabolic and immune 
regulator, in all animals with an organized intestine. In trout, little work has been 
done, but it is recognized that the gut microbiota, plays an important role in im-
mune function and education, contributing to resistance to pathogenic challenge 
(Balcázar et al., 2007; Araújo et al., 2015). Similarly, interactions between the animal 
diet or feed and the gut microbiota in early life, can have important implications on 
animal metabolism, especially insulin resistance (Geurden et al., 2014). A number 
of recent studies have identified the potential of using probiotic microorganisms 
in feed, to impact on trout production yields, protection from infection, antioxidant 
status and overall health (Ramos et al., 2013; Schubiger et al., 2015; Ghosh et al., 
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2016). Essential oils are recognized for their anti-microbial activities and for their 
ability to impact both on metabolic and immune health in different production ani-
mal species. Recent studies have identified essential oils as potential bioactive feed 
ingredients and alternatives to antibiotic growth promoters, in aquaculture. Certain 
essential oils, have been shown to inhibit a number of important trout pathogens in 
vitro (Menanteau-Ledouble et al., 2015). However, few studies have examined their 
impact on trout during production. In the present study, we used 454-pyrosequen-
cing of amplified V1-V3 regions of the 16S rRNA gene, present within the intestinal 
microbiota of farmed trout, over a 51 week dietary intervention, with either MO 
(mixed essential oil) supplemented feed or a control feed (standard feed without 
MO addition). The diets were iso-energetic and iso-lipidic, with fish oil replacing MO 
in the control diet. Although, no statistically significant effect of the dietary treat-
ments, on the trout intestinal microbiota, was observed, the gut microbiota chan-
ged dramatically from juvenile stage (< 500 g body weight) to mature adult stage (> 
500 g body weight). The microbiota of the juvenile fish, was characterized by relati-
vely lower species richness and evenness, and was dominated by the Actinobacte-
ria phylum, particularly the Corynebacterium genus. This bacterial genus comprised 
more than 50% of the resident intestinal microbiota in fish, up to the size of about 
350 g of weight. However, in adult fish (about 1 Kg of weight) Corynebacterium and, 
more generally, the Actinobacteria phylum, comprised a sub-dominant minority of 
the intestinal microbiota, thus confirming recent work by other authors, who moni-
tored the intestinal microbiota of rainbow trout using next generation sequencing 
(Wong et al., 2013). We showed that the adult fish  microbiota was dominated by α- 
and γ-Proteobacteria, in good agreement with previous studies (Wong et al. 2013; 
Ingerslev et al. 2014). 
In our study, the addition of essential oil to the standard rainbow trout feed, did not 
impact on the composition of the gut microbiota, or the relative abundances of the 
dominant genera either in juvenile, nor adult fish. However, we did not examine the 
impact of gross dietary change, e.g. changes in the relative proportions of protein, 
fat or carbohydrate in the animal feed or the type and quality of protein (e.g. animal/
fish meal v vegetable protein). Gross dietary composition, has recently been shown 
to impact significantly, on the microbial ecology of the adult rainbow trout gut, and 
also impact on its contribution to host immune or anti-pathogen defences (Inger-
slev et al. 2014). Similarly, rearing conditions, such as water quality and density 
of rearing, have also been shown to impact on animal health, physiology and gut 
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microbiota in farmed fish species (Giatsis et al., 2015).
In summary, although addition of essential oil (GrowNat-MixOil Aqua), at 200 ppm 
to commercial rainbow trout feed, did not impact significantly on production yield 
or on the intestinal microbiota of either juvenile or adult fish, it did have subtle ef-
fects on trout fillet physiochemical characteristics, including resistance to oxidative 
damage and reduced weight loss during storage, two important parameters, which 
determine product shelf-life and susceptibility to spoilage. High resolution 16S 
rRNA profiling, of the rainbow trout gut microbiota, identified significant differences 
in composition between, juvenile and adult fish, but further studies are required to 
delineate the relative influence of age, gross dietary composition and rearing condi-
tions, on the successional development of the gut microbiota in rainbow trout and 
how it impacts on animal health and final product quality. 
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6.5 Figure & 
Table
T3 T4 T5 T6
T4 0.0406 - - -
T5 0.0174 0.5291 - -
T6 0.9307 0.0406 0.0054 - 
T7 0.0054 0.0085 0.0043 0.0043
Table 1. Observed OTU: pairwise comparisons using Wilcoxon rank sum test. P value adjustment method: fdr.
Table 2. Colour parameters measured at three sites of fillets from Control e MixOil fish at three times of refrigerated storage. 
(1)  Residual Standard Deviation. Different superscripts in the same line, within criterion, indicate significant differences.
ns: not significant.
 
diet (d) days of storaGe (s) p value RSD(1)
Control MixOil 1 4 7 D S D x S  
Nr of fish 15 15 10 10 10     
Dorsal site  Dorsal site
L* 26.85 30.23 18.99 A 44.75B 21.87A ns <0.001 ns 5.08
a* 17.95 16.49 22.17B 7.23A 22.25B ns <0.001 ns 3.82
b* 16.37 19.13 20.95B 7.51A 24.78B ns <0.001 ns 5.16
Chroma 24.70 25.45 31.12B 10.46A 33.64B ns <0.001 ns 5.20
Hue 42.59A 48.97B 43.29 45.75 48.29 <0.05 ns ns 7.04
Ventral site Ventral site
L* 30.05 32.65 20.03A 44.7C 29.32B ns <0.001 ns 4.08
a* 20.94 18.29 27.53C 9.39A 21.93B ns <0.001 ns 3.80
b* 23.59 21.03 28.47B 8.59A 29.86B ns <0.001 ns 5.96
Chroma 31.90 28.00 39.99B 12.74A 37.11B ns <0.001 ns 6.22
Hue 46.33 47.83 45.86A 42.47A 52.90B ns <0.001 ns 5.28
Caudal site Caudal site
L* 24.35A 28.53B 18.90A 41.17B 19.25A <0.05 <0.001 ns 4.21
a* 22.38B 19.44A 25.91B 10.31A 26.51B <0.05 <0.001 ns 3.86
b* 20.21 22.92 24.47B 9.25A 30.98B ns <0.001 ns 4.88
Chroma 30.50 30.23 36.15B 13.86A 41.08C ns <0.001 ns 4.72
Hue 41.66A 47.87B 43.21A 41.9A 49.19B <0.05 <0.05 ns 6.21
217
 
diet (d) days of storaGe (s) p value RSD(1)
Control MixOil 1 4 7 D S D x S  
Nr of fish 15 15 10 10 10     
Dorsal site  Dorsal site
L* 26.85 30.23 18.99 A 44.75B 21.87A ns <0.001 ns 5.08
a* 17.95 16.49 22.17B 7.23A 22.25B ns <0.001 ns 3.82
b* 16.37 19.13 20.95B 7.51A 24.78B ns <0.001 ns 5.16
Chroma 24.70 25.45 31.12B 10.46A 33.64B ns <0.001 ns 5.20
Hue 42.59A 48.97B 43.29 45.75 48.29 <0.05 ns ns 7.04
Ventral site Ventral site
L* 30.05 32.65 20.03A 44.7C 29.32B ns <0.001 ns 4.08
a* 20.94 18.29 27.53C 9.39A 21.93B ns <0.001 ns 3.80
b* 23.59 21.03 28.47B 8.59A 29.86B ns <0.001 ns 5.96
Chroma 31.90 28.00 39.99B 12.74A 37.11B ns <0.001 ns 6.22
Hue 46.33 47.83 45.86A 42.47A 52.90B ns <0.001 ns 5.28
Caudal site Caudal site
L* 24.35A 28.53B 18.90A 41.17B 19.25A <0.05 <0.001 ns 4.21
a* 22.38B 19.44A 25.91B 10.31A 26.51B <0.05 <0.001 ns 3.86
b* 20.21 22.92 24.47B 9.25A 30.98B ns <0.001 ns 4.88
Chroma 30.50 30.23 36.15B 13.86A 41.08C ns <0.001 ns 4.72
Hue 41.66A 47.87B 43.21A 41.9A 49.19B <0.05 <0.05 ns 6.21
218
Table 3. Texture parameters of the fillets from Control e MixOil fish at three times of refrigerated storage. (1) Residual Standard 
Deviation. Different superscripts in the same line, within criterion, indicate significant differences. ns: not significant.
 
 
diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S
Nr of fish 15 15 10 10 10     
MDA 1.230B 0.917A 1.009 1.121 1.090 <0.01 ns ns 0.285
α-tocopherol (1) 22.87B 20.46A 25.29C 18.78A 20.93B <0.05 <0.001 ns 3.189
γ-tocopherol (1) 5.23 5.46 5.51B 4.77A 5.77B ns <0.001 ns 0.905
Table 4. MDA (mg/kg of muscle) and tocopherols content (mg/kg of muscle) of the fillets from Control e MixOil fish at three 
times of refrigerated storage. (1) Residual Standard Deviation. Different superscripts in the same line, within criterion, indicate 
significant differences. ns: not significant.
 
 
diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S
Nr of fish 15 15 10 10 10     
pH 6.31 6.22 6.160A 6.420B 6.230A ns <0.01 ns 0.148
CMT* 2.059 2.306 0A 2.092B 4.456C ns <0.001 ns 0.582
Enterobacteriaceae* 0.372 0.656 0 0.580 0.962 ns ns ns 1.062
Pseudomonadaceae* 0 0.325 0 0 0.488 ns ns ns 0.547
Table 5. pH and microbiological characteristics of the fillets from Control e MixOil fish at three times of refrigerated storage. 





diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S  
Nr of fish 15 15 10 10 10     
Hardness (N) 7.00B 5.98A 6.33 6.76 6.39 <0.05 ns ns 1.14
Cohesiveness 0.29 0.31 0.30 0.29 0.30 ns ns <0.05 0.03
Resilience 0.06 0.07 0.06 0.07 0.07 ns ns ns 0.01
Gumminess (N) 2.05 1.88 1.95 2.01 1.93 ns ns ns 0.43




diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S
Nr of fish 15 15 10 10 10     
MDA 1.230B 0.917A 1.009 1.121 1.090 <0.01 ns ns 0.285
α-tocopherol (1) 22.87B 20.46A 25.29C 18.78A 20.93B <0.05 <0.001 ns 3.189
γ-tocopherol (1) 5.23 5.46 5.51B 4.77A 5.77B ns <0.001 ns 0.905
 
 
diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S
Nr of fish 15 15 10 10 10     
pH 6.31 6.22 6.160A 6.420B 6.230A ns <0.01 ns 0.148
CMT* 2.059 2.306 0A 2.092B 4.456C ns <0.001 ns 0.582
Enterobacteriaceae* 0.372 0.656 0 0.580 0.962 ns ns ns 1.062
Pseudomonadaceae* 0 0.325 0 0 0.488 ns ns ns 0.547
 
 
diet (d) days oF storage (s) P Value RSD(1)
Control MixOil 1 4 7 D S D x S  
Nr of fish 15 15 10 10 10     
Hardness (N) 7.00B 5.98A 6.33 6.76 6.39 <0.05 ns ns 1.14
Cohesiveness 0.29 0.31 0.30 0.29 0.30 ns ns <0.05 0.03
Resilience 0.06 0.07 0.06 0.07 0.07 ns ns ns 0.01
Gumminess (N) 2.05 1.88 1.95 2.01 1.93 ns ns ns 0.43
Adhesiveness (Nmm) 0.77 0.94 1.10 0.74 0.72 ns ns <0.05 0.70
220
Figure 1. Comparison of alpha diversity of fish samples from T3 to T7, regardless of diet  (observed OTUs, Chao 1 and 
Shannon Index).
Figure 2. Beta diversity estimates of the rainbow trout gut microbiota. (A to C) Use of UniFrac to measure phylogenetic 
distances between the gut microbiotas of individual trout from all treatment groups. Unweighted UniFrac PCoA plotted 
against the PC1 versus PC2 axes (A), the PC1 versus PC3 axes (B) and the PC2 versus PC3 axes (C).
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Figure 3. Relative abundance of classes identified in the intestinal tract of rainbow trout. The labels under each column indi-
cate the  sample names corresponding to fish tank with C and MO diets at different time (T3, T4, T5, T6 and T7). The legend 
includes only the 12 most abundant taxa.
222 Figure 5. The fillet yield of fish fed two diets, analysed at different time during the storage.
Figure 4. Sites where colour measurements were performed and where samples for the WHC and the texture analyses were 
taken.
223Figure 6. The drip loss and the Water Holding Capacity (WHC) of fillets from fish fed two diets, analysed at different time during the storage. Different superscripts indicate significant differences.




Figure 1. Beta diversity estimates of the rainbow trout gut microbiota. (D to I) Use of UniFrac to measure phylogenetic 
distances between the gut microbiotas of individual trout from all treatment groups. (D, E and F) Weighted UniFrac PCoA 
plotted against the PC1 versus PC2 axes (D), the PC1 versus PC3 axes (E) and the PC2 versus PC3 axes (F). Along axis 1, 
accounting for 88.6 % distance show a separation between T7 (purple, n = 12) and others time (T3, T4, T5, T6, n = 21). 
Figure 2. PCoA of rainbow trout microbiota, at different time points (T3-T7), based upon Bray-Curtis dissimilarity. Along axis 
1, accounting for 84.8 % dissimilarity show a separetion between T7 (purple, n = 12) and others time (T3, T4, T5, T6, n = 21).  
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Figure 3. 16S rRNA gene sequences, at genus level, reveal similarities between intestinal microbiota of rainbow trout raised 
under different diet. Shown are relative abundances of bacterial genus in each sample. The labels under each column are 
sample names corresponding to fish tank with control and MixOil diets at different time (T3, T4, T5, T6 and T7). The legend 
includes only 12 taxa most abundant.
Fig. 4 Rarefaction curves of OTUs clustered at 97% phylotype similarity level. The samples were labeled respect to sampling 
time (T3, T4, T5, T6, T7), and treatments ( C – control and MO – MixOil).
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7. Methods for study the 
human gut microbiota
Intestinal microorganisms constitute a rich ecosystem, with about 17 families, 50 
genera and more than 1,000 species of bacteria. Their composition, which depends 
largely on environmental conditions, is also variable between individuals. A hid-
den ocean of bacterial diversity that had never been seen by cultivation, began to 
appear from microscopic observations, where the number of cells far outweighed 
colonies grown, on  nutrient media agar plates. Many of these cells were shown to 
be metabolically active, even though they could not replicate on laboratory media. 
Additional evidence for the presence of bacterial taxa that cannot be grown in the 
laboratory, came from molecular tools, especially DNA based molecular tools, as 
resumed below (Tab. 4).
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technique descriPtion adVantages disadVantages




Labour intensive, <30% 
of gut microbiota have 
been cultured to date 
qPCR
Amplification and quantification of 
16S rRNA. Reaction mixure con-
tains a compound that fluorescens 





PCR bias, unable 
to identify unknown 
species
DGGE/TGGE
Gel separation of 16S rRNA ampli-
cons using denaturant/temperature
Fast, semi-quantita-
tive, bands can be 





Fluorescently labelled primers 
are amplified and then restriction 
enzymes are used to digest the 
16S rRNA amplicon. Digested 









nucleotide probes hybridize 
complementary target 16S rRNA 
sequences. When hybridization 
occurs, fluorescence can be enu-
merated using flow cytometry
Phylogenetic identifi-
cation, semi-quanti-
tative, no PCR bias
Dependent on probe 




otide probes hybridize comple-
mentary nucleotide sequences. 




Cross hybridization, PCR 
bias, species present in 





Cloning of full-length 16S rRNA 




PCR bias, laborious, 
expensive, cloning bias 
Direct sequenc-
ing of 16S rRNA 
amplicons Massive parallel sequencing of partial 16S rRNA amplicons
Phylogenetic identi-
fication, quantitative, 
fast, identification of 
unknown bacteria 









Expensive, analysis of 
data is computationally 
intense
Tab. 4 Culture independent molecular techniques used to characterize the gut microbiota 
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Most molecular methods use the phylogenetic information present in the 16S rRNA 
gene, universally present across the kingdoms Bacteria and Archaea, which inclu-
des DNA regions conserved across different phylogenetic levels and hyper-variable 
DNA sequences regions, allowing species level classification. Typical molecular 
methods used to identify microorganisms present in an environmental sample or 
to enumerate microorganisms in a culture independent manner, are very briefly 
discussed below:
Fluorescent in situ hybridization (FISH)
Used for visualising phylogenetically known microorganisms in various environ-
mental samples such as stool, clinical specimens and animal tissues. One of the 
advantages of this method is that it allows the analysis of intact microbial cells 
under the microscope or with the aid of flow cytometry. Another main advantage 
of FISH is that it is a quantitative method allowing accurate enumeration of mi-
crobial cells directly in samples. Based on the chosen probe, this technique can 
be  used to detect and enumerate microorganisms at different phylogenetic levels 
down to species level in some cases. FISH allows the study of differential microbial 
abundance, it is rapid,  quantitative and accurate but unknown species can not be 
enumerated or identified and in the case of 16S rRNA probes it can not be used to 
enumerate bacteria to the strain level (Amann et al., 1995). Other disadvantages of 
FISH are that hybridization efficacy depends on the permeability of target cells, the 
specificity of probes, the activity and abundance of ribosomes and 16S rRNA within 
the target cell (Swann et al., 2011) and the manual scoring and signal integration 
is difficult, time consuming and prone to operator error. Combining FISH with flow 
cytometry can overcome some of these problems. 
Flow cytometry (FCM) 
Represents a powerful tool to analyze intestinal microbiota especially when combi-
ned with FISH (Rigottier-Gois et al., 2003). It was first developed for counting and 
studying mammalian cells (Festin et al., 1987), but now it is commonly used to stu-
dy the intestinal microbiota (Collado et al., 2008). The principle is that the cells are 
streamed through a capillary, during which a laser beam is used to detect the cells. 
The advantages of this technique are that it allows for the analysis of microbiota 
quantitatively and qualitatively, analyzing different parameters, such as the cell size, 
the metabolic state, and the density; it is time efficient and can proces smore than 
7.1 Culture independent molecular 
biology techniques
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10 000 cells/s, it does not require DNA extraction or amplification and it has high 
accuracy. The disadvantages of this technique are that it relies on liquid samples, 
since the size of bacteria cells is smaller than the mammalians this may affect the 
accuracy of the results, and so requires a complex data analysis (Bunthof, et al., 
2002).
Quantitative polymerase chain reaction (q-PCR) 
Based on the amplification of defined DNA sequences, quantitative PCR (qPCR) 
targeting specific groups of gut bacteria uses primers targeting phylogenetically in-
formative regions of the 16S rRNA gene are commonly employed. The advantages 
of this technique are that it has a low detection limit (lower to 102 cell/g of faeces) 
and it allows large scale studies thanks to robotic manipulation of 96 well plates 
(Swann et al., 2011). However, the accuracy of the method is dependent upon 
the efficacy/reproducibility of DNA extraction and the presence/absence of  PCR 
inhibitory compounds and PCR clean-up (Rastogi and Sani, 2011). It is also difficult 
to relate intensity signals to the real number of bacteria present in a given sample, 
since different bacteria possess different copy numbers of the target 16S rRNA 
gene. Combined, these limitations make qPCR generally less accurate than FISH 
for enumeration of bacterial taxonomic groups in intestinal/faecal samples.
Phylogenetic microarray
The comprehensive analysis of the diversity and dynamics of the gut microbiota 
composition is possible by microarrays targeting ribosomal RNA gene sequences 
(Kovatcheva-Datchary et al., 2009). The advantage of the phylogenetic microarray 
analysis is that constitutes high resolution of profiling of complex intestinal ecosy-
stems with tens of thousands of individual phylogenetic probes targeted different 
species and groups of bacteria. This is a considerable advantage over q-PCR or 
FISH, which are labour intensive. The Human Gut Chip (HuGChip)  is an example 
microarray designed and developed to analyze and characterise the human gut 
microbiota (Rajilić-Stojanović et al., 2009). Explorative probe design strategies 
coupled to the microarrays are well suited to survey complete microbial commu-
nities, including microorganisms with uncharacterized sequences (Dugat-Bony et 
al., 2012). The usefulness of standard microarray formats is often limited by hard to 
interpret signal patterns caused by an accumulated number of false-positive signals 
(Peplies et al., 2003).
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Denaturing/temperature gradient gel electrophoresis 
(DGGE) 
D/TGGE is a microbial fingerprinting technique that separates amplicons - of rou-
ghly the same size based on double stranded sequence melting properties across a 
gradient of denaturing chemicals (e.g. urea) or temperature. The main advantage is 
that it allows the seperation and visualization of DNA amplicons of different sequen-
ce but of the same length, allowing seperation of DNA species from a single PCR 
from mixtures of different microorganisms. It provides a quick way of looking at bio-
diversity in a microbial sample and does not require bacterial culture. Furthermore it 
does not require any specific sequence information before probe design, as primers 
targeting phylogenetically conserved regions of the 16S rRNA gene can be used 
to amplify even uncultured or un-classified microorganisms within phylogenetically 
related groupings. The disadvantages are that this is a qualitative assessment of 
biodiversity, technically challanging, often prone to low reproducibility and one must 
sequence DNA amplicons or bands seperated by D/TGGE to obtain any phyloge-
netic information, which for complex microbial consortia can be labour intensive. 
Another problem is the depth of coverage, as only a limited number of different 
amplicons can be seperated on any one gel, limiting analysis to the top few percent 
of microorganisms present within a given sample (Douterelo et al., 2014;.Rettedal et 
al., 2010). 
Next Generation Sequencing (NGS) 
The increasing use of NGS to analyze complex microbial communities, is due to 
lower costs of sequencing and to an ever greater development of bioinformatic 
tools essential for their interpretation and provide a better understanding than tra-
ditional culture based methods. Several technical variables can significantly impact 
results, such as DNA extraction protocol, amplification and purification, along with 
sequencing depth, which can limit the ability to accurately quantify proportions of 
microorganisms present in a given sample or to compare results between different 
laboratories. Bacterial 16S ribosomal RNA (rRNA) genes contain nine “hyper-va-
riable regions” (V1 – V9), that allows the discrimination and then identification/
classification of specific microorganisms in ecological samples (eg. organic ma-
terial, soil). The length of the 16S rRNA fragment used to assign taxonomic iden-
tity increases the confidence of phylogenetic classification. However, none of the 
currently available technologies (e.g. Roche 454 GS-FLX, Illumina MiSeq, HiSeq 
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and Ion PGM), offer full-length (about 1600 bp) gene sequencing at sufficient depth 
to allow for multiplexing large numbers of samples on the same run to species level 
identification.
Bioinformatics Methods and Biological Interpretation 
for NGS Data
High throughput sequencing technologies have made it essential the development 
of bioinformatic tools capable of analyzing and processing efficiently huge data 
sets and enable biological interpretation of the results obtained. NGS pipelines 
were built to performs in a single workflow, with little to no impact on standard 
computing performance. Here are reported only two of these, QIIME, which is cur-
rently the most widespread and MICCA that was developed in Fondazione Edmund 
Mach (S. Michele all’Adige, Italy).
QIIME
Quantitative Insights Into Microbial Ecology (QIIME) is an open-source bioinfor-
matics pipeline for performing microbiome analysis from raw DNA sequencing 
data. The software package is designed for microbial community analysis based 
on DNA sequence data, and provides a single analysis framework for analysis of 
raw sequence data through publication-quality statistical analyses and interactive 
visualizations. QIIME was originally developed to analysis of Roche 454 amplicon 
sequence data. In the latest versions workflows have been added to analyze data 
from different sequencing platforms, such as Illumina, and different types of data, 
such as shotgun data. The package contains many tools that enable the user to 
analyse and compare microbial communities, such as OTU picking, taxonomic 
assignment, and construction of phylogenetic trees from representative sequences 
of OTUs, and through downstream statistical analysis, allows to display and pro-
duce publication-quality graphics. It provides three high-level protocols for OTU 
picking. Described as de novo, closed-reference, and open-reference OTU picking 
(Navas-Molina et al., 2013).
MICCA
Microbial community analysis (MICCA), is a open-source pipeline that efficient-
ly combines quality filtering, clustering of Operational Taxonomic Units (OTUs), 
taxonomy assignment and phylogenetic tree inference, providing accurate results 
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and reaching a good compromise among modularity and usability (Albanese et al., 
2015). It can be used with any kind of reads obtained by different sequences as Ro-
che 454 or Illumina. MICCA is composed by several executable Python scripts and 
wraps lots of external applications. Main features are: supports gapped alignment 
and IUPAC codes for primer trimming; quality filtering with sliding windows; denovo 
and reference-based clustering (Greengenes, Silva and UNITE QIIME-formatted 
databases are supported); denovo chimera filtering; taxonomy assignment with 
RDP classifier and BLAST+ (Greengenes, Silva and UNITE QIIME-formatted data-
bases are supported); denovo and template multiple sequence alignment (MSA); 
phylogenetic tree reconstruction. Despite this new platform slightly underestimates 
the number OTU compared to QIIME, it is able to precisely reconstruct OTU com-
position of the samples analyzed and covers a similar variety of biological diversity. 
Moreover it showsa greater consistency in the results obtained, compared to QIIME 
(Albanese et al., 2015).
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The molecular foundations of the gut microbial–mammalian cross talk is raising 
interest in the research world at both physiological and biochemical levels (Martin 
et al., 2012). Metabolites are the byproducts of cellular metabolism, (Villas-Bas 
et al., 2007), whose formation critically depends on enzymes responsible for the 
pathways in which they are involved. As intermediates of biochemical reactions, 
metabolites have an important role in connecting many different pathways in and 
across organisms. The metabolome is the complete set of metabolites associated 
with an organism, which is divided into endo- and exo metabolomics, covering 
intra- and extra-cellular metabolites, respectively; changes in the metabolome typi-
cally reflect gene and protein expression (Hollywood et al., 2006). An unspecified 
analysis of intracellular metabolites is called “metabolic fingerprinting” (Liang et al., 
2015). The metabolomics is a research field which aims at comprehensive analysis 
of a metabolome. It provides a key understanding of cell and organism communi-
cation mechanisms, which play a crucial role in the symbiotic relationships between 
gastrointestinal tract (GIT) microbiota and the host (Putignani et al., 2014). Recently, 
some studies have highlighted the potential to combine culture independent micro-
biological techniques with biofluid metabolite profiling, linking bacteria within the 
gut microbiota with metabolic activities within the host animal at the systems level, 
through the creation of data matrices (Swann et al., 2011).  Below a summary table 
of the main analytical techniques used (Tab. 5).
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method descriPtion adVantages disadVantages
NMR spectrometry
1H - NMR
Analyses high energy and 
phospholipid metabolim  
to quantify amino acids, 
carbohydrates, fatty acids, 
lipids and phospholipids. 
Gives detailed structural in-
formation, particularly using 
2-D-NMR of isolated me-
tabolites, provides technical 
insights for characterizing 





request, high precision, 
high temporal reso-
lution, fast, sensitivity 
can be improved by 
magic angle spinning, 
low per-experiment 
cost, minimal sample 
preparation required, 
average analytical 
time of ten minutes, 
non-destructive, quan-
titative
Less sensitive than 
mass spectrome-
try,  small chemical 
bias, low sensitivity, 
convoluted spectra, 
more than one peak 
per component, librar-
ies of limited use to 
complex matrix, time - 
from few min to h de-
pends on the strength 
of the magnet
31P - NMR
Quantifies high energy 
phosphates (e.g. ATP, 
phosphocreatine), phos-
pholipid precursors and 
sugar phosphates
13C - NMR
Quantifies metabolic fluxes 
of 13C-labelled precursors 
(e.g. 13C-labelled glucose 
fluxes through glycolysis), 
TCA cycle, pentose-phos-
phate cycle and de novo 
fatty acid synthesis
HR - MAS - 1H - NMR In vitro tissue applications
Mass spectrometry (MS)
LC - MS
Full spectrum analysis 
of solutions with multiple 
metabolites
High sensitivity and 
specificity, full spec-
trum analysis, current 





to sample, not fully  
quantitative without 
appropriate standards
GC - MS 
Tab. 5 Common analytical techniques used in metabolomics 
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GC-MS
Mass spectrometry (MS) has played an important role in the development of 
methods for profiling of metabolites due to its selectivity and sensitivity. Gas chro-
matography coupled with mass spectrometry (GC-MS) is commonly used for total 
and targeted profiling and despite the high sensitivity, requires a more comprehen-
sive sample preparation. In the study of intestinal microbiota, GC-MS Solid-Phase 
Microextraction (SPME), has been used to compare human faecal profiles during 
aging (Mayor A, 2014), to identify volatile markers of GI diseases (Probert et al., 
2009), to evaluate the in vitro effect of prebiotics and probiotics (Vitali et al., 2012) 
or effects, after drugs administration, on the gut microbiota (Maccaferri et al., 2010). 
Its wide use is due to its rapid qualitative and quantitative analysis of metabolites, 
especially short and volatile molecules, present in biological samples and with the 
possibility to further improving the separation peak capacity through the addition of 
a second and orthogonal dimension of separation (Metz et al., 2007).
LC-MS
Liquid chromatography-mass spectrometry is used for both targeted metabolomi-
cs (allowing accurate quantitation of up to a few hundred specified metabolites) or 
untargeted metabolomics or metabolite profiling (which has the potential to quali-
tatively profile thousands of metabolites in a given sample).  The untargeted meta-
bolic profiling allows the detection and quantitation of candidate markers that can 
be used to describe an altered physiological state, growth condition, or intake of 
particular foods for example (Metz et al., 2007). High-performance liquid chromato-
graphy (HPLC) is the most widely used analytical separation technique for the qua-
litative and quantitative determination of compounds in solution. Although with less 
separation efficiency than capillary gas chromatography, the dominance of HPLC 
as a premier analytical technique is no accident. The applicability to diverse analyte 
types, from small organic molecules and ions to large biomolecules and polymers 
is one of the most prominent advantage. The coupling of HPLC to MS gave it an 
excellent separation capability with high sensitivity and specificity, as well as preci-
sion and robustness. Orbitrap mass spectrometer., which bring the specificity and 
confidence of high-resolution, accurate-mass (HRAM) data with liquid chromato-
graphy (LC), has begun to be widely used to investigate putative biomarkers of die-
tary intake in human studies (Ulaszewska et al., 2016). While Hydrophilic interaction 
chromatography (HILIC) provides an alternative approach to effectively separate 
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highly polar and ionic compounds and therefore suitable for samples that contain 
predominantly polar metabolites such as urine (Lei et al., 2011). Mass spectrometry 
is becoming a universal detection method for ionic or ionizable compounds with 
high speed, sensitivity, and selectivity. The developments of triple-quadrupole MS-
MS, high-resolution MS (e.g. time-of-flight (TOF) and orbital trap), and hybrid MS 
(e.g. Q-TOF or ion trap–orbital trap) in combination with UHPLC and 2D-LC allowed 
the development and application for bioanalytical assays, multiresidue analysis of 
complex samples, and life science research (Fekete et al., 2014; Dillen et al., 2012).
NMR
Nuclear magnetic resonance (NMR) spectroscopy is a non-destructive analytical 
tool that can be used to study biological fluids without intensive sample proces-
sing. Despite this, the low resolution and sensitivity which enables the annotation 
and quantification of only a limited number of low molecular weight molecules, 
in addition to being an expensive technique, limits its use (Jansson et al., 2009). 
1H-NMR is especially attractive since protons, with high isotopic natural abundan-
ce (99.985%), are ubiquitous presence in organic compounds and its sensitivity 
is the highest among all the NMR observable nuclei (Hu et al., 2008). Recently, 
NMR-based metabolic profiling of biological fluids has emerged as a valuable tool 
to investigate the profiling of at least part of the mammalian metabonome and can 
monitor how it changes under different perturbations, such as nutritional studies 
(Savorani et al., 2013), human disease diagnosis (Emwas et al., 2013) and detection 
of altered metabolic activity of the gut microbiota (Le Gall et al., 2011). The physi-
cal connection of HPLC (or LC) and MS (LC–MS) to NMR (LC–NMR) increases the 
capability of solving structural problems of mixtures of unknown compounds (Silva 
Elipe, 2003).
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7.3 In vitro / in vivo models 
of the gut microbiota
In vitro models
Since the healthy intestine is not easily accessible for most research purposes, 
attempts have been undertaken to simulate the intestinal microbial ecosystem in vi-
tro. Thus far, several authors have described successfully a continuous multi-stage 
culture system for simulating the microbial community in the large intestine (Miller 
and Wolin 1981; Veilleux and Rowland 1981; Gibson et al. 1988; Macfarlane et al. 
1989). Currently available models of the large intestine range from simple batch 
fermentation systems to more or less sophisticated, well-controlled, single- and 
multi-vessel continuous bioreactor systems. 
Batch cultures have the advantage of providing results within a relatively short time 
period of about 24–48 h (Gibson and Fuller 2000), but do not reflect the near stable 
in vivo conditions, even for such short incubation times (Rumney and Rowland 
1992).  
Continuous culture systems are, therefore, preferred, formed either of one or of 
more vessels, depending on complexity and/or purpose. A single stage chemostat 
simulating the human colon, was developed more then 20 years ago, mimicking the 
nutrient availability and environmental conditions extrapolated from our knowledge 
of the in vivo conditions (Allison et al. 1989). Several dynamic fermentation models 
have been developed in recent years, with the purpose to establish in vitro a relati-
vely stable microbial ecosystem under physiologically relevant colon conditions. 
Continuous or semi-continuous flow systems, allow to replicate the ecological con-
ditions of the human gut, thanks to studies performed by Macfarlane in the 90's. 
Continuous growth media flow, elimination of waste materials (mimicking the fecal 
expulsion), allows the maintenance of a high-like large bowel, microbial biodiversity. 
These in vitro model have been used to study a huge (pato)physiolical conditions, 
as dietary interventions, DNA transfer between microbial members of intestinal tract 
and pre-probiotic activities (Steer et al., 2000).
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In vivo models
In human populations many factors are difficult or impossible to control, such as 
genotype variation, large interindividual variation of the gut bacterial species, and 
current and past environmental exposures. Animal models provide the ability to 
control most of these parameters. The dominant bacterial phyla of the gut micro-
biome found across a wide range of mammals are conserved. Despite this many 
species of bacteria found in mice are not present in humans (Ley et al., 2005), 
limiting the ability to directly extrapolate human data. One solution to this problem 
is to colonize a germ-free animal with human faeces. The species found in each 
animal after transplantation resemble the donor human microbiota, but the relative 
abundance of each taxonomic group IS altered to more closely resemble the typical 
microbiota of the recipient animal (Rawls et al., 2006). “Humanized animals” have 
been established by several groups in an attempt to study the human microbiome 
under controlled conditions (Gootenberg and Turnbaugh, 2011). Another animal 
model is zebrafish, which provides advantages  in the study of the human gut mi-
crobiome, such as transparent body, allowing real-time visualization of fluorescently 
labeled microorganisms throughout the gut (Rawls et al., 2007), the possibility to 
perform chemical screens and genetic tests (Patton and Zon, 2001) for investiga-
ting host genes or signaling pathways that are regulated by members of the gut 
microbiota. Pigs have been proposed as model for studying the human gut micro-
biome since their diet is omnivorous and the digestive tract and physiological traits 
are similar to humans and with the possibility to humanize them as well (Pang et 
al., 2007). To discover the molecular underpinnings of host–commensal interactions 
ì insect models such as drosophila have sometimes been employed. Their rapid 
growth and high reproductive capacity allow to be cultivated on a large scale and 
are particularly suited to studies focused on ageing. Furthermore the microbiota 
combined with the vast collections of mutant flies can produce a model of symbio-
sis with enormous potential to reveal new insights into host–symbiont interactions 
at single gene the level (Douglas et al. 2011; Kostic et al., 2013). 
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There are many potential signaling mechanisms by which gut microbiota could 
influence human (patho)physiology, including through microbial metabolism, with 
release of several bioactive-compounds (e.g. SCFA, 3-indoxyl sulphate, TMA, 
serotonin). The study shown here has sought to shed light through a multidiscipli-
nary approach, on the interconnected dynamics governing the fermentative activity 
of the intestinal microbiota in the distal colon and to identify the metabolic profiles 
generated in order to understand the possible impact on the body human.
Inulin modulates microbial metabolism of digested red meat
In support of early in vitro studies from the 1980’s, the prebiotic inulin improved 
protein metabolism by the faecal microbiota under simulated distal colon environ-
mental conditions, by increasing the consumption of amino acids, such as tryp-
tophan and phenylalanine, but at the same time reducing  the production of poten-
tially toxic metabolites such as TMA, 5-aminopentanoic acid (cadaverine pathway) 
and phenol. Shifting relative abundance in favour of Butyricicoccus, Butyricimonas, 
Coprococcus and Dorea in detriment of other genera, such as Blautia and Lachno-
spiraceae incertae sedis and Clostridium cluster XVIII, have been observed. Howe-
ver, there was considerable inter-individual variation in response to either digested 
meat or inulin between faecal donors, limiting statistical strength of observations. 
Moreover, inulin did not appear to increase the relative abundance of bifidobacte-
ria, suggesting a greater effect of pH than substrate availability in determining the 
relative abundance of different bacteria within the distal colon. Several factors are 
involved in the onset of a predominant macronutrient-utilizing organisms, such 
as compounds related to partial degradation products, fermentation products 
and growth or inhibitory factors, which arise not only by the presence of speci-
fic compounds, but also competitive or synergistic interactions between two or 
more bacterial populations. Many microbial communities show significant division 
in metabolic work. End products of some organisms are metabolites for others; 
working together they turn raw resources into fully metabolized nutrients. The en-
teric microbiota play also a major role (largely through enzymatic deconjugation) in 
re-absorbing many compounds excreted in bile and eliminate them via the urine or 
recycle back into the bile. Such analysis of diet microbial metabolism would allow 
researchers to piece together a metabolic network that goes beyond genus boun-
daries. Therefore, combined analysis of the metagenomic and metabolome enable 
estimates of how metabolites are transferred and transformed through a commu-
nity. Fermentable carbohydrates (such as Inulin) may decrease the concentration 
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of putrefactive compounds that are generated during proteolytic fermentation by 
providing the microbiota an additional source of energy. Although in vitro batch cul-
ture provide a technically simple way of studying complex biological systems, they 
give us the opportunity to correlate ecological niches and metabolic activities with 
particular phylogenetic groups among the microbiota of the human bowel.
Measuring the impact of the prebiotic inulin on gut microbiota tryptophan 
metabolism 
The role of tryptophan metabolites in intestinal and systemic (patho)physiology is 
still poorly understood. In the TRP fermentation with inulin supplementation, the 
amount of BCAA’s such as valine, leucine, and isoleucine, were reduced compared 
to TRP alone, while there was an increase of lactate, acetate and ethanol. BCAA 
may have been consumed by a more metabolically active microbiota in the presen-
ce of the fermentable substrate inulin or alternatively, less BCFA may have been 
produced due to an energetic preference for carbohydrate fermentation over amino 
acid fermentation. Both TRP and TRP with inulin added fermentations, modulated 
the microbial diversity within the fermentations over time and, at the genus level 
Alistipes, Barnesiella, Clostridium IV, Desulfovibrio, Odoribacter, Oscillibacter, 
Phascolarctobacterium had significantly lower relative abundance (p < 0.0011) in 
the presence of inulin, compared to TRP alone. This in vitro study confirms that the 
presence of a fermentable carbohydrate reduces microbial metabolism of TRP into 
indole metabolites redirecting it towards microbial biomass formation. Diet:microbe 
interactions in the distal colon may therefore play an important role in the bioavaila-
bility of TRP and its indole derivatives possibly impacting on TRP pathways linked 
to host health in the gut, periphery and along the gut:brain axis. TRP bioavalability 
and conversion into indole metabolites in particular appears to have important 
consequences for human health, impacting on the pathophysiology of immune and 
metabolic diseases, including obesity and on brain function. Inulin had a dramatic 
impact not only on the production of indole TRP catabolites, but also apparently on 
the bioavailability of TRP itself. Both were reduced in the presence of the fermen-
table carbohydrate, indicating that diet:microbiota interactions might play an impor-
tant role in TRP availability and associated biological activities in vivo. Similarly, this 
study also supports the recent findings that pH as well as the type and quantity of 
growth substrate can have a dramatic impact on both the composition and meta-
bolic activity or growth of bacteria and in this case illustrating that the bifidogenic 
effect of inulin may not be as obvious in the distal colon as it is in the proximal or 
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transverse colon.
Measuring gut microbiota metabolism of neuroactive compounds
Metabolites produced by the faecal microbiota under simulated distal colon con-
ditions were measured for selected neuroactive compound (dopamine, tyrosine, 
tryptophan, phenylalanine, glutamate and methionine). Considerable inter-individual 
variation in response to different fermentation substrates was observed, with the fa-
ecal microbiota of different donors showing different metabolite production profiles. 
This may account for the lack of statistical significance of changes within microbial 
relative abundance and alpha – or beta – diversity within and amongst the fermen-
ted substrates. However, some differences were noted in terms of absolute abun-
dances using FISH. Indeed, for the aromatic amino acids and dopamine, changes 
in metabolite profiles appeared to cluster into two distinct groups suggesting the 
existence of metabotypes or signature metabolic responses dependent on micro-
biome structure. Intriguingly, comparative analysis of 16S rRNA community structu-
res between these two “metabotypes” revealed statistically significant differences 
between important groups of gut bacteria at the family level., including organisms 
already suspected of forming alternative community structures within the human 
microbiome, specifically the Prevotellaceae and Bacteroidaceae. Nutrition has an 
important impact on the gut:brain axis. Some of neurotransmitters, essential mo-
lecules for the brain functioning, are derived from essential amino acids, which in 
turn are freed by breakdown of dietary protein. Gut bacteria modulate various host 
metabolic reactions and have the capacity, through digestion and fermentation of 
food, to generate many neurotransmitters and neuromodulators. These metabolites 
released through gut lumen may induce epithelial cells and modulate neural signa-
ling acting directly on primary afferent axons or indirectly within the enteric nervous 
system. Physiologic factors that influence brain pools of these amino acids, notably 
diet, influence their rates of conversion to neurotransmitter products with functional 
consequences. Using NMR based metabolomics with multivariate data analysis, 
this study aimed to confirm the importance amino acid fermentation in the distal 
colon to production of neuroactive compounds and also the highlight the utility 
of using metabolomics in examining questions related colon fermentation by gut 
microbiota and metabolome level changes. Although this is only an in vitro study, 
with its natural limitations, it offered food for thought on how gut microbiota could 
be involved in the metabolism of these compounds, and how it could affects on 
human physiology. We believe this to be the first step for screening small molecules 
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that can provide effective modulation of metabolic pathways and maybe neuronal 
activities. Through future metatranscriptomics analysis we could identify microbial 
expression profiles related with a specific catabolism and further understand amino 
acid breakdown by the gut microbiota.
Growth, gut microbiota and fillet quality of rainbow trout 
In this experiment we evaluated the effects of diet on the gut microbiota of farmed 
trout over the course of production and in response to a dietary intervention with 
essential oils. During production, animal diet changes according to life stage, with 
a reduction of 10% of protein from the young (<3 months) to adult fish, with a shift 
from fish protein flour to soybean and vital wheat gluten vegetal proteins, while 
carbohydrates increased by 7 % and fats by 3%. Previous metagenome-based 
fingerprinting and high-throughput sequencing on bacterial 16S rRNA genes indi-
cated that fish gut was dominated by Actinobacteria, Proteobacteria, Fusobacteria, 
Bacteroidetes and Firmicutes. Strong impact of diet on the gut microbiota of an 
important human food production species, suggests that gut microbial ecology 
may be an important factor to consider when designing new and improved fish 
production systems or diets. Importantly, this study showed clear differences in the 
gut microbiota composition and diversity between juvenile trout and adult trout, 
with the later having signficiantly higher alpha- and beta-diversity and a microbiota 
dominated by Proteobacteria, while the microbiota of young animals was domina-
ted by Actinobacteria, mainly Corynebacterium. The high inter-individual variability  
reduces our ability to evaluate the effect of mixoil on the microbiota and develop 
microbial species to be used as biomarkers (in every time point-condition we have 
an outlier). This high variability suggests to preselect the animals for further analy-
ses based on a proven  zootechnical effect of mixoil, on growth performance para-
meters or on markers of inflammation and intestinal mucosa integrity. The juvenile 
gut microbiota observed was lower in species diversity with respect to the other 
published studies on the effects of plant diet, yet biodiversity increases in some 
animals at later timepoints (T6). We can speculate that further investigation should 
focus on mature animals exposed to a more complex diet. Finally our results show 
the potential of this animal model to study the host–microbiota interactions, using a 
metagenomics approach to evaluate the interaction of environment, genetics, and 
microbiota in health and disease.
Only certain nutrients are absorbed by the gut, which is a selective system able 
through this control, to exchange chemical signals and information with the human 
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body. The gut acts as a signal transducer, a neuroendocrine sensor, and an immu-
nological recognition and presentation system. The gut microbiota play a vital role 
in converting the foods we eat into nutrients and also bioactive compounds with 
activities both within the gut and systemically. By leveraging the knowledge gained 
through these studies, we may understand the interactions which bind diet and 
microbe and improve human health thanks to improved or in-formed dietary advice 
and/or new functional foods. Furthermore by levering the gut:brain axis through 
dietary modulation of the gut microbiota it may be possible to increase mental heal-
th, regulate brain development and improve cognitive function. Future studies need 
to focus on discovery and understanding at the functional level of specific microbial 
pathways and products that contribute to our physiology and that may contribute 
to disease processes. The exploration of gut microbiota contributions to human 
host physiology and diseases represents an incredibly exciting and potentially ferti-
le territory in biomedical research. These findings have important consequences for 
our understanding of nutritional specialisation amongst human colonic bacteria and 
for predicting how dietary composition, including the addition of prebiotics, can be 
used to manipulate microbiota composition and metabolic output. In vivo feeding 
experiments cannot readily distinguish effects mediated via the gut environment, for 
example, changes in gut transit or pH, from the direct selective effects of the sub-
strate. Future in vivo nutritional studies will provide more evidences upon effects of 
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